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Abstract 
Systematic sampling and analysis of wastewater is an increasingly used tool to 
complement more traditional techniques for assessing consumption of licit and illicit 
chemical substances in the population. The use of wastewater sampling and 
analysis contributes to a broader field that is referred to as wastewater-based 
epidemiology (WBE). Both spatial and temporal analysis can be conducted 
quantitatively, quickly and cost effectively using the WBE approach.  
In brief, per capita exposure to a given chemical within a population is estimated by 
measuring the concentration of that chemical or a metabolite in a representative 
wastewater sample multiplied by the volume of wastewater represented by the 
sample, divided by the population size from which the sample originates and 
correcting by factors such as the excretion factor of the metabolite or chemical, 
molecular weight change and potential stability of the chemical within the sewer. It 
has previously been determined that the population size is the largest uncertainty for 
WBE estimates.  
The aim of this thesis it to therefore identify useful markers that allow population 
estimation for a given wastewater sample and apply this technique including to 
assess per capita exposure/release of a group of chemicals that have not been 
examined in previous WBE studies.  
The approach for this thesis was to systematically collect samples on a day when the 
population is well defined. For this we collected samples on the 2011 Census Day in 
Australia from 10 wastewater catchments ranging in size from approximately 1,500 
to 500,000 people. By providing catchment maps to the Australian Bureau of 
Statistics, the accurate population size for each catchment was determined.  
The most obvious choice of a potentially useful population markers are endogenous 
chemicals such as creatinine. Therefore, in Chapter 2, creatinine was assessed as a 
population marker. It was found that there was no correlation between the mass load 
of creatinine in wastewater and the population. Using laboratory-scale sewer 
reactors with conditions representative of both gravity sewers and rising mains, it 
was found that creatinine, while stable in collected samples, is unstable under sewer 
conditions. We therefore conclude that creatinine is not suitable for predicting 
differences in population size particularly when different sewer systems are 
compared.  
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In Chapter 3, a method was developed to quantify 96 chemicals in wastewater 
influent and applied to the census wastewater samples to identify potential 
population size markers. Thirteen chemicals including acesulfame, caffeine, and 
pharmaceuticals and personal care products were detected in all samples and found 
to have a good correlation (R2 > 0.8) between mass load and population size. A 
Bayesian inference model was developed which incorporated these potential 
population size markers to provide a population size estimate. The model was 
validated using a leave-one-out approach for all sites and comparing the population 
size estimate from the model with the accurate census population data. It was shown 
that for small catchments, the uncertainty of the estimate as measured by the width 
of the posterior was 1.1 to 2.4 times narrower than the width of the posterior using 
only the WWTP operator population size estimates. For large WWTP catchments, 
the width of the posterior using the population size model was between 5 and 40 
times narrower than the WWTP operator population size estimates. Additionally, it 
was found that the posterior width of the model was improved with addition of more 
chemicals in the model.  
In Chapter 4, using laboratory-scale sewer reactors, the impact of in-sewer 
degradation of the population markers identified in Chapter 3 was evaluated. It was 
found that five of the fourteen markers were stable under all conditions over the 12 
hour study period. Those which were unstable ranged from little degradation over the 
study period and only under certain conditions to rapid degradation regardless of 
sewer conditions. Additionally we assessed whether or not the degradation of these 
chemicals impacted the population size estimation model by excluding the unstable 
compounds from the model. We found that the uncertainty of the estimate did not 
decrease through exclusion of the unstable chemicals.  
In Chapter 5 we assessed whether WBE can be expanded to chemicals other than 
those previously assessed (i.e. illicit drugs, alcohol and tobacco). For this a method 
was developed to analyse organophosphorous flame retardants (PFRs) in 
wastewater influent. Using the samples collected during census, it was estimated 
that 2.1 mg person-1 day-1 enter Australian wastewater. In addition we found a good 
correlation (r2 ≥ 0.87) between the population size and mass load for each of the four 
main contributors (TBOEP, TCIPP, TDCIPP and TCEP).   
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Overall, this thesis demonstrates that the uncertainty of WBE estimates can be 
improved through identifying population markers, and developing and calibrating a 
population model. Additionally, we found that WBE is not limited to assessing 
exposure/consumption of the chemicals previously assessed (i.e. alcohol, illicit drugs 
and tobacco) and can be expanded to other chemical groups.  
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_________________________________________________________ 
Chapter 1: Introduction and aims 
 
_________________________________________________________ 
 
1.1. Wastewater-based epidemiology: an emerging tool for assessing 
chemicals used by large populations of people 
Finding links between environmental stressors and human health is typically a 
complex undertaking. Identifying such links in a timely manner is crucial if the goal is 
to prevent or reduce exposure before widespread health effects occur. Measuring 
exposure to environmental stressors is often costly and is usually limited to small 
cohort studies which may not be representative of the larger community. However, a 
relatively new approach for assessing exposure at the community level by 
systematic sampling and quantitatively analysing markers of chemical exposure 
within raw wastewater has gained in popularity in the last decade. This field has 
been termed wastewater analysis (WWA) or wastewater-based epidemiology (WBE).  
Wastewater-based epidemiology is based upon the assumption that traces of the 
chemicals we consume or are exposed to are excreted either unchanged or as a 
mixture of unchanged and metabolites in both our urine and/or faeces and as a 
result end up in wastewater (Castiglioni et al. 2014). As wastewater networks are 
municipal, the wastewater itself contains chemical residues which are representative 
of whole communities. Therefore analysis of wastewater is representative of whole 
communities and can be used as a non-invasive tool to monitor chemical 
consumption and exposure. This non-invasive approach has great potential 
particularly for assessing consumption of chemicals which typically have clandestine 
usage such as illicit drugs (Daughton 2001). Additionally, as samples are 
representative of whole communities, it can be used to assess chemical 
consumption differences between cities (van Nuijs et al. 2009b) and even countries 
(Ort et al. 2014b). The main advantage of WBE, particularly for estimating illicit drug 
consumption, is it provides evidence-based, near-real-time and objective estimates 
of illicit drug consumption in a given wastewater catchment with shorter study times 
and reduced costs compared to traditional methods such as surveys. The approach 
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can also be used during special events such as festivals (Lai et al. 2013c), over long 
periods of times to identify changes, and also to cross compare between locations. 
Initially applied to measure illicit drug consumption in Milan (Italy), Lugano 
(Switzerland) and London (United Kingdom), the first results indicated that the 
estimates from WBE were in line with national annual prevalence data hence 
showed much promise (Zuccato et al. 2008). Since then, WBE for estimating illicit 
drug consumption has been applied in multiple cities in Australia (Lai et al. 2015, Lai 
et al. 2013a, Lai et al. 2013b, Lai et al. 2016a, Lai et al. 2016b, Lai et al. 2016c, Lai 
et al. 2011, Lai et al. 2013c), Canada (Metcalfe et al. 2010), Europe (Ort et al. 
2014b) and the United States (Banta-Green et al. 2009). 
Wastewater-based epidemiology has recently received global attention in regards to 
illicit drug surveillance (Thomas and Reid 2011). Of particular note is that the 
European Monitoring Centre for Drug and Drug Addiction has now included illicit 
drug consumption estimates from WBE analysis in their Perspective on Drugs report 
(EMCDDA 2016). Further developing WBE techniques and applying them to other 
chemical groups should produce improved assessments of human exposure to 
chemicals. This will encapsulate the short term goals of determining which chemicals 
and chemical groups we can measure as well as detecting per capita regional 
differences, which can then be applied to the long term goal of monitoring per capita 
exposure changes.  
As the main focus of WBE has been on measuring illicit drug consumption, there are 
certain compounds which have been more thoroughly investigated than others. The 
most commonly investigated chemicals using WBE are shown in Table 1.    
 
Table 1 Most common chemicals and their target residues assessed using the wastewater-based epidemiology approach. 
Chemical 
Group 
Consumed 
chemical 
Target residue Reference 
Alcohol Ethanol ethyl sulphate, 
ethyl glucuronide 
(Reid et al. 2011) 
Illicit drugs cocaine  benzoylecgonine, 
cocaine 
(Lai et al. 2011, van 
Nuijs et al. 2011c) 
methamphetamine amphetamine, 
methamphetamine 
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MDMA MDMA 
THC THC-COOH 
Tobacco nicotine cotinine, nicotine, 
trans-3’-
hydroxycotinine 
(Harman et al. 2011) 
 
 
1.2. Back-calculating chemical consumption/exposure from 
wastewater analysis 
Wastewater-based epidemiology relies on the principle that when substances are 
ingested they are metabolised and then excreted as the parent compound and/or 
their metabolites and that these ultimately enter the urban sewer networks. 
Therefore, by measuring concentrations of target compounds (𝐶𝐶𝑖𝑖) in wastewater 
samples which are representative of whole days, multiplying by the daily flow (𝐹𝐹), 
correcting for excretion factors (𝑅𝑅𝑖𝑖
𝐸𝐸𝑖𝑖
) and dividing by the population (𝑃𝑃) the amount of a 
chemical consumed on a per capita basis is calculated:  
𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷 𝑐𝑐ℎ𝑒𝑒𝑒𝑒𝐷𝐷𝑐𝑐𝐷𝐷𝐷𝐷 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑒𝑒𝑐𝑐𝑐𝑐𝐷𝐷𝑐𝑐𝑐𝑐𝑖𝑖 � 𝑒𝑒𝑚𝑚𝑑𝑑𝐷𝐷𝐷𝐷1000 𝑐𝑐𝑒𝑒𝑐𝑐𝑐𝑐𝐷𝐷𝑒𝑒� =  𝐶𝐶𝑖𝑖 × 𝐹𝐹 × 𝑅𝑅𝑖𝑖𝐸𝐸𝑖𝑖𝑃𝑃  
To confirm consumption of a given chemical using the WBE approach, the target 
residue is usually a human specific metabolite of the parent compound excreted 
primarily in the urine. Therefore pharmacokinetic data is required for each chemical 
which outlines the average excretion and the ratio of the molar mass of the parent 
compound to that of the metabolite. Table 2 outlines the pharmacokinetic parameters 
used when back-calculating consumption of the most common chemicals in WBE 
studies.   
 
1.3. Limitations and uncertainties of wastewater-based epidemiology 
Generation of WBE data involves many steps and each step has its own uncertainty 
which affects the overall quality of the final data. The uncertainty for each parameter 
is expressed as a percentage (relative standard deviation, RSD). This approach 
allows for Gaussian error propagation to be used to calculate the total uncertainty for 
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the consumption measurement of a given chemical using the WBE approach (Lai et 
al. 2011). The uncertainties are related to the sampling, stability of the markers, the 
analytical measurement, reliability of back-calculation of consumption data such as 
excretion, flow measurement, and the population size. Only some of these 
uncertainties have been investigated and few techniques have been identified and 
introduced to reduce these uncertainties.   
The common uncertainties associated with back-calculating the consumption of 
chemicals using the wastewater-based epidemiology approach as outlined by 
Castiglioni et al. is shown in Figure 1. 
 
 
 
 
 
 
1.3.1. Sampling Uncertainty  
The first uncertainty of WBE and one which can be controlled is the sampling 
uncertainty. Collected samples should be representative of the wastewater released 
Analytical uncertainty 
(1-34%) 
Use of internal 
standards, quality control 
and interlaboratory 
calibration reduce this 
uncertainty 
Population uncertainty 
(7-55%) 
Markers of population size 
proposed but none 
validated using accurate 
population data. WWTP 
operator estimates 
commonly used. 
Stability uncertainty 
(<10%) 
Chemical, wastewater, 
wastewater system and 
wastewater resident 
time dependant.  
Sampling uncertainty 
(5-10%) 
Catchment, sampling 
mode and frequency 
specific 
𝐶𝐶𝑖𝑖   ×    𝐹𝐹  ×    𝑅𝑅𝑖𝑖𝐸𝐸𝑖𝑖
𝑃𝑃
 
Flow uncertainty 
(>20%) 
Reliant on WWTP 
measurement. Can be 
cancelled out if using 
chemical loads to 
normalise population 
Parent:metabolite 
ratio uncertainty 
No uncertainty as it 
is the molar mass 
ratio of parent 
compound to 
metabolite  
Excretion 
uncertainty  
known? 
Chemical specific. 
Potentially 
influenced by 
demographic and 
other factors. 
Figure 1 Uncertainties associated with back-calculating the consumption of chemicals using the wastewater-based 
epidemiology approach as outlined by Castiglioni et al. (Castiglioni et al. 2013). 
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within a catchment over a given period (typically 24 hours). Ort et al. (Ort et al. 
2010b) thoroughly evaluated the sampling mode and frequency required in order to 
reduce sampling artifacts and found that they can range from non-significant to more 
than 100%. To control the sampling uncertainty they outlined that continuous flow 
proportional sampling is best in order to capture the most representative sample and 
avoid over interpretation of results. However, Castiglioni et al. noted that the 
continuous flow proportional sampling method is rarely adopted but the sampling 
uncertainty based on other sampling methods such as frequent flow or volume 
proportional sampling for large catchments still manage to keep the random 
sampling uncertainty below 10% (Castiglioni et al. 2013).  
An additional consideration to the sampling uncertainty is that conventional sampling 
methods focus only on representatively collecting chemicals associated with the 
dissolved phase and thus chemicals which partition to the particulate matter in 
wastewater are not representatively sampled.  
 
1.3.2. Analytical Uncertainty  
The emergence of WBE has primarily been driven by environmental and analytical 
chemists and thus the analytical uncertainties have been investigated thoroughly and 
protocols have been established to reduce these uncertainties. Many but not all 
WBE analytical methods employ solid-phase extraction (SPE) to concentrate target 
residues in order to measure them with certainty (van Nuijs et al. 2014). Most 
analytical analyses are conducted using liquid chromatography coupled to mass 
spectrometry. These methods are optimized for each specific target residue with an 
emphasis on separating potentially interfering chemicals from the target analytes 
both in terms of chromatographic separation and mass spectra such as by using 
multiple reaction monitoring or high-resolution mass spectrometry. This is particularly 
important as wastewater is a complex matrix containing an enormous range of 
chemicals (Grabic et al. 2012). Using such a method also allows for labelled 
analogues of target residues such as deuterated or carbon labelled standards, which 
are measured simultaneously, to both identify and reduce impacts of matrix effects 
and in turn improve upon the accuracy of the analytical method (Castiglioni et al. 
2013). Even using such methods, the analytical uncertainty remains between 6 and 
26% (Castiglioni et al. 2013).  
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 1.3.3. Uncertainty associated with chemical loss in the wastewater and in 
the sewer system  
Chemical stability is an important uncertainty to consider for WBE as it is not just 
limited to the stability of the target residues in the collected samples but also the loss 
of the chemicals within the sewer. For some chemicals, the stability improves by 
chilling or freezing the collected samples, changing the conditions of the sample 
such as by acidifying or adding a preservative such as sodium metabisulphite, or by 
stabilizing the chemical by exchanging it onto a solid phase immediately after 
collection. While the stability of chemicals in collected samples can be controlled to 
some extent (Chen et al. 2012a), the transformation processes during in-sewer 
transport cannot.  
There are two major processes in sewers which determine chemical stability and 
fate. The first is the mass transfer between phases i.e. sorption and uptake by 
organisms. The second is the alteration of the structure of the chemicals themselves 
such as via metabolism, reduction or oxidation of the chemicals (McCall et al. 2015). 
Different sewer types also favour certain microbial conditions. For instance, rising 
mains sewers favour anaerobic activity whereas gravity sewers favour aerobic 
activity (Hvitved-Jacobsen et al. 2013). For chemicals which do degrade or are 
transformed, the extent of degradation is also dependent on the exposure to such 
microbial or environmental conditions. Therefore degradation/transformation within 
sewers for some chemicals is entirely dependent on the specific sewer catchment 
itself and also the point at which it enters the sewer catchment. It is therefore 
necessary to conduct degradation/transformation studies on target residues to 
understand their fate in the sewer in addition to experiments to assess their stability 
in collected wastewater samples and how to preserve those which do 
degrade/transform. 
 
1.3.4. Correction factor uncertainties 
The back-calculation of chemical consumption by people within the specified 
catchment relies upon multiple correction factors. These correction factors include 
the stability of the target residues in the wastewater and the metabolism of the 
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parent compound in humans. However, most WBE, as outlined by the equation 
above only take into account the pharmacokinetic correction factors of parent 
chemical to metabolite ratio, and excretion factors. These factors however are 
chemical specific and as such have their own chemical specific uncertainties. For 
some chemicals some methods for back-calculating consumption have been 
relatively well investigated. As an example, the metabolism of cocaine in humans is 
reasonably well understood, producing a major metabolite, benzoylecgonine, which 
has an average excretion rate of 35% and a molar mass ratio (parent to metabolite) 
of 1.1. The excretion profile is also known for the main routes of cocaine 
administration which include intravenous (injection), intranasal (snorting), ingestion 
and inhalation (of smoke). A table of the ratio of the molar pass of the parent 
compound to its metabolite and the average excretion for the most commonly 
assessed illicit drugs using the WBE approach is shown in Table 2. 
Even for a chemical such as cocaine with known pharmacokinetics, the uncertainty 
of back-calculation as assessed using best practice requirements outlined by 
Castiglioni et al. is approximately 26% (Castiglioni et al. 2013). For other chemicals 
there is limited data, particularly for emerging compounds such as novel 
psychoactive substances or chemicals with non-intentional consumption such as 
flame retardants and thus the uncertainty remains unknown.  
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Table 2 Pharmacokinetic parameters from the literature required for back-calculating chemical consumption using the 
wastewater-based epidemiology approach for some example chemicals. Table adopted from (Lai 2013) and (Castiglioni 
et al. 2015).  
Consumed chemical Target residue ratio of the molar 
mass of the 
parent compound 
to its metabolite 
(𝑹𝑹𝒊𝒊) 
Average 
excretion (𝑬𝑬𝒊𝒊) (%) 
cocaine  benzoylecgonine, 
cocaine 
1.1 
1.0 
35[1,2,3,a] 
7.5[1,2,3,a] 
methamphetamine amphetamine, 
methamphetamine 
1.1 
1.0 
5.5[4,5,6,b] 
39[4,5,6,b] 
THC THC-COOH 0.9 0.6[6,7,c] 
nicotine cotinine, 
nicotine, 
trans-3’-
hydroxycotinine 
 
0.9 
1.1 
0.8 
30[8,9,10] 
13[8,9,10] 
44[8,9,10] 
1(Ambre et al. 1984); 2(Ambre et al. 1988); 3(Cone et al. 2003); 4(Baselt 2008); 5(Khan and 
Nicell 2012); 6(Postigo et al. 2010); 7(Zuccato et al. 2008); 8(Hukkanen et al. 2005); 9(Byrd 
et al. 1992); 10(Randall and Baselt 2004); aroutes of administration include injection, 
snorting and smoking ( n = 26); bbased on oral administration (n = 32); cbased on smoking  
 
1.3.1. Uncertainty associated with flow 
So far there has been limited research conducted on the uncertainty associated with 
flow measurements. In most cases flow measurements are provided by WWTP 
operators and there is limited potential for the researchers to validate the accuracy of 
the measurement and or calibrate the flow meters. Measuring flow in sewers is a 
complex task and the uncertainty is generally considered around 20% even under 
optimal conditions (Ort et al. 2010b). Well maintained flow meters in rising main 
(pressurised) sewers are considered to more accurately measure the flow than flow 
meters in open channel, partially filled, gravity fed sewers. However, without 
considerable investment into the calibration of any flow meter, the uncertainty of the 
flow measurement remains unknown. One option to reduce the uncertainty of the 
flow is to normalise loads of chemicals in the wastewater against other chemicals in 
the same sample to cancel out the errors in the flow measurement (Lai et al. 2011).  
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This however has its own associated uncertainties such as the homogeneity of 
consumption of the chemicals used for normalisation and the stability of these 
chemicals in the sewer. 
 
1.3.2. Uncertainty associated with population 
As outlined in the review of WBE uncertainties by Castiglioni et al., the major 
uncertainty of WBE studies is that of the catchment population size which even using 
best practice requirements still remains between 7 and 55%.  
There are considered to be two population types per catchment. These are the de 
jure population (the people who reside in the catchment) and the de facto population 
(the people who are present in a catchment during a given period which includes 
people who are working there, holidaying there, and excludes the usual residents 
who are not present during that period).  
For WBE, the de facto population is the most important as it reflects the population 
who contributed to the wastewater during the sampling period.  
The most common approach to estimate the de facto population include estimates 
based on hydrochemical parameters (e.g. biological oxygen demand (BOD), 
chemical oxygen demand (COD), nitrogen (N) and phosphorous (P)), census data, 
and design capacities of the WWTPs. One difficulty of using the most recent census 
data is that populations are dynamic and the census data may become quickly 
outdated.  
Hydrochemical parameters may be more reflective of the de facto population, but 
there are multiple factors which influence the load of these in the wastewater 
These include input from industry as well as processes occurring within the sewer 
such as chemical processes and microbial activity. The hydrochemical population 
estimates have an additional uncertainty as they require accurate flow data of the 
wastewater influent in order to be calculated. Castiglioni et al. concluded that the 
current best practice to reduce the uncertainty of the population estimate is to 
consult experts from each individual WWTP to identify the major industrial sources of 
hydrochemical parameters. By doing this, population estimates can be calculated 
using the hydrochemical parameter/s which are least influenced by industry. 
As an alternative approach to using the common methods such as hydrochemical 
parameters or the most recent census data, Lai et al. proposed the measurement of 
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high use human specific markers such as pharmaceuticals (e.g. atenolol, 
carbamazepine and hydrochlorothiazide) and an artificial sweetener (acesulfame) 
(Lai et al. 2011). By correcting the measured mass load by excretion data for each of 
these chemicals and comparing against national audit data, Lai et al. showed that for 
the catchment investigated, atenolol was the best population marker. This is 
because its use in the general population is relatively high (1 - 3% in Australia), it is 
required to be consumed regularly, it is thought to be relatively stable in the sewer as 
it shows little removal during wastewater treatment, and the back-calculated 
consumed load strongly agreed with the population estimate provided by the WWTP 
staff.   
While atenolol was found to be a good population marker for the specific catchment 
investigated, it may not necessarily be a good marker for other catchments such as 
where the age demographic is younger (the demographic for atenolol consumers is 
greater than 65 years of age, ABS, 2006). Therefore, other markers of population 
size which are more representative of the population need to be identified. Preferably 
these markers would be human specific endogenous markers.  
Daughton recognised the shortcomings of the commonly parameters used for 
assessing population size and proposed what he considered to be ideal attributes for 
chemicals in wastewater to have in or to be used as population markers (Table 3) 
(Daughton 2012a). In this assessment he proposed to use endogenous markers 
such as creatinine and coprostanol to be used as population markers. 
 
Table 3 Ideal attributes for chemicals in wastewater biomarkers targeted for estimating population as published in 
Daughton (2012a) 
Attribute  Example  Potential problem 
Must be excreted into sewage Excretion via urine rather than faeces 
poses fewer sampling and analytical 
challenges 
Excretion via faeces creates a non-
homogenous sample stream and 
requires more comprehensive 
sample preparation 
Uniqueness to human 
metabolism 
Coprostanol (CoP) is produced in 
significant quantities primarily by 
higher vertebrates that synthesize 
cholesterol 
Input possible from other animals 
where industrial/agricultural sewage 
is mixed with human sewage or 
runoff carrying animal faeces into 
combined sewers (both would 
serve to confound data) 
Exogenous sources are 
minimal 
Low occurrence in raw or cooked 
foods 
Creatinine occurs in meats and can 
be created from creatine during 
cooking (can confound data) 
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Attribute  Example  Potential problem 
Minimal intra-individual 
variance in daily excretion 
Daily levels excreted by an individual 
vary minimally over time 
Stress or disease can affect the 
excretion of all biomarkers 
Minimal inter-individual 
variance in daily excretion 
Per capita daily excretion across a 
population varies minimally 
A wide spectrum of physiological 
variables can dictate the excretion 
of biomarkers (age, gender, 
genetics, stress) 
Daily per capita excretion in 
sewage is independent of 
extraneous variables 
Minimal effect from season, weather, 
geographic locale, water-use 
restrictions, medication usage, diet 
Diet can influence excretion 
variance for both creatinine and 
CoP 
Occurrence levels independent 
of design and usage sewerage 
system 
Length of sewerage distribution pipes 
and residence time of sewage in 
pipes 
Time-dependent degradation by 
microorganisms during sewage 
transit can lead to variable 
reductions in biomarker levels 
Minimal degradation of 
biomarker in flowing sewage 
(levels persist in sewage) 
Slow degradation allows sampling 
raw sewage further downstream, 
permitting better mixing of influent 
“pulses”; ensures minimal losses 
during transit through sewer 
connections of varied lengths and 
residence times 
Sewage pulses with widely varying 
biomarker levels (compounded by 
changing pulse frequency) greatly 
increase the required frequency of 
sampling a 
Levels in raw sewage well 
above method detection limit 
(MDL) 
Few analytical interferences; easier 
implementation of a routine method 
Isobaric biomarker isomers often 
become common interferences with 
methods using mass spectrometry 
Minimal potential for 
exogenous interference from 
other sources 
Exogenous sources include residues 
of target analyte on analyst's hands 
Residues of target analytes can 
sometimes be excreted as sweat 
(e.g., drugs) or remain from prior 
dermal contact or direct application 
(e.g., personal care products) 
(Daughton and Ruhoy 2009) 
Homogenous distribution; 
biomarker preferably partitions 
to aqueous phase 
Minimal partitioning to dissolved or 
suspended solids or sludge 
Partitioning to solids increases the 
complexity of sampling and sample 
preparation 
Minimal degradation of analyte 
in sampled sewage (levels 
persist in sewage) 
Refractory to microbial degradation 
or to further physicochemical 
degradation during sample shipment 
or storage 
Preservatives may be required to 
inhibit microbial degradation in 
stored or shipped samples 
Minimal de novo, ex vivo 
formation of analyte in sewage 
Minimal formation by microbial 
activity during sewage transit and 
during sewage treatment 
Sampling of raw sewage as early 
as possible in influent stream may 
be necessary 
Minimal sample clean-up and 
sample preparation 
Requires minimal pre-concentration 
to meet MDL 
Excretion of biomarker in the form 
of conjugates may require 
additional hydrolysis step 
Analytical determination uses 
instrumentation routinely 
available; analytical 
methodology amenable to 
standardization 
Conventional GC/MS, LC/MS, or 
immunoassay 
Innovative “research grade” 
methodologies are too costly or 
complex for wide implementation 
Minimal capital investment in 
instrumentation; minimal 
analyst time 
Allows for high-frequency sampling “Research grade” methodologies 
are too costly for wide 
implementation 
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Attribute  Example  Potential problem 
High sample through-put Amenable to automation; reduces 
cost 
Analyst intervention reduces 
timeliness of results 
Potential for in-stream 
continuous sampling or 
monitoring 
Equilibrium passive samplers (EPS) 
allow for passive, time-integrated 
sampling;b in-stream sensors 
facilitate real-time data 
Discrete sampling gives biased 
results because of stream 
heterogeneity and sewage pulses 
Minimal occupational hazards 
for technicians 
Minimal hazards from samples, and 
from analytical reagents or reactions 
Handling raw sewage poses risks 
associated with pathogen exposure 
a The challenges associated with obtaining representative samples from an STP are discussed by Ort et al. 
(2010b). 
b Examples of EPS (Zabiegała et al., 2010) include polar organic chemical integrative samplers (POCIS) and 
semipermeable membrane devices (SPMD). 
 
Creatinine was proposed due to its wide use in clinical chemistry to normalise urine 
samples as it is a continually produced nitrogenous waste product which is cleared 
by the kidney. However, in order for creatinine to be used as a population marker 
further assessment would be required in terms of stability in wastewater and within 
the sewer network. Additionally, it was noted that even though creatinine has been 
extensively used to normalise urine samples since the 1950s, there is considerable 
debate surrounding the high intra- and inter-day excretion variance and thus 
calibration of the mass load in wastewater against a true population size would be 
required. 
Unlike creatinine which may have high intra- and inter-day excretion variance, 
Daughton proposed coprostanol as its variance is comparatively low and is 
considered to be stable over time (de Leon et al. 1987). Coprostanol is the major 
human metabolite of cholesterol accounting for 60% of the sterol content in faeces. It 
is fully excreted as it is fully saturated hence poorly absorbed from the gut. However, 
a large uncertainty remains around the use of coprostanol as a population marker as 
it is poorly water soluble and thus its partitioning to organic matter is likely (Takada 
and Eganhouse 1998).  
 
As outlined above, multiple population markers have been proposed but none have 
been validated since no reliable population data were available (such as calibration 
against samples collected during a census). Additionally, their persistence in 
wastewater and within the sewer is also unknown. With such limited research on the 
uncertainties of population size and measuring population changes, the 
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establishment of more reliable markers for population size should be the focus in 
order to reduce the overall uncertainty of WBE. 
 
1.4. Aims 
The overall aim of this thesis is to evaluate and propose an approach to reduce the 
uncertainty of population size estimates for WBE studies. This was to be achieved 
first by identifying and evaluating markers of population size (Chapters 2 and 3). 
Chapter 3 also proposed a model for assessing population size using a suite of 
markers that could reduce the population size uncertainty (Appendix 5 and 6 are 
additional publications which apply the population model developed in Chapter 3). 
Subsequently, the uncertainty of the model itself was assessed in Chapter 4 through 
the assessment of the impact of in-sewer degradation on the selected population 
markers.  
 
Chapter 5 explored the applicability of WBE for measuring exposure of emerging 
chemicals (in this case organophosphorous flame retardants for which there is 
limited exposure data in Australia). In addition to this aim, this study contains the first 
application of the population model developed in Chapter 3 to estimate the 
population size for a new WWTP catchment.  
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_________________________________________________________ 
Chapter 2: Assessment of creatinine as a population marker 
_________________________________________________________ 
 
As outlined above, defining the population size is an essential element for 
wastewater-based epidemiology to estimate the per capita consumption, chemical 
exposure and to facilitate cross comparison of sites (Castiglioni et al. 2014). 
Attempts at measuring the population contributing to the wastewater have been 
made (e.g. measuring different hydrochemical parameters (Andreottola G. 1994)) but 
in most wastewater-based epidemiology studies, design capacity of the WWTP or 
census estimates are used and there may be high variability between these 
estimates (Castiglioni et al. 2014). Daughton proposed that the wastewater itself may 
contain chemical markers which have the potential to quantify the population 
contributing to a wastewater sample. Furthermore,  
For this chapter, creatinine, an endogenous compound arising from the breakdown 
of creatine phosphate in muscles was investigated as a primary population marker. 
In previous assessments of population markers, head-counts have been estimated. 
The novelty of this study was accessing an accurate head-count via wastewater 
samples collected from 10 sites across Australia on Census Day 2011. As these 
samples are related to an accurate population, they provide the most accurate 
assessment of population size markers to date. 
 
 
The following publication is incorporated as Chapter 2: 
___________________________________________________________________ 
 
Thai, P.K., O'Brien, J.W., Jiang, G., Gernjak, W., Yuan, Z., Eaglesham, G., Mueller, 
J.F., 2014. Degradability of creatinine under sewer conditions affects its potential to 
be used as biomarker in sewage epidemiology. Water Res 55, 272-279. 
___________________________________________________________________ 
 
Peer–reviewed and published by Water Research 
Accepted author manuscript 
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2. Abstract 
Creatinine was proposed to be used as a population normalising factor in sewage 
epidemiology but its stability in the sewer system has not been assessed. This study 
thus aimed to evaluate the fate of creatinine under different sewer conditions using 
laboratory sewer reactors. The results showed that while creatinine was stable in 
wastewater only, it degraded quickly in reactors with the presence of sewer biofilms. 
The degradation followed first order kinetics with significantly higher rates in rising 
main conditions than in gravity sewer conditions. Additionally, daily loads of 
creatinine were determined in wastewater samples collected on Census Day from 10 
wastewater treatment plants around Australia. The measured loads of creatinine 
from those samples were much lower than expected and did not correlate with the 
populations across the sampled treatment plants. The results suggested that 
creatinine may not be a suitable candidate to be a biomarker for population 
normalisation purpose in sewage epidemiology, especially in sewer catchments with 
high percentage of rising mains.  
 
Keywords: stability, sewer reactor, degradation, sewer biofilms, wastewater analysis 
2. Graphical Abstract 
 
2.1 Introduction 
Sewage epidemiology (or wastewater analysis) has become a popular approach to 
estimate the consumption of illicit drugs at the population level and has been applied 
Gravity sewer
Rising main
Sampling bottle
Creatinine
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to different communities (Baker et al. 2012, Banta-Green et al. 2009, Daughton 2011, 
Lai et al. 2011, Postigo et al. 2011, Thomas et al. 2012, van Nuijs et al. 2011b). Until 
now, most studies have estimated the total mass of drug use in the catchment and 
then used the population number provided by the wastewater treatment plant (WWTP) 
to normalise the drug use (e.g. to mass used (g)/ 1000 people) in different catchments 
for comparison purposes. However, this population number estimated by the WWTP 
may differ from the actual population and the uncertainty incurred in estimating 
population size could be as high as 55%, the highest among uncertainties related to 
sewage epidemiology approach (Castiglioni et al. 2013).  
A number of researchers have recognised and attempted to address the issue of 
population variation in the sewer catchment during illicit drug consumption monitoring. 
The general approach is to find a chemical or a suite of chemicals in wastewater as 
surrogates to estimate the number of inhabitants in the catchment. Lai et al. (2011) 
have analysed different pharmaceuticals and an artificial sweetener to estimate the 
contributing population but recognised that the issues of compliance and demography 
(and thus the level of medicine use) can affect the certainty of the population 
estimation. van Nuijs et al. (2011) used the concentrations of phosphorous, nitrogen, 
biological oxygen demand and chemical oxygen demand to calculate the real-time 
number of inhabitants. However, these hydrochemical parameters are influenced by 
factors that cannot easily be controlled such as the composition of sewage (i.e., 
industrial, domestic, or mixed) which lead to large uncertainties in population 
estimation (Castiglioni et al. 2013). Castiglioni et al. (2013) also suggested that the 
estimation of population for a sewer catchment could be improved by using suitable 
biomarkers consumed or excreted in known amounts by a population such as 
creatinine and prescribed medicines.  
Creatinine, a popular urinary biomarker, has been proposed as a per capita 
normalizing parameter to make illicit drug monitoring data comparable between sites 
(Daughton 2001, Daughton 2012a). The reason is that creatinine is widely used in 
clinical chemistry as a normalising parameter, and there is extensive published data 
on its excretion. In his recent review paper, Daughton (2012) has performed a desktop 
evaluation of creatinine as a potential biomarker for population estimation against a 
list of important attributes. While creatinine fulfils several criteria, an important 
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attribute, the stability of creatinine in the sewer system, was not assessed due to a 
lack of available data.  
Since the publication of Daughton’s review, two new studies have used creatinine as 
a normalising parameter to compare per capita drug consumption estimates for 
different wastewater samples with expected changes of contributing population 
(Brewer et al. 2012, Burgard et al. 2013). However, in those studies, the stability of 
creatinine was only assessed in wastewater only as part of the sampling and storage 
stability test but not under conditions similar to the actual sewer system. 
A sewer system typically consists of rising main sewers and gravity sewers. Rising 
main sewers are generally fully filled with wastewater and have anaerobic biofilms 
dominated on the pipe walls. Meanwhile, gravity sewers are only partially filled with 
wastewater and may sustain both aerobic and anaerobic biofilms/sediments (Hvited-
Jacobsen, 2013). Since biofilms are rich in microorganisms, which are capable of 
transforming/degrading various chemical compounds, it is hypothesized that 
creatinine can be transformed/degraded more strongly in sewers by those biofilms 
microbes than in wastewater alone where the microbial populations is scarer. Indeed, 
it has been reported that biofilms in rising main sewer produced substantially higher 
sulfide compared to suspended microorganisms in wastewater (Gutierrez et al. 2008, 
Mohanakrishnan et al. 2009). And Thai et al. (2013) also reported that sewer 
conditions enhanced the degradation of cocaine and 6 acetylmorphine compared to 
wastewater alone. Moreover, redox condition of the sewer, i.e. aerobic or anaerobic, 
can also influence biological transformation processes of chemicals including 
creatinine. It is thus necessary to study the fate of creatinine under different sewer 
conditions close to reality.  
In this study, we attempted to address this problem by i) investigating the degradation 
of creatinine in the sewer system using laboratory-scale sewer reactors and; ii) looking 
for a correlation between the actual population in the sewer catchment (census data 
with samples collected on Census Day) with the mass load of creatinine in the sewer 
system. The results obtained will help to clarify the possibility of using creatinine as a 
biomarker for population estimation in a sewage catchment. 
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2.2 Materials and Methods 
2.2.1 Chemicals and reagents  
Reagent grade creatinine was purchased from Sigma Aldrich (Castle Hill, Australia). 
Creatinine-d3 was purchased from Cambridge Isotope Laboratories (MA, USA).  
LCMS grade solvents (methanol and acetonitrile) were purchased from Merck 
(Darmstradt, Germany). Deionised water was produced by a MilliQ system (Millipore, 
0.22 μm filter, 18.2 MΩ cm-1).  
 
2.2.2 Analysis of creatinine  
A chromatography method originally developed to analyse creatinine in serum by Hetu 
et al. (2010) was adapted and modified to analyse creatinine in wastewater. Creatinine 
in wastewater samples was measured by an liquid chromatography-tandem mass 
spectrometry (LC-MS/MS) system comprising of a Shimadzu Nexera LC system 
(Kyoto, Japan) connected to an ABSciex 5500QTRAP mass spectrometer (ABSciex, 
Concord, Ontaria, Canada). The LC system consists of a Shimadzu LC-20AB high-
pressure pump, a SIL-20AHT autosampler and a CTO-20A column oven. An in-line 
degasser (DGU-20A3) was placed prior to the solvent delivery system. Separation 
was achieved using only a Phenomenex SecurityGuard strong cation exchange (SCX) 
cartridge (4.0 x 3.0 mm) (Phenomenex, CA, USA) using an ammonium acetate 
gradient at 0.6 mL/min. The gradient starts with 85% A: 15% B and holds for 40 
seconds before ramping up to 100% B in 10 seconds and holding for 2 minutes before 
re-equilibrating at 15% B for a further 2 minutes. Mobile phases A and B both contain 
75% methanol and 25% Milli Q water with 0.4% acetic acid and an ammonium acetate 
concentration of 1.0 mM for A and 10 mM for B.  
The acquisition is operated under multiple reaction monitoring (MRM) in positive APCI 
mode. All data were collected using ABSciex Analyst software (version 2.1). 
Quantitation was performed using MultiQuant version 2.1 software (ABSciex).  
Samples were prepared for analysis by adding 10 μL of internal standard (10 μg.mL 
creatinine-d3 in water) to 1 mL of filtered sample in the vial. The vials were then 
vortexed to mix well before analysis. 
Calibration curves (5, 10, 25, 50, 100, 250, 500, 1000 ng/mL) were run three times in 
each batch of instrumental quantification and the calibration curves were linear within 
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the range. The limit of detection (LOD) for creatinine is 3 ng/mL based on the signal 
to noise of 3. The corresponding limit of quantification (LOQ) is 10 ng/mL based on 
the signal to noise of 10.  
The repeatability and reproducibility of the method were evaluated using both a 
wastewater sample (mean concentration of 38 ng/mL) and a spiked wastewater 
sample (200 ng/mL) with 10 replicates. The relative standard deviations were 3.5% 
and 1.7%, respectively. Recovery was calculated by subtracting the absolute average 
of the wastewater sample from the spiked wastewater sample and showed an average 
recovery of 112% (108 – 116%). The chromatograms of standard and real sample 
were shown in the Supplemental Materials (Figure S- 1). 
Procedural blanks, procedural recoveries and matrix spike recoveries were analyzed 
in every batch of samples and were considered acceptable as no positive detection 
was observed for the blank samples and the recoveries of spiked samples are within 
the recorded range. 
 
2.2.3 Laboratory-scale sewer reactors  
The use of laboratory-scale sewer reactors to investigate the biotransformation and 
degradation of various chemicals has been described previously (Jiang et al. 2009, 
Thai et al. 2014a). The experiment employed well-controlled laboratory-scale reactors 
to simulate typical sewer conditions (Figure 1), which have been reported in many 
studies about in-sewer processes and the control of activities of sewer biofilms. 
(Gutierrez et al. 2008, Jiang et al. 2011a, Jiang et al. 2010, Jiang et al. 2013, 
Mohanakrishnan et al. 2009) In this study, three different sewer reactors were 
employed, namely a rising main (RM) sewer reactor, a gravity sewer (GS) reactor and 
a control (CR) sewer reactor without biofilms. Detailed description of the reactors can 
be found in Thai et al. (2013). 
Sewer biofilms in RM and GS reactors have been cultivated for 12 months using real 
wastewater before the experiments. Domestic wastewater, collected weekly from a 
local pumping station in Brisbane (Australia) was used as the feed. The sewage (pH 
around 7.5) typically contained sulfide at concentrations of <3 mg-S/L, sulfate at 10-
25 mg-S/L, total COD and soluble COD at 450-600 mg/L and 260-450 mg/L, 
respectively, with the latter including volatile fatty acids at 50-120 mg-COD/L. The 
sewage was stored at 4 °C and heated up to 20 °C before being pumped into the 
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reactors. The reactors were fed with sewage through a peristaltic pump (Masterflex 
7520-47) every 6 hours, a typical sewage hydraulic retention time in sewers (Hvited-
Jacobsen, 2013). Every feed pumping event lasted for 2 minutes, delivering one 
reactor volume (0.75 L) of sewage into each reactor. To ensure homogeneous 
distribution in reactors, gentle mixing was provided with magnetic stirrers at 250 rpm 
(Heidolph MR3000).  
Prior to the degradation tests for creatinine described in Section 2.4, batch tests were 
conducted to determine the biological activities of sewer biofilms, i.e. sulfate reduction 
and methanogenesis, in the sewer reactors. Wastewater samples were then taken at 
0, 20, 40, and 60 minutes after feeding for the analysis of dissolved inorganic sulfur 
and methane. Detailed procedures of the biofilms activity test can be found in Jiang et 
al. (2010).  
  
2.2.4 Batch tests for the degradation of creatinine in sewer reactors 
Batch tests in triplicate were conducted to investigate the degradation of creatinine 
under different sewer conditions. For each replicate of the batch test, wastewater 
newly taken from the same pumping station was warmed to 20oC and its pH was 
adjusted to 7.5 using either 1M NaOH or 1M HCl solution. The temperature and pH 
were selected to be comparable with OECD guideline No. 314 (OECD, 2008) and with 
other studies on the stability of chemicals in wastewater (Chen et al. 2012a, Plosz et 
al. 2013, van Nuijs et al. 2012). The temperature- and pH-adjusted wastewater was 
then pumped into the RM and GS reactors using a peristaltic pump (Masterflex 7520-
47). Care is taken to ensure that the liquid in each reactor was replaced with newly 
prepared wastewater. The CR reactor was manually filled with newly prepared 
wastewater from the top.  
Working solution of creatinine (100 µg/mL) prepared in deionised water was spiked 
into each of the three reactors to obtain an initial creatinine concentration in the range 
of 1 µg/mL, which is similar to the range of creatinine in wastewater samples reported 
previously (Burgard et al. 2013, Chiaia et al. 2008).  
Continuous mixing was maintained for each reactor with magnetic stirrers at 250 rpm 
(Heidolph MR3000) during all the batch tests. The mixing enhanced surface aeration, 
producing aerobic/anaerobic conditions in the GS reactor and aerobic conditions in 
the CR (dissolved oxygen around 0.5 mg/L). Wastewater samples were then taken at 
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time 0, 0.25, 0.5, 1, 2, 3, 6, 9 and 12 h after spiking the reactors. For each sample, 
aliquots of 1 mL were immediately filtered into 2-mL vials using 0.45 µm regenerated 
cellulose syringe filters (Phenomenex, Australia). Six µl of 2M HCl was added to each 
vial to adjust the samples to approximately pH 2 to reduce microbial activity. The 
samples were then frozen at -20°C until analysis.  
 
2.2.5 Wastewater sampling on Census Day 
Twenty-four hour composite samples were collected from the inlets of 10 WWTPs on 
or around the 2011 Population Census Day in Australia (9th August 2011). Different 
sampling modes were used including continuous flow proportional, high-frequency 
volume or time proportional, depending on the equipment available at each treatment 
plant (Table S- 1). These WWTPs are from the Australian Capital Territory (1 WWTP), 
South Australia (2 WWTPs), Tasmania (1 WWTP) and Queensland (7 WWTPs). After 
collection, samples were preserved by acidifying to pH 2 with 2M HCl and shipped on 
ice (chilled or frozen) to the laboratory. Samples were then stored at -20°C until 
analysis. For analysis, thawed samples were filtered into 2-mL vials using 0.45 µm 
regenerated cellulose syringe filters, spiked with internal standard (creatinine-d3), and 
directly injected into LC-MS/MS system.  
The samples collected around the Census Day were assumed to reflect the 
consumption/exposure/excretion of the census population in each sewer catchment. 
The catchment maps provided by WWTPs were sent to the Australian Bureau of 
Statistics (ABS) for population counts (Persons Enumerated or population residing in 
the catchment on Census Day). It is noted that census participation in Australia is 
compulsory and it is estimated that the error of the 2011 Census is approximately 1.7% 
of the population. For the purpose of this study the ABS Census values were not 
adjusted. 
 
2.3 Results and Discussion 
2.3.1 Biological activities in sewer reactors.  
The results of the biological activities tests confirmed that RM, GS and CR reactors 
have produced the expected sewer conditions (Thai et al. 2014a). The RM reactor was 
under anaerobic condition, supported by the production of sulfide and methane. The 
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activity of sulfate-reducing bacteria and methanogenic archaea in the RM reactor was 
measured to be 4.3 ± 0.3 mg S/L-h and 18.9 ± 3.2 mg COD/L-h respectively, similar 
to previously reported values in both laboratory-scale and real sewers (Guisasola et 
al. 2008, Jiang et al. 2011a, Jiang et al. 2011b), confirming that the laboratory setup 
can mimic actual conditions of sewer pipes. Despite continuous aeration, the dissolved 
oxygen in the GS reactor was measured to be below 0.5 mg/L, indicating there is 
aerobic activity consuming oxygen. Similar to many typical gravity sewers, it is likely 
that anaerobic conditions also developed at the bottom of the reactor where oxygen 
could not reach. Measured anaerobic activity in the GS reactor is low in terms of sulfate 
reduction (0.17 ± 0.05 mg S/L-h) and methane generation (1.5 ± 0.15 mg COD/L-h). 
This is primarily due to the aerobic conditions, and also partly due to the continuous 
dissipation of gases through the air-water interface. No significant gas production 
activity was detected in the CR reactor as it lacked the sewer biofilms compartment. 
Detailed discussion can be found in Thai et al. (2013) where it demonstrated that the 
biological activities observed in the laboratory-scale reactors coincide well with those 
in real sewer systems. 
 
2.3.2 Degradation of creatinine in the sewer reactors.  
Since creatinine is very soluble in water (log Kow = -1.76) and has negligible vapour 
pressure we assumed that volatilisation and adsorption of creatinine were also 
negligible during the 12-h test period. Therefore, all losses of creatinine during the 
experiment in sewer reactors were attributed to the degradation of creatinine in 
wastewater.  
Figure 2 shows the degradation profiles of creatinine under different sewer conditions. 
The graph represents the relative concentrations of creatinine during the tests with the 
initial concentrations regarded as 100%.  
The results reveal that creatinine is relatively stable in wastewater alone (i.e. without 
biofilms) where the concentration of creatinine at 12 hours is not significantly different 
from the initial concentration (Figure 2). This result suggests that the microbial activity 
in the liquid-phase of the sewer system (wastewater) does not have considerable 
impact on the degradation of creatinine. It is in agreement with data from other studies 
where creatinine was observed to be either stable or degraded relatively slowly in the 
wastewater matrix. (Bisceglia et al. 2012, Brewer et al. 2012, Burgard et al. 2013) 
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Meanwhile, after 12 hours, degradation accounted for 27% of creatinine loss in the GS 
reactor while creatinine degraded almost completely in the RM reactor. The 
concentrations of creatinine were nearly depleted after 9 hours of batch test in the RM 
reactor. In the RM reactor, degradation can be considered complete after 9 hours. It 
should be noted that there seems to be a lag phase at the early stage in the RM reactor 
which may be due to the homogenization. 
The data from the CR reactor re-affirmed the stability of creatinine reported previously 
in wastewater (Brewer et al. 2012, Burgard et al. 2013) and deionized water (Bisceglia 
et al. 2012) (f) which is reasonable because creatinine has been found to be stable in 
urine samples, a form of concentrated wastewater with minor microbial activities 
(Garde et al. 2003, Liu et al. 2012) (Table 4). Meanwhile, the loss of creatinine in the 
reactors with biofilms are significant (p<0.01), i.e. 27% and 99% for GS and RM 
reactors, respectively (Table 4). It is reasonable to assume that the microbial activity 
of the biofilms in the sewer reactors accelerates the degradation rate of creatinine 
compared to wastewater alone as it is the case for some illicit drugs (Thai et al., 2013). 
Only Bisceglia reported in his dissertation a similarly high degradation rate of 
creatinine in wastewater alone (Bisceglia et al. 2010). It is possible that the wastewater 
used in the experiment of Bisceglia (2010) has stronger microbial activity than those 
used in other studies (Brewer et al. 2012, Burgard et al. 2013). 
While the significant loss of creatinine in biological sewer reactors was related to the 
existence of active sewer biofilms, the difference of degradation rates in RM and GS 
reactors was potentially because of the different type of biofilms and thus different 
biological processes. Some microbes were reported to use creatinine as alternative 
nitrogen sources to survive nitrogen limitation situations (Bendt et al. 2004) although 
this is not the case for the wastewater which had an ammonium level of around 50 mg 
N/L. Creatinine was also suggested to be utilized as a source of both carbon and 
nitrogen at the same time by various microorganisms (Shimizu et al. 1986, Yamada et 
al. 1985). Since anaerobic microorganisms prevail in the RM reactor while both 
aerobic/anaerobic microbes were present in the GS reactor it seems that the 
abundance of anaerobic microbes was related to the degradation rate observed. 
The data obtained from the batch tests were analysed to identify the degradation 
kinetics. While the data of creatinine in CR reactor indicated no significant degradation 
was observed during the experiment, the degradation of creatinine in the GS and RM 
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reactors fits well with first order kinetics (Table 5). The degradation rate of creatinine 
in RM reactor is much faster than that in the GS reactor suggesting that anaerobic 
biofilms might be more active in degrading creatinine than aerobic biofilms as 
discussed in the previous section. Although this study did not determine the metabolic 
product(s) of creatinine degradation, it demonstrated that creatinine is susceptible to 
degradation under actual sewer conditions due to the prevalence of microbial activities 
and relatively long hydraulic retention time. 
  
2.3.3 Measured load of creatinine and the population  
The daily loads of creatinine were calculated (creatinine concentration × daily flow) for 
10 WWTPs and compared with the corresponding population served by the WWTP to 
see if there is any correlation. No correlation was found between those two data sets 
(Figure 3 and Table S- 1). This is likely due to the different levels of degradation due 
to different sewer configurations and different lengths of residence time. The 
measured concentrations of creatinine at the WWTP are 1-3 orders of magnitude 
lower than the estimates from human excretion, which supported the results observed 
in laboratory scale sewers.  
It is noted that the concentration of creatinine measured in most wastewater samples 
in this study are much lower (up to 2 orders of magnitude) compared to data reported 
previously in the US (Brewer et al. 2012, Chiaia et al. 2008). One possible explanation 
is that the hilly geography of Australian towns requires sewer systems with more rising 
main pipes than those in the US and thus results in much more degradation of 
creatinine in Australian sewer systems. The two WWTPs in Australia with the highest 
per capita loads of creatinine measured in this study (WWTP 6 and WWTP 10 in Table 
S- 1) also receive industrial waste which includes wastewater from slaughterhouses 
which potentially contains large quantities of creatinine in either waste blood or urine.  
We applied the method using creatinine analysis in wastewater developed by Brewer 
et al. (2012) to estimate the creatinine excretion by the population. By using this 
method, our calculation from data of Chiaia et al. (2008) showed that the measured 
loads of creatinine in WWTPs in the US were 50% less than the expected load based 
on per capita excretion data. Brewer et al. (2012), using daily creatinine load to 
estimate the population, has underestimated the population by at least 50% (and as 
low as 15% of the maximum population). Those results also suggested that the loads 
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of creatinine from WWTPs cannot be used to directly estimate the number of people 
in the catchment without knowing the extent of creatinine degradation within the sewer 
system. 
2.3.4 Implication for the applicability of creatinine in sewage epidemiology 
The findings of the sewer reactor experiments indicate that the activity of 
microorganisms in the sewer system on creatinine is stronger than that in the 
wastewater alone due to the presence of biofilms on the sewer walls. This activity has 
significantly enhanced the degradation rate of creatinine in the sewer, especially under 
anaerobic condition (rising mains). This confirmed the results reported previously on 
the activity of sewer biofilms on the degradation of illicit drug biomarker (Thai et al., 
2013) and sulfide production (Gutierrez et al. 2008, Mohanakrishnan et al. 2009). 
The degradation of creatinine in the sewer system may limit its potential to be used as 
a biomarker for the estimation of population size or to be used as a normalisation 
chemical similar to its role in clinical chemistry (urinalysis) to compare any wastewater 
parameters among different WWTPs (or sewer catchments). Although both the reactor 
data and the data from different WWTPs indicated the degradability of creatinine in 
the sewer system, a controlled field study to confirm this finding is necessary.  
It is also beneficial to investigate in detail the degradation pathway of creatinine in 
sewer to better understand the initiator of the process and see if one can assess the 
extent of creatinine degradation by using its transformed products/metabolites. 
Meanwhile, we recognise the potential of creatinine to be used as a biomarker for 
monitoring population changes in a specific sewer catchment. The reasoning is that 
each sewer system would potentially function with reasonable reproducibility (i.e. 
consistent parameters that affect degradation) for creatinine degradation (average 
retention time, ratio of rising main/gravity sewer etc.) so that the level of degradation 
could be assumed similar among days. But this will not be practical, in our opinion, 
when the degradation of creatinine in the system render the load of creatinine 
negligible (i.e. only a small fraction of excreted creatinine can be measured at the 
WWTP).  
As this study indicates the different effects of different sewers (GS and RM) on 
creatinine, more knowledge about the sewer system, such as the ratio of GS and RM 
sewer in addition to the average residence time, is required to understand/evaluate 
the degradation of creatinine in a sample collected in a specific sewer system. 
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The demonstrated capability of the sewer reactor to mimic real sewers in terms of 
types of biofilm, microbial populations and biological activity will promote them as 
essential tool to investigate the in-sewer fate of chemicals of interest including further 
studies about the transformation/degradation of creatinine in GS and RM for the 
purpose of applying them in the sewer epidemiology approach. However, some factors 
such as A/V ratio, flowing condition and hydraulic retention time should be carefully 
considered during the design of the lab-scale sewer reactors to best represent the 
actual sewer system. 
 
2.4 Conclusions 
This study evaluated the stability of creatinine under different sewer conditions using 
sewer reactors. It also compared the actual daily loads of creatinine in 10 WWTPs in 
Australia with the corresponding census populations. The main conclusions are: 
1.  Creatinine is stable in wastewater only but the simulated sewer conditions (RM 
and GS) enhanced its degradation, probably due to the presence of sewer 
biofilms.  
2. Creatinine degradation under RM and GS conditions follows first order kinetics 
with degradation rate significantly higher under RM conditions than under GS 
conditions.  
3. No correlation was found between daily loads of creatinine and populations in 
10 WWTPs in Australia thus hindering the applicability of using creatinine as 
normalising biomarker in sewer epidemiology.  
4. Further studies about degradation pathway of creatinine in the sewer system 
as well as a field trial are necessary to fully evaluate the potential of creatinine 
in sewer epidemiology. 
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2. Figures 
 
Figure 2 Sewer reactors with carriers to grow biofilms using wastewater. 
 
 
 
Figure 3 Degradation profiles of creatinine under different sewer conditions. Error bars represent the standard deviation 
of 3 replicates. 
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Figure 4 Daily load of creatinine vs population in 10 different WWTPs in Australia. 
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2. Tables 
 
Table 4 Degradation of creatinine in wastewater. 
 
Chiaia et al. 
(2008)  
Bisceglia 
et al. 
(2010) 
Bisceglia 
et al. 
(2012) 
Brewer et 
al. (2012) 
Burgard 
et al. 
(2013) 
This study 
pH = 7.5; 20 °C; 12 h. 
Experiment
al 
conditions 
Wastewater 
collected 
from 
different 
WWTPs. 
Wastewate
r 31°C; 
23°C; 9°C; 
24 h  
Deionize
d water 
and 
wastewat
er pH = 
12 
55°C; 3 h 
Wastewate
r collected 
from one 
WWTP. 
4°C; 24 h 
Wastew
ater20°
C; 
72 h 
Waste-
water 
 
Gravity 
sewer 
(aerobi
c) 
 
Rising 
main 
(an-
aerobic) 
 
Concentrati
on range 
(mg/L) 
0.22-1.5 0.06-0.09 0.31-0.55 ~1.2 1.9-10.7 ~1.0 
Degradatio
n 
n/a 
Complete 
loss at 
31°C; 
23°C; 40% 
loss at 9°C   
relatively 
stable 
13% loss  
Stable 
in first 
48h. 
17% 
loss in 
last 24h 
Stable 
27% 
loss 
after 
12h 
99% 
loss 
after 
12h 
 
 
Table 5 Linear regression of creatinine degradation in different sewer reactors. 
 First order kinetics 
 Half-life (h) R2 
Control (wastewater only) n.a a 0.02 a 
Gravity sewer (GS 
reactor) 
24.8 0.96  
Rising main (RM reactor) 2.0 0.95 
a not significantly deviated from zero 
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_________________________________________________________ 
Chapter 3: Assessment of pharmaceuticals and personal care 
products as population markers and the development of a 
population model 
_________________________________________________________ 
 
 
Chapter 2 investigations suggest creatinine is too unstable within the sewer 
environment and no correlation was observed between the daily mass load of 
creatinine in wastewater influent and the population size. Therefore we decided to 
assess pharmaceuticals and personal care products (PPCPs) as population markers 
and to avoid the limitations of using a sole population marker, develop a model which 
includes multiple population markers. Chapter 3 focuses on the assessment of a 
suite of PPCPs as population size markers and the development of a model using 
the best population size markers identified from this assessment.  
The following publication is incorporated as Chapter 3: 
___________________________________________________________________ 
O'Brien, J.W., Thai, P.K., Eaglesham, G., Ort, C., Scheidegger, A., Carter, S., Lai, 
F.Y., Mueller, J.F., 2014. A model to estimate the population contributing to the 
wastewater using samples collected on census day. Environ. Sci. Technol. 48, 517-
525. 
_________________________________________________________________ 
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Abstract:  
An important uncertainty when estimating per capita consumption of e.g. illicit drugs 
by means of wastewater analysis (often referred to as sewage epidemiology) relates 
to the size and variability of the de facto population in the catchment of interest. In 
the absence of a day-specific direct population count any indirect surrogate model to 
estimate population size lacks a standard to assess associated uncertainties. 
Therefore, the objective of this study was to collect wastewater samples at a unique 
opportunity, i.e. on a Census Day, as a basis for a model to estimate the number of 
people contributing to a given wastewater sample. Mass loads for a wide range of 
pharmaceuticals and personal care products were quantified in influents of ten 
sewage treatment plants (STP) serving populations ranging from approximately 
3,500 to 500,000 people. Separate linear models for population size were estimated 
with the mass loads of the different chemical as the explanatory variable: fourteen 
chemicals showed good, linear relationships, with highest correlations for 
acesulfame and gabapentin. Bayesian inference was then used to estimate de facto 
population using the population size provided by STP staff as prior knowledge and 
updated that with the measured chemical mass loads. Cross validation showed that 
large populations can be estimated fairly accurately with a few chemical mass loads 
quantified from 24-h composite samples. In contrast, the prior knowledge for small 
population sizes cannot be improved substantially despite the information of multiple 
chemical mass loads. In the future, observations other than chemical mass loads 
may improve this deficit, since Bayesian inference allows including any kind of 
information relating to population size. 
 
 
3. Abstract Art: 
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 Key Words: wastewater, population, estimation, model, Bayesian Inference, 
pharmaceuticals 
 
3.1 Introduction: 
The first documented attempt for estimating the de facto population that is serviced 
by a sewage treatment plant (STP) was developed in the 1970s through a model 
developed for Ocean City in Maryland. This model was to measure tourist influx and 
adjust the number of rostered medical staff appropriately(Goldschmidt and Dahl 
1976). The underlying assumption of the model was that population increase is 
correlated and thus can be estimated from water consumption. However, daily per 
capita water consumption may be variable for several reasons including seasonal 
variations, industrial wastewater input and ex/infiltration of water in the 
sewer(Daughton 2012a, Editorial 2009, Russo 2009).  
The de facto population count, all people present in a given area, is an important 
parameter where chemical loads obtained through wastewater analysis (WWA) are 
used to estimate consumption or exposure of a given population which is sometimes 
referred to as ‘sewer epidemiology’. In particular, there is emphasis on using this 
technique for objective assessment of illicit drug use in the general population 
through WWA(Daughton 2012b). Wastewater analysis data are commonly 
normalised on a per capita basis, i.e. the amount of chemical that was consumed per 
1000 people, per day in a particular catchment. It was recognised that a de jure 
population (usual residents) may not be adequate for this normalisation because: i) 
administrative regions for de jure populations may not coincide with geographic 
catchments of STPs, ii) de jure population estimates may be outdated since they are 
not carried out very frequently, and iii) transient changes are not accounted 
for(Daughton 2012a). Therefore, it was suggested to use a de facto population, i.e. 
the number of people that effectively contributed to the wastewater sample during 
sample collection since it appropriately accounts for population fluxes into or out of 
the catchment, i.e. regular commuters, visitors, tourists etc. People can travel daily in 
and out of catchments for a range of reasons—to work, to study, to go on holiday 
and various other activities—with visits varying both in timing and duration. The 
importance of these population movements has been recognised and discussed by 
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Charles-Edwards and Bell(Charles-Edwards and Bell 2012). Lai et al. highlighted 
that variations in the number of tourists may be substantial in specific locations, such 
as vacation destinations(Lai et al. 2013a).  
Historically, and for practical reasons, wastewater samples are collected over 
periods of 24 hours and conceptually it would be desirable to also have reliable de 
facto population values on a daily basis. The calculation for estimating daily 
consumption of a chemical per person via WWA was first published by Zuccato et 
al.(2008) where 𝐷𝐷 is the chemical of interest, 𝐶𝐶𝑖𝑖  is the concentration of the chemical in 
the sample, 𝐹𝐹 is the total daily volume of water during the sampling period, 𝑅𝑅𝑖𝑖 the 
ratio of the molar mass of the parent chemical to its metabolite, 𝐸𝐸𝑖𝑖 the average 
excretion of the chemical and 𝑃𝑃 is the number of people who contributed to the 
sample. 
𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷 𝑐𝑐𝑒𝑒𝑒𝑒 𝑐𝑐𝐷𝐷𝑐𝑐𝐷𝐷𝑐𝑐𝐷𝐷 𝑑𝑑𝑒𝑒𝑐𝑐𝑚𝑚 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑒𝑒𝑐𝑐𝑐𝑐𝐷𝐷𝑐𝑐𝑐𝑐𝑖𝑖 =  𝐶𝐶𝑖𝑖 ∙ 𝐹𝐹 ∙ 𝑅𝑅𝑖𝑖𝐸𝐸𝑖𝑖𝑃𝑃  
Recently, a number of experimental approaches have been applied to address the 
uncertainty of 𝑃𝑃. For example, Van Nuijs et al.(2011c) normalised their yearlong data 
from the largest STP in Belgium through measuring biological oxygen demand, 
chemical oxygen demand, nitrogen and phosphorous. However, these markers are 
not human-specific as multiple sources can contribute to these loads within sewers 
including food waste and industrial wastewater(Castiglioni et al. 2013, Daughton 
2012a). Instead, to estimate the de facto population, Lai et al.(2011) proposed an 
approach where human-specific markers were measured including both parent 
compounds and/or excreted metabolites of prescription pharmaceuticals (atenolol, 
gabapentin, hydrochlorothiazide, methadone and venlafaxine). The measured mass 
load of each pharmaceutical was then compared with the expected mass load 
according to records in the Australian Pharmaceutical Benefits Scheme database. 
The authors however acknowledged limitations associated with this approach such 
as accuracy of national annual consumption data and the stability of these chemicals 
in sewer systems. Therefore, they suggested another potential human marker, 
acesulfame (an artificial sweetener), because this chemical is not metabolised and is 
fully excreted after consumption. Additionally acesulfame is relatively persistent in 
wastewater(Brorström-Lundén et al. 2008, Buerge et al. 2009), and thus may be a 
useful population marker.  
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Daughton(2012a) alternatively proposed the concept of using endogenous markers 
for population estimation and put forward the potentials and limitations of creatinine 
and coprostanol. Brewer et al.(2012) used creatinine loads to assess relative trends, 
i.e. diurnal and between-day variations over multiple days at a single STP serving 
approximately 50,000 people. Burgard et al.(Burgard et al. 2013) also used 
creatinine to normalize their data for population change but this was for a much 
smaller population of >500 people and was sampled much closer to the source. 
There are, however, limitations with creatinine to be used as a single population size 
marker such as unknown stability in the sewer under varying conditions and there 
are potentially other sources of creatinine input such as abattoir waste(Martin-Tereso 
et al. 2010). Additionally, a recent survey in the United States identified that 34.1% of 
children and adolescents who use dietary supplements take creatine to build body 
mass(Evans et al. 2012) which may lead to increased excretion of its primary 
metabolite creatinine and bias results(Wyss and Kaddurah-Daouk 2000).  
One key problem associated with the development and validation of population 
estimation models concerns the lack of accurate data of populations (i.e. the true 
number of people who contribute to a given wastewater sample) which can ultimately 
be used to validate such models. Thorough population censuses provide an 
opportunity to obtain such data with small error and thus should be utilised. 
Renaud(Renaud 2007) investigated coverage for five countries (Australia, Canada, 
United Kingdom, United States of America and Switzerland) and found 
undercoverage more prevalent and ranged from 1 to 3%. Overcount was only 
observed for the 2000 United States of America census with an estimated 0.5% 
overcoverage.  
The aim of this study was to i) obtain accurate population data for 10 STP 
catchments in Australia on Census Day (a day-specific geo-referenced population 
count), ii) measure mass loads of chemicals and assess their individual capability for 
estimating population size and iii) use Bayesian inference to incorporate chemical 
markers which are representative of population size into a population estimation 
model and validate this model on a leave-one-out basis (cross validation).  
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3.2 Methods: 
3.2.1 Measurement of daily chemical mass loads 
3.2.1.1 Wastewater sampling 
Twenty-four hour composite samples were collected from the raw inlets – before the 
primary clarifier – of ten STPs between the 9th and 11th of August 2011. The STPs 
cover urban, semi-rural and rural catchments located throughout Australia including 
the Australian Capital Territory (one STP), South Australia (two STPs), Tasmania 
(one STP) and Queensland (six STPs) with populations ranging from 3,500 to 
640,000 (estimated number of people provided by STP operators). A summary of 
each site including sampling mode, daily wastewater volume and population can be 
found in Table 6. After collection samples were preserved by acidifying to pH 2 with 
2M hydrochloric acid and shipped on ice (chilled or frozen) to the laboratory. The 
samples were stored at -20°C prior to analysis.
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Table 6 Site summary of the sewage treatment plants and samples collected in this study. Enumerated Population on Census Day is the number of people who spent the majority of 
Census Day in that catchment area. Usual population is the number of people who reside in the STP catchment area. Best estimate of the model is the estimated number of people for 
that site using the Bayesian inference model calibrated in this manuscript. 
STP 
Size STP ID Date Sampled (D/M/Y) State 
Sampling 
Mode 
ΔT 
or 
ΔV 
Daily Flow 
(Megalitres) 
Nominal 
Population 
(STP 
operator 
estimate) 
de facto 
(ABS 
census) 
de jure 
Usual 
Population 
Best 
estimate 
of our 
model 
(S14) 
80% Inter-
quantile of 
posterior 
Ratio of 80% 
Interquantile 
Prior to 80% 
Interquantile 
Posterior for S14 
% Difference 
of STP 
estimate and 
our best 
estimate 
% 
Difference of 
ABS census 
and our best 
estimate 
S
m
al
l 
STP 1 10/08/2011 South Australia 
Volume 
Proportional 
10 
m3 1.6 3,500 3,682 3,692 3,542 4,169 1.06 1.2 -3.8 
STP 2 10/08/2011 South Australia 
Volume 
Proportional 
20 
m3 3.8 10,000 8,995 9,272 9,398 9,818 1.26 -6.0 4.5 
STP 3 11/08/2011 Tasmania 
Continuous 
Non-Flow 
Proportional 
NA 12.6 28,000 25,698 25,992 29,912 18,768 1.87 6.8 16 
STP 4 09/08/2011 Queensland Time Proportional 
20 
min 4.1 26,600 38,005 38,000 24,143 16,671 1.96 -9.2 -37 
STP 5 10/08/2011 Queensland Time Proportional 
60 
min 10.2 40,000 43,513 43,648 50,442 21,083 2.42 26 16 
La
rg
e 
STP 6 10/08/2011 Queensland Volume Proportional 
100 
m3 21.4 100,000 86,882 86, 592 96,386 22,538 5.52 -3.6 11 
STP 6 11/08/2011 Queensland Volume Proportional 
100 
m3 21.2 100,000 86,882 86, 592 103,615 22,372 5.75 3.6 19 
STP 7 10/08/2011 Queensland Time Proportional 
20 
min 15.6 96,000 92,104 92,486 85,590 19,648 6.2 -11 -7.1 
STP 7 11/08/2011 Queensland Volume Proportional 
20 
min 15.2 96,000 92,104 92,486 87,132 19,623 6.27 -9.2 -5.4 
STP 8 09/08/2011 Queensland 
Continuous 
Flow 
Proportional 
NA 57.1 330,000 230,117 211,340 235,904 19,896 19.6 -29 2.5 
STP 8 10/08/2011 Queensland 
Continuous 
Flow 
Proportional 
NA 56.4 330,000 230,117 211,340 220,000 19.238 19.7 -33 -4.4 
STP 8 11/08/2011 Queensland 
Continuous 
Flow 
Proportional 
NA 58.0 330,000 230,117 211,340 243,855 19,263 19.8 -26 6.0 
STP 9 09/08/2011 
Australian 
Capital 
Territory 
Time 
Proportional 
60 
min 80.3 345,000 342,459 338,888 340,843 17,954 26.6 -1.2 -0.5 
STP 10 11/08/2011 Queensland Time Proportional 
20 
min 127.4 643,000 495,027 474,520 454,490 15,130 49.6 -29 -8.2 
ΔT = time between samples, ΔV = volume between samples, de facto (ABS census) = enumerated people on Census Day, de jure Usual Population = persons usually residing at the address 
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3.2.1.2 Analytical standards 
Analytical grade formic acid was purchased from Sigma Aldrich (Castle Hill, 
Australia). Analytical grade hydrochloric acid 32% was purchased from Univar 
(Ingleburn, Australia). Water was purified through a MilliQ system (Millipore, 0.22 μm 
filtered, 18.2 mΩ cm-1). Analytical grade pharmaceutical and personal care product 
(PPCP) solutions were prepared using only high purity standards (see SI for further 
information) and diluted into MilliQ water for a calibration set. Liquid chromatography 
grade acetonitrile was purchased from Merck (Darmstadt, Germany). Mobile phases 
were filtered using Sartorius Stedim 0.45 µm RC filters (Goettingen, Germany). 
 
3.2.1.3 Chemical analysis 
Wastewater contains many PPCP’s which are usually measured by solid phase 
extraction (SPE) and concentration. We focussed on PPCP chemicals which could 
be directly measured in filtered (0.45 µm, 47 mm nylon filter membranes 
(Phenomenex, Lane Cove, Australia)) wastewater without the need for extraction 
and concentration using either negative or positive ionisation modes on LC-MS/MS 
because for near real-time population estimation it is important that the time, cost, 
sample preparation and analysis types required are minimised.  
An in-house analytical method from Queensland Health Forensic and Scientific 
Services was optimised and applied for screening 96 PPCPs in wastewater. This 
method is an adaption of U.S. EPA Method 1694(U.S. Environmental Protection 
Agency 2007). Chemical analysis was performed using an AB/Sciex API 5500 QTrap 
mass spectrometer (AB/Sciex, Concord, Ontario, Canada) with an electrospray 
ionization (ESI) interface coupled to a Shimadzu Nexera HPLC system (Shimadzu 
Corp., Kyoto, Japan). Separation was achieved on a Luna C-18 (2) column (3 µm, 
100 Å, LC Column 150 mm x 3 mm, Phenomenex) using a mobile phase gradient of 
1 to 95 % acetonitrile with 0.1% formic acid. Instrumental parameters can be found in 
the Supporting Information.  
For quantification both filtered samples and calibration standards (5 – 100 µg L-1) 
were spiked with deuterated standards ranging from 20 to 200 µg L-1 depending on 
chemical sensitivity prior to direct injection analysis. Reagent blanks were prepared 
with MilliQ water acidified to pH2 with HCl. For quality control and assurance, all 
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samples including the reagent blanks were spiked with the deuterated standards and 
were run in triplicate. The results were averaged. Positive reagent blank results were 
averaged and subtracted from the measured concentration within the samples. The 
analytical method was reproducible with the LOD for most chemicals of 1 µg L-1 
within wastewater and a linear quantitation range between 5 and 100 µg L-1.  
 
3.2.1.4 Population count on Census Day (ABS census) 
The population census is costly and as such only occurs every five years in 
Australia. Sampling was therefore organised to correspond with the Census Day. 
Ten STPs participated in this study and samples were collected either on or around 
the 2011 ABS Census Day, the 11th August 2011 (Table 6). Each STP provided a 
map with boundaries of the physical catchment they serve. The Australian Bureau of 
Statistics (ABS) determined the population connected to each STP by intersecting 
geo-referenced census data available at the administrative level “Statistical Area 1” 
with the catchment maps. There are approximately 54,000 “Statistical Area 1” 
regions covering Australia with approximately 400 people per region. The data 
returned by the ABS was for both Enumerated Population (population count based 
on where people spent most of their time on Census Day, hence de facto population) 
and Usual Population (population count based on residential addresses, hence de 
jure population). A site summary is provided in Table 6 (ABS, Customised report, 
2012). While census participation in Australia is compulsory, a number of quality 
assurance procedures are in place to ensure the accuracy of the data such as a post 
enumeration survey conducted a month after census where a sample survey is 
conducted and compared with the census data which indicated that the 2011 census 
undercounted the population by approximately 1.7%(Australian Bureau of Statistics 
(ABS) 2011). For the purpose of this study we used the Enumerated Population 
provided by the ABS (subsequently referred to ABS census) as de facto population.  
 
3.2.2 Relationships of chemical mass loads with population size 
As the aim of this study was to develop and calibrate a model for the de facto 
population using mass loads of a broad range of chemicals, two criteria were chosen 
to identify these chemicals. Criteria 1: the chemical must be measurable via direct 
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injection on LC-MSMS in all of the samples we collected. Criteria 2: the mass load of 
the chemical must show a correlation with population size. Therefore, daily mass 
loads were calculated for the chemicals which were measured in all of our samples 
and plotted against the census population. This unique reference data set covers a 
wide range of STPs allowing the calibration of a separate model for each chemical. 
The models are based on the reasonable assumption that the mass load entering 
the treatment plant per day of a chemical is proportional to the contributing 
population. This implies that the measured mass load 𝑒𝑒𝑖𝑖 of chemical 𝐷𝐷 should be 
modelled as:  
𝑒𝑒𝑖𝑖 = 𝛽𝛽𝑖𝑖𝑃𝑃 +  𝜖𝜖𝑖𝑖 
where 𝑃𝑃 is the corresponding population, 𝜖𝜖𝑖𝑖 the error term, and 𝛽𝛽𝑖𝑖 the estimated 
parameter for chemical 𝐷𝐷. The error term accounts for differences in consumption 
between locations and daily variations. It is assumed that 𝜖𝜖𝑖𝑖 is independent normally 
distributed with standard deviation 𝜎𝜎𝑖𝑖 that is independent of the population.  
Basically, there are three options for the error term that will be discussed 
subsequently: 𝜖𝜖1) a relative error term, i.e. the standard deviation is proportional to 𝑃𝑃, 
𝜖𝜖2) a constant error term (independent of 𝑃𝑃), and 𝜖𝜖3) an error term whose standard 
deviation decreases for large 𝑃𝑃. 
Measurement errors are often modelled with a relative error term (𝜖𝜖1). Conceptually, 
one might expect the error term: 𝜖𝜖3 the variability of an aggregate consumption of a 
large population, to be small, whereas a consumption pattern from a few individuals 
in a small population may lead to large deviations. However, in view of the available 
data (see Figure 4) there is neither evidence for 𝜖𝜖1 nor 𝜖𝜖3 and only the constant error 
term 𝜖𝜖2 seems to be substantiated.  
With this error term and the estimated parameter 𝛽𝛽𝑖𝑖 the predictive probability density 
𝑐𝑐𝑖𝑖(𝑒𝑒|𝑃𝑃) for mass load 𝑒𝑒𝑖𝑖 for a given population is defined. In paragraph 2.4 all 
single chemical models are combined to estimate the population. 
 
3.2.3 Population estimation 
For the population estimation the probability distribution of the population given 𝑐𝑐 
measured mass loads, 𝑐𝑐𝑃𝑃𝑃𝑃𝑃𝑃(𝑃𝑃|𝑒𝑒1, … ,𝑒𝑒𝑛𝑛), is of interest. This distribution is calculated 
according to Bayes theorem: 
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𝑐𝑐𝑃𝑃𝑃𝑃𝑃𝑃(𝑃𝑃|𝑒𝑒1, … ,𝑒𝑒𝑛𝑛) =  𝑐𝑐1(𝑒𝑒1|𝑃𝑃) … 𝑐𝑐𝑛𝑛(𝑒𝑒𝑛𝑛|𝑃𝑃)𝑐𝑐𝑃𝑃𝑃𝑃𝑃𝑃(𝑃𝑃)∫𝑐𝑐1(𝑒𝑒1|𝑃𝑃) … 𝑐𝑐𝑛𝑛(𝑒𝑒𝑛𝑛|𝑃𝑃)𝑐𝑐𝑃𝑃𝑃𝑃𝑃𝑃(𝑃𝑃)dP 
∝  𝑐𝑐1(𝑒𝑒1|𝑃𝑃) … 𝑐𝑐𝑛𝑛(𝑒𝑒𝑛𝑛|𝑃𝑃)𝑐𝑐𝑃𝑃𝑃𝑃𝑃𝑃(𝑃𝑃) 
where 𝑐𝑐𝑖𝑖(𝑒𝑒𝑖𝑖|𝑃𝑃) are the predictive probability densities of the chemical models (see 
2.3) and 𝑐𝑐𝑃𝑃𝑃𝑃𝑃𝑃(𝑃𝑃) represents the prior knowledge about the population. For numerical 
computation the proportional relationship is sufficient, so that the integral in the 
denominator need not be evaluated. The resulting posterior distribution, 
𝑐𝑐𝑃𝑃𝑃𝑃𝑃𝑃(𝑃𝑃|𝑒𝑒1, … ,𝑒𝑒𝑛𝑛), can be summarized by its mean and the uncertainty can be 
expressed by the standard deviation or quantiles for confidence intervals. 
In the current study, the prior knowledge about the population 𝑐𝑐(𝑃𝑃) is parameterized 
as gamma distribution. The mode was set to the population estimates provided by 
STP operators and the standard deviation was assumed to be 50% of this value. 
 
3.2.4 Assessing the influence of multiple chemicals   
To assess how the estimate changes with inclusion of multiple chemicals, five 
estimations for the same catchment were made with different numbers of measured 
chemical loads. The first uses only the highest correlating substance for mass load 
versus population (acesulfame) and is labelled substance model 1 (S1). Each 
progressive model doubles the number of substances used for its estimate in the 
order of highest correlating substances for mass load versus population first. As 
there are 14 substances identified as suitable markers for population size, we 
therefore have 5 models with each named after the number of substances they 
contain (S1, S2, S4, S8, S14). A summary of the chemicals which are included in 
each model can be found in Table 7.  
 
3.2.5 Cross-validation 
The predictive capability of the model is validated with a leave-one-out cross-
validation. Thereby, the parameters of the linear regression models (Section 2.3) are 
estimated without one location. For this location the population is then estimated 
based on measured mass loads and compared with the ABS census. This is 
repeated for all locations. The average of all errors provides an estimation of the 
predictive error.  
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 3.2.6 Implementation  
All calculations were programmed using the freely available statistics software 
package R(R Core Team 2012). The summary statistics of the posterior distribution 
are based on 10,000 samples obtained by importance sampling. A link to the code is 
provided in the Supporting Information (SI).  
 
3.3 Results and Discussion: 
3.3.1 Selection of chemicals 
Of the 96 chemicals screened, only fourteen were quantifiable without extraction or 
concentration in most samples. Ten of these have known Australian per capita 
consumption as they are subsidized by the Australian Government through the 
Pharmaceutical Benefit Scheme (PBS). These are atenolol, carbamazepine, 
codeine, furosemide, gabapentin, hydrochlorothiazide, ibuprofen, naproxen, 
norfloxacin and paracetamol. Two are commonly found in food and beverages 
(acesulfame and caffeine), one is an imaging contrast medium (iopromide) and the 
other (salicylic acid) is a metabolite of acetylsalicylic acid which is used as the active 
ingredient in aspirin and other medications primarily for pain relief and as an anti-
inflammatory. Linear regressions for mass loads versus population as counted on 
Census Day were computed for each individual chemical (summary of annual 
consumptions and linear regressions in Table 7). With the exception of iopromide 
(R2=0.38, with one obvious outlier removed from the dataset, otherwise R2=0.62, see 
SI) all selected markers showed strong correlations (R2>0.8) between population and 
mass load. Therefore, they can be used as markers to estimate population size. 
Including or excluding iopromide in the estimation of population size does not affect 
results substantially since the weight of iopromide compared to the other substances 
is low. This is due to the low R2 (see Table 7 and Figure S- 3), which is caused by 
the wide variation of iopromide mass loads, as a consequence of its highly variable 
spatio-temporal application pattern. 
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Table 7 Summary of chemical mass load versus population size, annual Australian consumption and inclusion in the 
Bayesian inference models 
 
Chemical Internal Standard 
βi = Slope of 
chemical mass 
load (Li)[kg/day] 
versus population 
(P)[People] (95% 
Conf. Int.) 
R2 
Total 
Australian 
Consumption 
(kg/year) 
Included in Model 
S1 S2 S4 S8 S14 
Acesulfame acesulfame-d4 7.5e-6 (7.3e-6 – 7.7e-6) 0.995 
Data not 
available      
Atenolol atenolol-d7 3.0e-7 (2.4e-7 – 3.5e-7) 0.823 6,906
a      
Caffeine caffeine-d3 1.1e-5 (9.1e-6 – 1.3e-5) 0.869 
Data not 
available      
Carbamazepine carbamazepine-d10 8.6e-8 (7.2e-8 – 1.0e-7) 0.849 13,436
a      
Codeine 
acetyl 
sulfamethoxazole-
d5 
4.1e-7 (3.6e-7 – 
4.6e-7) 0.908 4,132
a      
Furosemide 
2,4-
dichlorophenylaceti
c acid 
1.2e-7 (9.6e-8 – 
1.4e-7) 0.839 5,911
a      
Gabapentin 
acetyl 
sulfamethoxazole-
d5 
9.8e-7 (9.0e-7 – 
1.1e-6) 0.968 6,718
a      
Hydrochlorothiazide hydrochlorothiazide-13C,d2 
2.1e-7 (1.9e-7 – 
2.3e-7) 0.944 3,748
a      
Ibuprofen 
2,4-
dichlorophenylaceti
c acid 
9.2e-7 (8.1e-7 – 
1.0e-6) 0.919 10,859
a      
Iopromide 
2,4-
dichlorophenylaceti
c acid 
6.8e-7 (3.6e-7 – 
1.0e-6) 0.377 
Data not 
available      
Naproxen 
acetyl 
sulfamethoxazole-
d5 
4.2e-7 (3.7e-7 – 
4.7e-7) 0.912 15,103
a      
Norfloxacin norfloxacin-d5 8.5e-8 (7.5e-8 – 9.5e-8) 0.929 1,678
a      
Paracetamol 
acetyl 
sulfamethoxazole-
d5 
3.2e-5 (2.6e-5 – 
3.9e-5) 0.811 609,543
a      
salicylic acid 
2,4-
dichlorophenylaceti
c acid 
5.2e-6 (4.6e-6 – 
5.9e-6) 0.922 
Data not 
available      
a Data from DUSC Drug Utilisation Database 
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Figure 5 Population versus daily mass load of selected chemicals. The black line is the line of best fit. The grey lines 
indicate the 90% prediction interval. 
 
3.3.2 Cross validation  
To validate our approach we employed a leave-one-out cross validation. Bayesian 
updating lead to posterior distributions that are narrower than the priors (only 1.06-
2.42x for small STPs, but 4.98-39.5x for big STPs, see Table 6). Since the chemicals 
for S1 and S2 are the ones with the biggest weight in the estimation process, adding 
more chemicals typically leads to no major change of the best estimate. However, 
the width of the posterior can in most cases be further reduced by adding more 
chemicals, not substantially for small populations though. This explains why STP 
estimates for small catchments cannot be improved. In contrast, for most large STPs 
substantial over/underestimation for STP estimates could be improved (refer to last 
two columns of Table 6).  
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Figure 6 illustrates two examples reflecting different population types, a large, urban 
and a small, rural population. These two cases are used to outline the possible, wide 
range of outcomes. The best estimate using all 14 chemicals for all sites including 
the 80% interquantile of the posterior distributions are summarized in Table 6. 
 
 
Figure 6 Bayesian inference population estimation models for A: Large, urban catchment B: Small, rural catchment. The 
blue, dashed line shows the population estimate provided by STP operators. The red line shows the day-specific, geo-
referenced census population count (ABS, Customised report, 2012). The grey line is the assumed prior distribution and 
the black line (blue fill) indicates the posterior of the estimation based on mass loads of chemical markers (density). The 
%-value is the difference between the model’s best estimate (maximum density) and the census population count. A: 
STP 9 B: STP 1 (see Table 6). 
 
In the particular case of STP 9 which serves a large, urban catchment, the 
population estimate made by the STP operators was close to ABS census (Figure 
5A). Using acesulfame as a single parameter (S1) to estimate population leads to an 
underestimate of 7% between the model’s best estimate (maximum density of 
posterior distribution) and ABS census. Using four chemicals (S4) also 
underestimates the population size by 5% while using all 14 chemicals (S14) results 
in 0% difference between the model estimate and the ABS census count. Note that 
the 80% interquantile (difference between the 10% and 90% quantiles) decreases 
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from 23,795 (S1) to 16,216 (S14) demonstrating that the use of more chemicals 
leads to narrower posterior distributions in this case. This implies more confidence in 
the best estimate based on 14 chemicals compared to one chemical only. For STP 9 
all three values, STP estimate, ABS census and best estimate based on measured 
chemical loads, are similar. However, the Bayesian inference does not merely 
confirm the STP estimate and ABS census, it also provides a realistic estimate for 
accuracy (width of posterior). Furthermore, substantial differences from STP 
estimates can be revealed with our model: e.g. the STP estimate for STP 9 was 
330,000 people and our best estimate for three days was between 220,000 and 
243,855, which is a quarter to one third less, but very close to ABS census (3% 
difference only).  
In contrast, for STP 1, the smallest STP in this study, quantifying chemical loads in 
wastewater does not improve the population estimation: the posterior is almost 
congruent with the prior distribution. This is a direct consequence of the constant 
error term for the mass load models described in section 2.3. For a small catchment 
the predicted mass loads are small and so the corresponding relative errors are 
large. Therefore, the observed mass loads have a small weight and only little 
influence on the posterior. This is clearly visualized in Figure 6 for which S1 was 
carried out for each substance individually for both STP 9 and STP 1. When 
estimating the population based on a single compound only, the estimation is only 
unbiased if the consumption of the chemical in the catchment under investigation 
corresponds to the average consumption. This is best illustrated with acesulfame 
and gabapentin which showed the best correlation between population sizes and 
measured mass loads. If acesulfame is used as a single parameter (S1) the 
estimation for STP 9 is close to ABS census, however, if codeine is used as a single 
parameter, the population would be overestimated where as if atenolol was used as 
a single parameter the population would be underestimated as the consumption of 
these chemicals is different to that of the average consumption based on the other 
investigated STP catchments. This demonstrates that even in large STP catchments 
the aggregate consumption of an individual substance does not necessarily tend 
towards a nation-wide average. In small catchments this variation is expected to be 
even higher.  
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Figure 7 Individual substance distributions for estimating population size. A: Large, urban catchment (STP 9, see Table 6) 
B: Small, rural catchment (STP 1, see Table 6). The blue, dashed line shows the estimated population as provided by STP 
operators. The red line shows the day-specific, geo-referenced census population count (ABS, Customised report, 2012). 
The grey shading is the 80% Interquantile of the best estimate based on S14. The black lines (with coloured fill) indicate 
the posterior of the estimate based on the mass loads of each chemical marker (density). The width of the individual 
distributions reflects the goodness of fit of the individual models for each substance (Figure 4 and Table 7). 
 
3.3.3 Estimating the population size in other catchments 
It is expected that applying the Bayesian inference model with this calibration data to 
other large STPs in Australia would provide an accurate estimation of their 
population size as the calibration data collected represents over 6% of the Australian 
population and includes both urban and rural catchments. For applying the model to 
STPs in another country, unless there is confidence that the Australian calibration 
data is reflective of that country’s consumption of the chemical markers, then the 
population estimation model may require recalibration with site specific chemical 
loads and accurate population counts. Therefore we propose three options of how to 
use the model where our calibration is understood to not be applicable to the study 
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site. As the most accurate population count is preferred, the first option requires 
calibrating the Bayesian inference model with chemical mass loads using the same 
approach as this study. This requires wastewater sampling on a day when specific 
population counts can be obtained for the geographical wastewater catchment areas 
and should include a range of STPs including small and large populations and 
covering a wide range of demographics. However, specific population counts may 
not be available and thus we propose the second option where another form of 
population count such as number of tax payers in the geographical wastewater 
catchment area is used. An easier but less accurate method is to use STP operator 
estimated population counts of the population sites for the calibration of the Bayesian 
inference model. All three scenarios are outlined in Table 8. In all three options, 
including a range of STPs of different population sizes within the same geographical 
area under investigation adds more confidence to the calibration data. 
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Table 8 Options for calibrating a Bayesian inference model for estimating population size 
 Linear regression model calibration 
Population 
estimation 
method 
Population count 
used to estimate linear 
models for each 
chemical/marker 
Chemical mass 
loads 
Option 0 
Use Australian data 
(this paper/data set) 
Only measure 
chemicals in STP for 
which estimation 
should be done 
Option 1 
Day specific census data for 
several STPs 
Needed from 
several STPs 
Option 2 
Geographic Information 
System or alternative 
population count 
1..n 
Site specific 
Option 3 STP estimate 
1..n 
Site specific 
 
3.3.4 Options to recalibrate or apply the model elsewhere 
Census counts are conducted infrequently or may not be evaluated and available to the 
same extent as in our study for the calibration and validation of a model. Conceptually, due 
to the expected correlation of pharmaceutical loads with population size, one could also 
make an estimation based on sales data. However, sales data is typically only available on 
a country wide basis and, hence, we cannot make reliable catchment-specific estimates 
due to unknown spatio-temporal variability. Even with the strong assumption of spatio-
temporal homogeneity the following uncertainties remain: completeness of sales data (i.e. 
over the counter and internet), average compliance of us of medication, mean excretion 
rates and potential transformation in sewers. Uncertainty about all these parameters will 
affect estimations based on sales data to an unknown extent. Applying a Monte Carlo 
simulation may provide a distribution of results rather than only a point estimate, however, 
if no information on spatio-temporal variability is available, the confidence intervals may 
still not be realistic. In contrast, with our approach, all these uncertainties are considered 
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implicitly: i) systematic differences (e.g. incomplete sales data, non-compliance of use of 
medication) will lead to properly adjusted slopes in the linear regression models. ii) 
Random differences (e.g. day-to-day variation, demographics) will lead to bigger standard 
errors of estimated slopes, which in turn leads to wider confidence intervals of estimates 
obtained with Bayesian updating.   
Monitoring annual sales amounts of the selected pharmaceuticals may reveal changes in 
consumption patterns, which would require a re-calibration of the model. If per capita 
consumption is similar (either in Australia or another country, compare Table 7) the data 
from this study can be used (Option 0, Table 8). Whenever there is a Census Day, 
samples should be collected to calibrate and validate a model as in this study (Option 1, 
will be repeated in Australia in 2016). Since population size is likely to vary any day 
thereafter, we can use pharmaceutical loads in wastewater to estimate a day-specific 
population that contributed to any given wastewater sample. Option 2 is an alternative to 
obtain an estimate of the population connected to a STP: e.g. through cell phone 
mapping23 or the analyses of geo-referenced census data (available in some countries, 
however, mostly only for de jure population). Option 3 must be applied cautiously, as STP 
estimates may often be based on nutrient loads that have other sources (e.g. industry) 
and, therefore, overestimate the number of people (since the loads are population 
equivalents).  
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 _____________________________________________________________ 
Chapter 4: Impact of in-sewer degradation of pharmaceutical and 
personal care product (PPCP) population markers on a population 
model 
_____________________________________________________________ 
Using the model developed as part of Chapter 3 to estimate the population contributing to 
wastewater samples, a study was performed to assess the feasibility of determining de 
facto population size and the effect on estimating the population normalised drug 
consumption (PNDC) for a large community over an extended period. By analysing 311 
daily composite wastewater influent samples for the chemicals outlined in Chapter 3 and 
determining the de facto population size using the model, it was found that for the given 
community, the de facto population was on average 32% higher than the de jure 
population and as a result any PNDC using only the de jure population would lead to a 
22% systematic overestimation (Lai et al. 2015). Using the model, the uncertainty of the 
PNDC could be reduced by a factor of two hence demonstrating the importance of using 
such a model for future WBE studies.  
One aspect of the model however which was not addressed was the suitability of the 
selected chemicals as population markers for other catchments and whether or not in-
sewer degradation of these chemicals contributes to the uncertainty of the population 
model. As little is known about the in-sewer stability of these chemicals, Chapter 4 
assesses the stability of the fourteen chemical markers under sewer conditions (both 
pressurised and gravity) using laboratory scale sewers. Using the in-sewer degradation 
data and the data from our population modelling paper we then assessed whether or not 
degradation was a major source of uncertainty for the model established in Chapter 
3(O'Brien et al. 2014).  
  
81 
 
  
The following submitted publication is incorporated as Chapter 4: 
___________________________________________________________________ 
 
O'Brien, J.W., Banks, A.P., Thai, P.K., Eaglesham, G., Ort, C., Scheidegger, A., Carter, 
S., Lai, F.Y., Mueller, J.F., 2014. A model to estimate the population contributing to the 
wastewater using samples collected on census day. Environ. Sci. Technol. (submitted 2nd 
June 2016) 
___________________________________________________________________ 
 
In Review with Environmental Science and Technology 
Submitted author manuscript 
 
Title: Impact of in-sewer degradation of pharmaceutical and personal care products 
(PPCPs) population markers on a population model  
Authors:  
Jake W. O’Brien*a  
Andrew Banksa 
Jochen F. Muellera  
Guangming Jiangb 
Andrew J. Novica  
Christoph Ortc 
Geoff Eagleshama 
Zhiguo Yuanb 
Phong K. Thaia,d 
 
aThe University of Queensland, The National Research Centre for Environmental 
Toxicology (Entox), 39 Kessels Road, Coopers Plains, QLD 4108, Australia 
bThe University of Queensland, Advanced Water Management Centre (AWMC), St. Lucia, 
QLD 4072, Australia 
cEawag, Swiss Federal Institute of Aquatic Science and Technology, CH 8600 Dübendorf, 
Switzerland 
82 
 
dInternational Laboratory for Air Quality and Health, Queensland University of Technology, 
Brisbane, QLD 4001, Australia 
*j.obrien2@uq.edu.au 
* Tel. +61 (0)7 3274 9009, Fax +61 (0)7 3274 9003 
  
Abstract Art 
 
 
4. Abstract 
Wastewater-based epidemiology (WBE) has become a useful approach that has been 
adopted for monitoring of drug use at the population level and has been adopted to 
understanding consumption of and exposure to other chemicals. A key uncertainty of WBE 
is the size of the population which contributed to a given wastewater sample. Our previous 
study successfully developed and validated a Bayesian inference model to estimate the 
population size based on 14 chemical markers which are: (1) measurable via direct 
injection on LC-MSMS and (2) have mass loads which correlated well with population size 
(R2 > 0.8). However, the potential uncertainty of the model prediction due to in-sewer 
degradation of these markers has not been evaluated. In this study we tested the stability 
of these 14 population markers under both gravity and rising main sewer conditions and 
assessed whether in-sewer degradation of individual population markers impacts the 
population model. We found that five markers (acesulfame, atenolol, carbamazepine, 
gabapentin and ibuprofen), which formed the core of our model, were stable in the sewers 
over the 12 h study period while the others were not (ranging from very little degradation to 
rapid degradation regardless of sewer conditions). Excluding the unstable population 
markers from the population model did not improve the precision of the population 
estimates using the previously developed model. Therefore, we now propose that the core 
markers to be included in our population model for other sites should meet two additional 
criteria: (3) having negligible degradation in wastewater to ensure the stability of chemicals 
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during wastewater collection; and (4) less than 10% in-sewer degradation could occur 
during the mean residence time of the WWTP sewer network.  
 
4.1 Introduction: 
Wastewater-based epidemiology (WBE) has become a useful approach for monitoring of 
drug use at the population level (Baker et al. 2014, Banta-Green et al. 2009, Burgard et al. 
2014, Castiglioni et al. 2013, Lai et al. 2015, Lai et al. 2011, Ort et al. 2014b, van Nuijs et 
al. 2011b). Challenges remain to improve the accuracy of the approach and a key 
uncertainty associated with WBE relates to the population that has contributed to a given 
wastewater sample (Castiglioni et al. 2013) which is essential for the normalisation of the 
estimates. Normalised data is important to ensure that WBE is comparable across cities 
and even countries. A number of proxies have previously been proposed to address the 
population uncertainty. These include nutrients such as N and P, biological oxygen 
demand (BOD) and chemical oxygen demand (COD) (Been et al. 2014, van Nuijs et al. 
2011c), creatinine (Brewer et al. 2012), caffeine and nicotine (Senta et al. 2015), as well 
as selected pharmaceuticals and personal care products (PPCPs) and an artificial 
sweetener (Lai et al. 2011). But none of the proposed population markers were calibrated 
against accurate population counts and thus were not validated yet. In our previous paper, 
a Bayesian inference model was developed to estimate de facto population size using 14 
anthropogenic markers (Table 9) (O'Brien et al. 2014) using samples from 10 wastewater 
treatment plants (WWTPs) collected during the 2011 Australian Census. We subsequently 
applied this model successfully to support a study on daily drug use monitoring in a 
catchment in South East Queensland, Australia (Lai et al. 2015). However, we recognised 
that some chemicals may degrade in the sewer (Thai et al. 2014a). Therefore, it is 
important to investigate whether degradation during sewer passage contributes to the 
uncertainty of the population estimation model.  
In-sewer degradation is a result of both hydrochemical and biotransformation processes in 
the sewer and as such is dependent on the chemistry (e.g. metals, micropollutants, 
nutrients, pH) of the wastewater, the bioactivity in the sewer and residence time of the 
wastewater in the sewer(Jelic et al. 2014), (McCall et al. 2015). In real sewers the 
chemistry, bioactivity and residence times are dependent on the flow and composition of 
water entering from the catchment at the time(McCall et al. 2015). Additionally, sewers are 
complex systems comprising of a multitude of pipes ranging from small, pressurised pipes 
called rising mains (RM) to large partially filled gravity fed pipes called gravity sewers 
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(GS). As such the surface area which biofilm can grow on is dependent on both the size of 
the pipe and how full the pipe remains. The ratio of area of biofilm versus volume of 
wastewater is thus termed the A/V ratio. Sewer networks comprise of sections ranging 
from low A/V to high A/V with differing residence times in each. A major limitation of in-
sewer chemical degradation monitoring is that the observed degradation rates need to be 
statistically higher than the uncertainty of the chemical analysis and thus high A/V and 
residence times may be required. Using laboratory-scale sewer reactors overcomes this 
limitation as both the A/V and residence time can be controlled (Jiang et al. 2013, Thai et 
al. 2014a).  
 
The aim of this study is to 1) assess the stability of the 14 population markers proposed in 
O’Brien et al. (2014) under sewer conditions; 2) assess whether potential degradation of 
these population markers in the sewer impacts the population model. From this we 
propose a protocol to assess whether a chemical can be used as a population marker. 
 
4.2 Materials and Methods: 
4.2.2 Chemicals and reagents 
Analytical grade acetic acid was purchased from Sigma Aldrich (Castle Hill, Australia). 
Analytical grade hydrochloric acid 32% was purchased from Univar (Ingleburn, Australia). 
Water was purified through a MilliQ system (Millipore, 0.22 μm filtered, 18.2 mΩ cm-1). 
High purity PPCP native and labelled analytical standards were purchased from various 
suppliers as outlined in the SI. Calibration standards were prepared in MilliQ water. Liquid 
chromatography grade methanol was purchased from Merck (Darmstadt, Germany). 
Mobile phases were filtered using Sartorius Stedim 0.45 µm RC filters (Goettingen, 
Germany).  
 
4.2.3 Laboratory-scale sewer reactors 
Laboratory-scale sewer reactors, with high A/V (70.9 m2/m3) which is similar to A/V ratios 
of small pipes, were used to investigate the biotransformation and degradation of the 
population markers. These reactors have been described elsewhere (Jiang et al. 2010, 
Thai et al. 2014a, Thai et al. 2014b). Briefly, the system comprised of laboratory-scale RM, 
GS and a control reactor (CR). Earlier studies using these reactors have found them 
suitable for studies regarding in-sewer processes, the control of sewer biofilm activities 
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and the in-sewer degradation of chemicals (Gutierrez et al. 2008, Jiang et al. 2011a, Jiang 
et al. 2010, Jiang et al. 2013, Mohanakrishnan et al. 2009, Thai et al. 2014a, Thai et al. 
2014b). The sewer reactors are fed with domestic wastewater collected on a weekly basis 
from a local pumping station (Indooroopilly, Brisbane) which is typically at pH 7.5 with 
sulphide concentrations <3 mg S/L, sulfate between 10 and 25 mg S/L, total COD between 
450 and 600 mg/L, soluble COD between 260 and 450 mg/L which contains volatile fatty 
acids between 50 to 120 mg COD/L (Thai et al. 2014b). The collected wastewater is stored 
at 4 °C and warmed to ~20 °C prior to feeding into the reactors. Feeding events occur at 6 
hour intervals to mimic the typical hydraulic retention time of a real sewer (Hvitved-
Jacobsen et al. 2013) and last approximately 2 minutes during which time one reactor 
volume (0.75 L) of wastewater is delivered to the reactor. Magnetic stirrers set to 250 rpm 
(Heidolph MR3000) homogenise the wastewater in the reactors. Further description of the 
reactors can be found in Thai et al. (2014a).  
 
4.2.4 Batch tests for the degradation of PPCPs in sewer reactors 
To investigate the degradation of the PPCPs under different sewer conditions, batch tests 
were conducted in triplicate. To meet OECD guideline No. 314, wastewater from the 
sampling pump station was warmed to 20 °C however no pH adjustment was necessary 
(OECD 2008). These conditions are comparable with other studies on the stability of 
chemicals under sewer conditions (Chen et al. 2012a, Plosz et al. 2013, Thai et al. 2014b, 
van Nuijs et al. 2012). Preliminary analysis of the wastewater was conducted to determine 
the spiking amount. Only furosemide, iopromide and norfloxacin required spiking for 
degradation to be measured accurately to give a spiked concentration of 5-10 μg/L above 
concentrations already present in the wastewater but within the range usually found in 
previous wastewater studies. For this purpose, a working solution of PPCP standards from 
5 - 10 μg/mL was prepared in 50:50 methanol/deionised water and spiked in to the 
wastewater. Other chemicals can be tested with the residues already available in the 
wastewater matrix. The wastewater was then pumped using a peristaltic pump (Masterflex 
7520-47) into the RM and GS reactors ensuring that the wastewater in each reactor was 
entirely replaced with fresh wastewater. Mixing occurred continuously for the duration of 
the batch tests using magnetic stirrers set to 250 rpm (Heidolph MR3000). This not only 
improved homogeneity of the wastewater but also enhanced surface aeration (dissolved 
oxygen of ~0.5 mg/L) producing both aerobic and anaerobic conditions in the GS reactor. 
The CR was basically the same as the GS except that the walls are regularly cleaned 
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hence preventing the growth of biofilms, however, mixing still occurred which enhanced 
the aerobic conditions for the CR (DO = 0.5 mg/L). Wastewater samples were taken at 0, 
0.25, 0.5, 1, 2, 3, 6, 9 and 12 hours after the feeding event. Samples were immediately 
filtered using 0.20 μm PTFE syringe filters (Phenomenex, Australia) into 2 mL vials. Fifteen 
μL of 2 M HCl was added to each sample to acidify the sample to ~pH 2 and then samples 
were frozen at -20 °C prior to analysis. 
 
4.2.5 Chemical Analysis  
A slightly modified version of the chemical analysis outlined in O’Brien et al (2014) was 
performed using a Sciex QTrap 6500 (Sciex, Concord, Ontario, Canada) with electrospray 
ionization (ESI) interfaces coupled to Shimadzu Nexera HPLC systems (Shimadzu Corp., 
Kyoto, Japan). Separation was achieved on a Kinetix Biphenyl column (2.6 µm, 100 Å, LC 
Column 50 mm x 2.1 mm, Phenomenex) using a mobile phase gradient of 1 to 95 % 
methanol with 0.1% acetic acid. The QTrap 6500 was operated in scheduled multiple 
reaction monitoring (sMRM) mode with optimised parameters (Table S- 4). Data 
acquisition was performed using the Sciex software package Analyst Software 1.6 and 
quantification was performed using MultiQuant 3.0. Quantification was done using relative 
response factors of mass labelled internal standards.  
For dissolved sulphide, samples were analysed within 24 h of sampling using an ion 
chromatograph with an UV and conductivity detector (Dionex ICS-2000). For methane 
analysis, BD vacutainer tubes were allowed to reach gas/liquid equilibrium overnight. 
Methane in the gas phase was measured by gas chromatography (Shimadzu GC-9A) 
equipped with a flame ionization detector. Concentrations of methane in sewage were 
calculated using mass balance and Henry’s law (Guisasola et al. 2008). 
 
4.4 Results and Discussion: 
4.4.1 Biological activities in sewer reactors 
The biological activity of the RM and GS reactors used in this experiment has previously 
been found to represent the biological activity and associated degradation of chemicals 
within actual sewers (Thai et al. 2014a). The control reactor showed no significant 
methane or sulphide gas production as it doesn’t contain the sewer biofilms compartment 
as seen before (Thai et al. 2014b). The RM reactor produced sulphide and methane 
indicating that it was under anaerobic conditions. Activities of sulphate-reducing bacteria 
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and methanogenic archaea in the RM reactor were measured at 7.21 ± 0.74 mg S/L-h and 
29.73 ± 0.63 mg COD/L-h respectively which is similar to previously reported values for 
both real and laboratory-scale sewers (Guisasola et al. 2008, Jiang et al. 2011a, Jiang et 
al. 2011b, Thai et al. 2014b). Dissolved oxygen in the GS reactor was measured below 
0.33 mg/L despite continuous aeration which indicates aerobic activity consuming oxygen. 
It is also expected that anaerobic conditions may be present in the bottom of the reactor 
where oxygen could not reach. This is supported by the low reduction of sulphate (4.21 ± 
0.77 mg S/L-h) and the low production of methane (14.8 ± 2.31 mg COD/L-h).  
  
4.4.2 Degradation of PPCPs in the sewer reactors 
Figure 7 shows the concentration profile of chemicals of interest in the system over time 
normalised to the concentration at the start of the experiment expressed in percent (i.e. 
Ct/C0 x 100). To understand the degradation kinetics of the PPCP population markers, 
both linear regression (zero order) and pseudo first order regression were fitted to the data 
obtained from the batch tests (Table 9). For the pseudo first order, the regression intercept 
was set through 100% at time 0. The kinetic model chosen for the degradation of each 
compound was based on the fit to the model, i.e. the model with the higher R2 value. For 
compounds where degradation observed was within the uncertainty of measurements, we 
concluded that no degradation had occurred over the studied period (12 hours) and thus 
these compounds are stable.  
To our knowledge only Jelic et al. (2014) have investigated the fate of selected PPCPs 
under sewer conditions. That study however was conducted only in a pressurised sewer 
which is similar to that of the RM in our study. It is important to note though that the sewer 
reactors used for our experiment had fixed area to volume (A/V) ratios of 70.9 m2/m3 which 
is similar to A/V ratios of small pipes but higher than that of average sewers which typically 
use larger diameter pipes. Therefore the chemicals investigated in this study may have 
had more contact with biofilms and hence more degradation than would be expected in a 
typical sewer. This may explain why some discrepancy was observed between our results 
and that of Jelic et al. (2014) who had an A/V ratio of 8 m2/m3. As no other studies have 
looked at the degradation within a GS, we conducted a comparison between our results 
with available data on the removal efficiency of WWTPs for those PPCPs (Table 9). Such 
a comparison helps support our findings although we acknowledge that fate and transport 
processes during wastewater treatment are different from those during sewer passage 
(Blair et al. 2015, Liu and Wong 2013) (S1 SI). 
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It was observed that there are two groups of chemicals, those which had no measurable 
degradation (acesulfame, atenolol, carbamazepine, gabapentin and ibuprofen) and those 
which degraded over the studied period with half-life estimates ranging from 0.6 to 10 h in 
the GS and 0.6 to 11h in the RM. Detailed discussion for the degradation of each chemical 
can be found in the SI. 
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Figure 8 Degradation profiles of 14 population markers under different sewer conditions. Error bars represent the standard 
deviation of 3 replicate samples. The x axis is the time after the feeding event. The y axis is the concentration relative to the 
starting concentration (time zero) expressed as percent. Concentrations under control conditions are indicated by ×. 
Concentrations under gravity sewer (GS) conditions are indicated by ■. Concentrations under rising main (RM) conditions are 
indicated by ▲.  
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Table 9 Selection of kinetics models for degradation of the 14 population markers under sewer conditions. The model which fitted with the higher R2 value was selected except where 
linear regressions indicated no significant degradation (i.e. less than the uncertainty of the measurement). The selected model for each compound under the particular sewer condition is 
indicated by bolded text. Time before 10% loss under each sewer condition was calculated using the selected model for each compound.  
Chemical 
Correlation 
between mass 
load and 
population 
size(O'Brien et 
al. 2014) 
Linear regression (Zero order) First-order Kinetics Time before 10% loss (h) 
WWTP Removal 
Efficiency % Control Gravity Sewer Rising Main Control Gravity Sewer Rising Main Control Gravity Sewer 
Rising 
Main 
R2 Rankinga 
Slope 
(%/h) R
2 Slope (%/h) R
2 Slope (%/h) R
2 Half-life (h) R
2 Half-life (h) R
2 Half-life (h) R
2 
acesulfame 0.995 1 n.s.  n.s.  n.s.  >500 0.005 >500 0.000 100 0.075 >24 >24 >24 -(Buerge et al. 2009) 
atenolol 0.823 12 n.s.  n.s.  n.s.  94 0.070 96 0.062 43 0.108 >24 >24 >24 
<0-85.1%(Jelic et al. 
2014),(Luo et al. 2014) 
caffeine 0.869 9 n.s.  
-8.08 
 ± 0.37 
0.95
2 
-8.27  
± 0.8 
0.80
9 200 0.024 4.0 0.967 1.8 0.981 >24 0.61 0.28 
>49.9-99.6%(Blair et al. 
2015),(Luo et al. 2014) 
carbamazepin
e 
0.84
9 10 n.s.  n.s.  n.s.  150 0.024 170 0.011 >500 0.000 >24 >24 >24 
<0-62.3%(Jelic et al. 
2014),(Blair et al. 
2015),(Ryu et al. 
2014),(Rodayan et al. 
2014),(Luo et al. 2014) 
codeine 0.908 8 
1.02  
± 0.49 
0.11
7 
-7.13 
 ± 0.65 
0.78
4 
-7.77  
± 0.73 
0.82
0 >500 0.000 3.8 0.867 2.1 0.983 >24 0.57 0.32 13%(Rodayan et al. 2014) 
furosemide 0.839 11 
-6.08 
 ± 0.77 
0.71
5 
-5.9 
 ± 0.81 
0.68
0 
-4.57  
± 0.91 
0.50
1 5.7 0.764 5.8 0.731 1.9 0.708 0.87 0.88 0.29 
40 - 80%(Kasprzyk-
Hordern et al. 2010) 
gabapentin 0.968 2 n.s.  n.s.  n.s.  460 0.001 90 0.062 110 0.029 >24 >24 >24 
0 - 84%(Kasprzyk-Hordern 
et al. 2010),  
6.4%(Gurke et al. 2015) 
hydrochloro-
thiazide 
0.94
4 3 
1.39 
 ± 0.42 
0.25
2 n.s.  
-1.11  
± 0.48 
0.17
8 >500 0.000 300 0.009 59 0.175 >24 >24 9.01 
0(Radjenovic et al. 
2009),(Schroder et al. 
2010) - 
85%(Radjenovic et al. 
2007) 
ibuprofen 0.919 6 n.s.  n.s.  n.s.  320 0.002 71 0.029 270 0.004 >24 >24 >24 
72 - 100%(Kasprzyk-
Hordern et al. 2010),(Luo 
et al. 2014) 
iopromide 0.377 14 
-2.26  
± 0.86 
0.21
5 
-3.55 
 ± 0.63 
0.55
7 
-2.99  
± 0.9 
0.30
7 17 0.234 10 0.609 11 0.354 2.55 1.52 1.63 >80%(Kormos et al. 2011) 
naproxen 0.912 7 n.s.  
-3.15 
 ± 1.1 
0.20
0 
-3.26  
± 0.94 
0.32
3 48 0.038 23 0.193 22 0.314 >24 3.17 3.07 
43.3-98.6%(Ryu et al. 
2014),(Luo et al. 2014) 
norfloxacin 0.929 4 n.s.  
-4.46 
 ± 1.1 
0.39
6 
-4.89  
± 1.11 
0.43
9 >500 0.001 0.6 0.819 0.6 0.864 >24 0.09 0.09 
87 - 100%(Blair et al. 
2015),(Ternes 
1998),(Vieno et al. 2006) 
paracetamol 0.811 13 n.s.  
-8.31  
± 0.96 
0.69
3 
-6.74  
± 1.2 
0.56
0 120 0.070 1.5 0.949 0.8 0.986 >24 0.22 0.12 
98.7-100%(Ratola et al. 
2012),(Luo et al. 2014) 
salicylic acid 0.922 5 
-8.26  
± 0.55 
0.89
9 
-8.79  
± 0.66 
0.85
0 
-7.49  
± 1.14 
0.63
5 5.2 0.869 2.6 0.953 1.3 0.929 1.21 0.40 0.20 
89.6-100%(Ternes 
1998),(Lee et al. 
2005),(Luo et al. 2014) 
a = population biomarker rankings are from O’Brien et al. (2014)(2014) with 1 being the best marker, 14 the worst 
n.s. = not significantly different from zero; bolded values = kinetic model chosen  
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4.4.3 Implications of in-sewer degradation for PPCPs on a population model 
and recommendations for future population models 
In terms of ranking potential population markers in the population model proposed in 
our earlier work (O'Brien et al. 2014), acesulfame was selected as the best marker 
due to a strong correlation between mass load and population size (Table 9) (R2 = 
0.995) followed by gabapentin (R2 = 0.968), hydrochlorothiazide (R2 = 0.944) and 
norfloxacin (R2 = 0.929). We had assumed that these linear regressions would also 
take into account uncertainties such as degradation/transformation in the sewer, 
variability from the different sampling methods, and any differences in consumption 
and excretion in the different regions. Combined with the sewer degradation data 
obtained from this study, which is arguably from what would be considered a worst 
case scenario in terms of high levels of degradation processes, it can be suggested 
that uncertainty from degradation is not an issue for acesulfame, atenolol, 
carbamazepine, gabapentin and ibuprofen. Therefore, it is likely that the variability 
observed in the linear regressions for the mass loads of these population markers 
versus population size presented in O’Brien et al. (2014) reflects the variance 
associated with other factors such as differences in consumption and excretion as 
well as uncertainty associated with sampling and analysis.  
To understand if there is a link between degradation and the uncertainty associated 
with the correlations between mass loads and population, we correlated the R2 
values for the correlation between mass load and population size from the previous 
paper (O'Brien et al. 2014) and the time taken for 10% loss under each of the sewer 
conditions in this study and found that there was no relationship (Spearman’s rank 
correlation, p < 0.05) (Table S- 6). For example, norfloxacin was considered unstable 
under sewer conditions but had better correlation (R2 = 0.912) between population 
size and mass load than carbamazepine (R2 = 0.849) which was stable under all 
sewer conditions. One plausible explanation for why degradation did not affect the 
correlations between mass loads and population is that the sewer reactors had 
higher A/V ratios than that of average sewer systems. In our study, the A/V ratio was 
70.9 m2/m3 which is about 2-10 times higher than that of average sewers which 
typically comprise of larger diameter pipes. In a typical sewer system, the residence 
time in small pipes is much shorter as the small pump stations usually have higher 
running frequency (Jelic et al. 2014). Therefore, the degradation observed in our 
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study is likely representative of a worst case scenario while in actual catchments 
(such as for the catchments in the model calibration data), the extent of degradation 
is much lower and probably did not affect the overall uncertainty of mass load 
measurements. For degradation to affect a correlation there must be a crossover 
between residence time and degradation (e.g. the observed degradation in some 
catchments would be higher than others because of longer residence times). We 
speculate that other factors may be responsible for the higher uncertainty but this 
requires further investigation.  
To visualise the influence of stability on the uncertainty of our population estimate, 
we compared the coefficient of variation (CV) of the population estimate for each 
catchment based on all chemicals (s14 in the paper) and the stable chemicals 
identified in this study (Figure 8). For all WWTP catchment population estimates 
made using the model, the CV was lower (higher precision) by using all 14 
compounds in the model than just the stable chemicals. Individual substance 
distributions for the three largest WWTPs are shown in SI Figure S- 5.     
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Figure 9 Coefficient of variation expressed as percentage for posterior estimates for population size for each of the 
WWTPs from O’Brien et al. (2014) using all chemicals (s14, indicated by ▲) and using only the chemicals identified as 
stable in the sewer by this study (indicated by ▼).  
 
For future calibration of a population model, if the only chemicals identified are 
unstable in the sewer and/or where the stable chemicals have no relationship 
between mass load and population size, we propose to still use less stable markers 
but also include a metabolite/metabolites or transformation products which are 
produced from the degradation of the compound within the sewer. This will then 
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provide insight into degradation within the sewer and to also counterbalance the 
impact of the degradation of the parent chemical on the model.  
 
4.4.4 Importance of the quality of calibration data used in a population model 
The samples from our previous study used to calibrate the model covered a broad 
range of catchments from across Australia including small catchments, large 
catchments, different climate and geographic zones (from cold temperate to 
subtropical), inland and coastal catchments and catchments with potential cultural 
and socioeconomic differences. These factors may all influence the consumption, 
excretion and degradation of the population markers investigated and thus influence 
the calibration data. Despite these factors, the correlation between mass load and 
population size was still above R2 = 0.8 for 13 of the 14 population markers.  
In the model, an error term was included that accounts for differences in 
consumption between locations and daily variations of population size. It was implied 
that daily variations would include factors that would contribute to either the addition 
(increase in mass load) or removal (decrease in mass load) of a chemical in 
wastewater.  
Degradation is therefore one variable in daily variations and its effect on the 
population model is the extent that the degradation of a chemical would affect the 
variance in the correlation between mass load and the population size. However, if 
the combined impact of A/V ratios and mean residence times are all similar among 
catchments, then the chemical would degrade to a similar extent and we would get a 
systematic underestimation of total consumption. In such a case, there is still a good 
correlation between mass load and population size (assuming relatively 
homogenous consumption and excretion) and thus the population estimate would be 
unaffected by the degradation. The quality of the population estimates is therefore 
dependent on the quality (representativeness) of the calibration data and as such, 
calibration data for a different area or country should include catchments of both long 
and short residence times as well as a combination of GS and RM sewers. By 
including these in the calibration data, variability due to degradation is covered 
implicitly.  
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4.4.5 Applicability to other sewer catchments 
Degradation within sewers is dependent on the residence time in the sewer. Using 
data from the most comprehensive WBE study which covered 25 WWTPs in 2012 
and 47 WWTPs in 2013 (Ort et al. 2014b), we correlated mean residence time of 
each WWTP who provided a mean residence time (n = 50) against population size 
(Spearman’s rank correlation, ρ < 0.05) and found there is no relationship between 
mean residence time and population size (Figure S- 4). Therefore we consider that 
residence time is independent of population size and as such degradation can also 
be considered independent of population size. 
In our previous study (O'Brien et al. 2014), chemicals for population estimation were 
chosen using two criteria: (1) the chemical must be measurable via direct injection 
on LC-MSMS in all of the collected samples; (2) the mass load of the chemical must 
show a correlation with population size (R2 > 0.8). With the use of Bayesian 
inference to combine the chemicals which met these criteria into a population model 
it was apparent that they were capable of estimating the population size with high 
accuracy and that uncertainty reduced with the inclusion of more markers. While 
these two criteria were observed as suitable criteria for our specific catchments, to 
extend the applicability of the population model to any other catchments based on 
the knowledge about chemical degradation obtained in this study we now propose 
two additional criteria for “Best Practice” population markers: (3) degradation should 
be negligible under CR conditions to ensure the stability of chemicals during 
wastewater collection; and (4) the mean residence time of the WWTP sewer network 
(RM and/or GS) should be shorter than the time for 10% degradation to occur for the 
compound under sewer conditions. Degradation of less than 10% is considered 
acceptable for our population markers as it is the acceptable “Best Practice” 
tolerance for degradation of sewage drug biomarkers (Castiglioni et al. 2013). If no 
mean residence time is provided by WWTPs, we recommend using the 95th 
percentile of the mean residence time of all WWTPs (non-normally distributed) from 
the Ort et al. (2014b) study which was 10 hours. A protocol for selecting “Best 
Practice” suitable population markers based on these criteria is shown in Figure 9.  
Based on these criteria, for our calibration data and catchments, acesulfame, 
atenolol, carbamazepine, gabapentin and ibuprofen would all be considered “Best 
Practice” population markers particularly considering they had negligible degradation 
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under “high in-sewer degradation processes” and hence should be considered as 
potential population markers for all sites regardless of knowledge of mean residence 
time. Their stability was also greater than the longest mean residence time of the 
sewer catchments in the Ort et al. (2014b) study (15 hours). Hydrochlorothiazide can 
also be considered as a potential “Best Practice” population marker providing the 
sewer catchments do not have rising main sewers with mean residence times 
greater than 9 hours (Table 9). Furosemide, iopromide and salicylic acid were 
identified as highly degradable as all compounds degraded in the CR and thus 
should not be used as “Best Practice” marker (failing criteria 3). The use of 
naproxen, caffeine, codeine, norfloxacin and paracetamol as “Best Practice” markers 
would require further investigation as all had greater than 10% loss in <3 hours 
under both gravity and rising main sewer conditions (Table 9).   
 
 
Figure 10 Selection criteria of “Best Practice” population markers based on measurable levels (i.e. above LOQ), 
degradation in wastewater and within the sewer and correlation between mass load and population. Y = Yes. N = No. 
LOQ = limit of quantification. MRT = mean residence time. * = if mean residence time is unknown, assume 10 h as it is 
the 95th percentile of the mean residence times from the largest wastewater-based epidemiology study(Ort et al. 
2014b). 
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_________________________________________________________ 
Chapter 5: Wastewater analysis of Census Day samples to 
investigate per capita input of organophosphorus flame retardants 
and plasticizers into wastewater 
_________________________________________________________ 
 
Having identified suitable markers of population size from wastewater in Australia 
and having developed a population estimation model which incorporates all of these 
markers, it was decided to evaluate the application of wastewater-based 
epidemiology for other compounds of interest. The target group selected were 
organophosphate flame retardants. Organophosphate esters have a broad range of 
uses such as plasticisers and flame retardants but there has been an increase in 
usage since the ban of some brominated flame retardants. The increase in use is of 
particular concern as some organophosphorous flame retardants (PFRs) have 
shown toxicity including carcinogenicity and neurotoxicity. There is very little data on 
their use in Australia and thus the aim of this chapter was to investigate the use of 
PFRs by the Australian population, using WBE analysis.   
 
The following publication is incorporated as Chapter 5: 
___________________________________________________________________ 
 
O'Brien, J.W., Thai, P.K., Brandsma, S.H., Leonards, P.E., Ort, C., Mueller, J.F., 
2015. Wastewater analysis of Census day samples to investigate per capita input of 
organophosphorus flame retardants and plasticizers into wastewater. Chemosphere 
138, 328-334. 
___________________________________________________________________ 
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Accepted author manuscript 
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Highlights: 
• Organophosphorus esters (PFRs) were measured in Australian wastewater 
influent 
• Similar PFR concentrations were found in Australian wastewater as in US and 
Europe 
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• Per capita PFR loads into STPs were calculated using Census Day influent 
samples 
• We estimate annual use of PFRs in Australia and release to the aquatic 
environment 
 
5. Abstract:  
The use of organophosphate esters (PFRs) as flame retardants and plasticizers has 
increased due to the ban of some brominated flame retardants. There is however 
some concern regarding the toxicity, particularly carcinogenicity and neurotoxicity, of 
some of the PFRs. In this study we applied wastewater analysis to assess use of 
PFRs by the Australian population. Influent samples were collected from eleven 
wastewater treatment plants (STPs) in Australia on Census Day and analysed for 
PFRs using gas chromatography coupled with mass spectrometry (GC-MS). Per 
capita mass loads of PFRs were calculated using the accurate census head counts. 
The results indicate that tris(2-butoxyethyl) phosphate (TBOEP) has the highest per 
capita input into wastewater followed by tris(2-chloroisomethylethyl) (TCIPP), 
tris(isobutyl) phosphate (TIBP), tris(2-chloroethyl) phosphate (TCEP) and tris(1,3-
dichloroisopropyl) phosphate (TDCIPP). Similar PFR profiles were observed across 
the Australian STPs and a comparison with European and U.S. STPs indicated 
similar PFR concentrations. We estimate that approximately 2.1 mg.person-1.day-1 of 
PFRs are input into Australian wastewater which equates to 16 tonnes per annum.  
 
Keywords:  
Organophosphorus esters, Flame retardants, Plasticizers, Census, Wastewater 
analysis, Australia 
 
5.1 Introduction 
The use of organophosphate esters as flame retardants (referred to here as PFRs 
but sometimes referred to as OPEs or OPFRs) has increased due to the restrictions 
implemented on the use of some brominated flame retardants (Brommer et al. 2012, 
Reemtsma et al. 2008, Stapleton et al. 2009, United States Environmental Protection 
Agency 2005). In 2006, 20% of flame retardants in Europe were PFRs (van der Veen 
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and de Boer 2012). In addition to their use as flame retardants, some PFRs are also 
used as plasticizers, antifoaming agents and as additives for lubricants and hydraulic 
fluids (Marklund et al. 2005b). Tris(1,3-dichloroisopropyl) phosphate (TDCIPP) and 
tris(phenyl) phosphate (TPHP) are primarily used as flame retardants in 
polyurethane foams (Marklund et al. 2003, Reemtsma et al. 2008, Stapleton et al. 
2009) whereas other organophosphates such as tris(butyl) phosphate (TNBP) and 
tris(2-butoxyethyl) phosphate (TBOEP) are primarily used as antifoaming agents and 
plasticizers (Marklund et al. 2003, 2005b). In addition, TNBP and TPHP may be used 
as antiwear agents and/or extreme pressure additives in hydraulic fluids, lubricants 
and transmission and motor oils (Agency for Toxic Substances and Disease Registry 
1997). The global use of PFRs in 2011 was estimated at 292 000 tonnes (Townsend 
Solutions 2012) which is up from 186 000 tonnes in 2001 (Marklund et al. 2005b).  
 
There is concern regarding the toxicity of PFRs. Tris(2-chloroethyl) phosphate 
(TCEP) and TDCIPP are proven carcinogens. Tris(2-chloroisopropylethyl) (TCIPP) 
and TBOEP are suspected to be carcinogenic ((WHO) 1998, 2000). 
Tris(methylphenyl) phosphate (ortho-TMPP), TPHP and TNBP are all considered 
neurotoxins ((WHO) 1990, 1991a, b). Other concerns include neurodevelopment 
issues from exposure to TDCIPP, TCEP and TCIPP (Dishaw et al. 2011) and an 
association between decreased semen quality in men from exposure to TDCIPP and 
TPHP (Meeker and Stapleton 2010). TCEP, TCIPP and TDCIPP are all Priority 
Existing Chemicals as they are industrial chemicals with reasonable grounds 
that manufacturing, handling, storing, using or disposing of the chemical gives rise, 
or could give rise, to a risk of adverse health and/or environmental effects (NICNAS 
2014). 
PFRs may enter the environment via processes such as abrasion, volatilisation and 
leaching (Marklund et al. 2003, van den Eede et al. 2011, Wensing et al. 2005). 
Studies have indicated that indoor air, particularly within public buildings, may have 
higher PFR concentrations than outdoor air. PFR concentrations in air have been 
measured as high as 950 ng.m-3 (Marklund et al. 2005a). Additionally, high 
concentrations of PFRs have been measured in indoor dust with levels as high as 
5.5 g.kg-1. These high levels are mainly attributed to TBOEP which is found in floor 
polishes and waxes for linoleum floors and can account for up to 97% of the total 
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PFR concentrations. (Marklund et al. 2003). PFRs in dust may be a concern to 
humans as dust appears to be a relevant exposure pathway for certain flame 
retardants such as decabromodiphenyl ether assuming adults ingest on average 20 
mg.d-1 of dust and toddlers 50 mg.d-1 (Brommer et al. 2012, Jones-Otazo et al. 
2005).  
In Australia, there is no record of manufacturing PFRs and the only import data 
available is for TCEP and TCIPP as they are considered Priority Existing Chemicals 
(NICNAS 2001). This data shows that in 2001 the total import of TCEP and TCIPP 
was 410 tonnes and it was expected that 20 to 40 tonnes of TDCIPP would be 
imported. As there is no import data available for the other OPEs, a method is 
required to assess which PFRs are present in Australia and which may pose a health 
risk.  
Waste streams, including wastewater, are an important sink for many chemicals and 
wastewater analysis is increasingly being used as a tool for assessing changes in 
the consumption, exposure to and use of chemicals (Daughton 2012b). PFRs have 
previously been measured in municipal wastewater in Europe and United States; 
with an emphasis on their removal during wastewater treatment (Ratola et al. 2012). 
To date, only two studies have measured the load of PFRs entering wastewater 
treatment plants (STPs) (Marklund et al. 2005b, Schreder and La Guardia 2014) and 
one study measured the load of PFRs in wastewater effluent (Phillips and Chalmers 
2009). Additionally, a European wide study of 89 STPs found PFRs in all samples, 
however, they report only concentrations and not loads (Loos et al. 2012). To date, 
there are no published data on PFRs in Australian wastewater.  
The aims of this study are to i) identify key PFRs in wastewater influent ii) assess 
daily mass loads of PFRs and their associated per capita release into the 
wastewater stream, iii) evaluate differences between the per capita input of PFRs 
into wastewater of the different treatment plant catchments. This may form a basis 
for future assessment of changes in the release and associated use of these 
chemicals in Australia.  
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5.2 Materials and Methods: 
5.2.1 Standards and materials 
Solvents were pro-analysis quality or HPLC grade. Acetone, methanol, hexane were 
obtained from Promochem, (Wesel, Germany) and toluene from Fisher Scientific 
(Loughborough, UK). Standards of tris(2-chloroethyl)phosphate (TCEP), tris(1,3-
dichloroisopropyl)phosphate (TDCIPP), tris(phenyl) phosphate (TPHP), tris(butyl) 
phosphate (TNBP), 2-ethylhexyl diphenyl phosphate (EHDPP) and tris(2-
butoxyethyl)phosphate (TBOEP) were supplied by Sigma-Aldrich Chemie B.V. 
(Zwijndrecht, the Netherlands). Tris(isobutyl) phosphate (TIBP) was supplied by 
Merck (Darmstadt, Germany) and tris(2-chloroisopropyl)phosphate (TCIPP) from 
Ehrenstorfer (Augsburg, Germany). The internal standards TPHP-d15 and TNBP-d27 
were supplied by respectively, Sigma-Aldrich Chemie B.V. (Zwijndrecht, the 
Netherlands) and Cambridge Isotope Laboratories, Inc. (Andover, MA, USA). 
M6TBOEP, TCEP-d12 and TDCIPP-d15 were supplied by Wellington Laboratories Inc. 
(Guelph, ON, Canada). Formic acid 98% was obtained from Merck (Darmstadt, 
Germany). Oasis® MCX cartridges (150 mg/6 cc) were purchased from Waters, 
(Milford, MA, USA). 
 
5.2.2 Sample collection: 
Twenty-four hour composite samples were collected from the raw inlets – before the 
primary clarifier – of eleven STPs during the week of the 2011 Australian Census 
(i.e. between the 9th and 11th of August 2011). Thorough population censuses such 
as the Australian census provide unique opportunities to obtain accurate population 
data such as head count with small error. In Australia, participating in census is 
compulsory. There are also quality assurance procedures in place to ensure the 
accuracy of the data such as a post enumeration survey conducted a month after 
census which indicated that the 2011 census was undercounted by only 
approximately 1.7%(Australian Bureau of Statistics (ABS) 2011). Sampling 
wastewater influent during census allows for wastewater influent chemical loads to 
be normalised per capita with accuracy (O'Brien et al. 2014). The STPs sampled 
cover a variety of demographics and are representative of urban, semi-rural and 
rural catchments. For three of the sites, two days of samples were collected and for 
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one site three days of samples were collected. Ten catchments provided maps of the 
catchment boundaries in order for the Australian Bureau of statistics to determine 
accurate population estimates which ranged from approximately 3,500 in the 
smallest catchment to approximately 500,000 in the largest. For the site where 
accurate population could not be provided due to the lack of a catchment map, the 
population was calculated using mass loads of 14 chemicals in samples from that 
STP and the calibration data from a population estimation model (O'Brien et al. 
2014). A brief description of the sampling methods and catchment for each STP is 
provided in Table 10. This includes minimum and maximum temperatures as well as 
daily rainfall however as rainfall during the sampling period was minimal (median 0 
mm, maximum = 3.8 mm) we consider stormwater runoff into the sewer negligible. 
The collected samples were preserved by acidifying to pH 2 with 2M hydrochloric 
acid and shipped on ice (chilled or frozen) to the laboratory. The samples were 
stored and transported frozen at -20°C to the University of Amsterdam (VU) where 
they remained frozen prior to extraction and analysis. 
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Table 10 Site summary of the sewage treatment plants and samples collected for this study 
STP ID Date 
Sampled 
State Sampling 
Mode 
ΔT or 
ΔV (~T) 
Daily 
Flow (ML) 
Temperature 
(min - max) 
Rainfall 
(mm) 
Population 
Size 
STP 1 10/08/2011 SA V 10 m3  
(9 min) 
1.6 5.0 – 12.8 °C 3.8 3682 
STP 2 10/08/2011 SA V 20 m3 
(8 min) 
3.8 5.3 – 10 °C 3.0 8995 
STP 3 11/08/2011 TAS C C 12.6 6.9 – 9.6 °C 0.2 25 698 
STP 4 09/08/2011 QLD T 20 min 4.1 5.6 – 21.7 °C 0 38 005 
STP 5 10/08/2011 QLD T 60 min 10.2 5.5 – 23.7 °C 0 43 513 
STP 6 10/08/2011 QLD V 100 m3 
(7 min) 
21.4 3.5 – 17.4 °C 0 86 882 
STP 6 11/08/2011 QLD V 100 m3 
(7 min) 
21.2 7.4 – 17.9 °C 0 86 882 
STP 7 10/08/2011 QLD T 20 min 15.6 5.0 – 22.6 °C 0 92 104 
STP 8 10/08/2011 QLD T 15 min 35.0 5.6 – 23.1 °C 0 171 807* 
STP 8 11/08/2011 QLD T 15 min 35.0 8.2 – 20.4 °C 0 171 8 07* 
STP 9 9/08/2011 QLD CF C 57.1 9.8 – 21.9 °C 0 211 340 
STP 9 10/08/2011 QLD CF C 56.4 8.2 – 22.3 °C 0 211 340 
STP 9 11/08/2011 QLD CF C 58.0 11.3 – 21 °C 0 211 340 
STP 
10 
09/08/2011 ACT T 60 min 80.3 -0.2 – 13.1 
°C 
0.4 342 459 
STP 
11 
11/08/2011 QLD T 20 min 127.4 7.8 – 19.7 °C 0 495 027 
ACT = Australian Capital Territory. QLD = Queensland. SA = South Australia. TAS = Tasmania. C = 
continuous. F = flow proportional. T = time proportional. ΔT = time between samples. ΔV = volume between 
samples. ~T = average time between samples (Daily Flow/ ΔV). Population size is the enumerated de facto 
population in the catchment on Census Day (9th Aug 2011). * = population estimated using the Bayesian 
inference population estimation model of O’Brien et al. (2014). 
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5.2.3 Extraction: 
The analytical method used in this study is based on the method of Brandsma et al. 
(2014) further modified by Martinez Moral et al. (2014) for liquid samples being 
extracted using a solid phase extraction method. In brief, wastewater samples were 
centrifuged at 1700 g for 10 minutes. 10 mL aliquots of the supernatants were 
fortified with 50 µL internal standards (TNBP-d27 = 1813 ng/mL, M6TBOEP = 1600 
ng/mL, TCEP-d12 = 1600 ng/mL, TDCIPP-d15 = 1600 ng/mL, TPHP-d15 = 1812 
ng/mL), vortexed and refrigerated overnight at 4°C. Oasis MCX cartridges (150 mg/6 
cc) were conditioned with 5 mL methanol and 5 mL MilliQ water at a flow rate of 1 
mL per minute. Samples were loaded drip wise and the tubes and cartridges were 
rinsed with 3 mL pH2 formic acid in MilliQ water. The cartridges were then dried 
under vacuum for 30 minutes before elution with 6 mL methanol and 4 mL toluene. 
Eluates were concentrated using a gentle stream of nitrogen and a water bath held 
at 30°C to a final volume of 100 µL and transferred to vials. 
 
5.2.4 Analysis: 
Analysis of PFRs was performed on a GC/MS (HP6890 GC Agilent Technologies, 
Amstelveen, The Netherlands) with separation on a BPX5 capillary column (25 m x 
0.22 mm ID, 0.25 µm film thickness, SGE Analytical Science, Rotterdam, the 
Netherlands). The MS was run in the electron impact ionization (EI) mode. Full 
details are outlined in Brandsma et al. (2014). Selective ion monitoring (SIM) was 
performed, as given in Table 11.  
Quantification was performed using external calibration lines and labelled internal 
standards. The labelled internal standard TPHP-d15 was used for TPHP and EHDPP, 
TNBP-d27 for TNBP and TIBP, TCEP-d12 for TCEP and TCIPP, TDICPP-d15 for 
TDCIPP and M6TBOEP for TBOEP. As the internal standards were spiked prior to 
extraction, the internal standards correct for both extraction losses and matrix 
effects. 
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Table 11 GC-EI-MS retention time and monitoring ions of the PFRs studied. 
Compound Acronyma 
Retention 
time (min) 
Quantifier Qualifier 
LOD  
(μg/L) 
Tris(butyl) phosphate d27* TNBP-d27 8.80 167 231, 99 N/A 
Tris(butyl) phosphate TNBP 8.96 155 211, 99 3.0 
Tris(isobutyl) phosphate TIBP 7.75 155 211, 99 0.8 
Tris(2-chloroethyl) phosphate 
d12* 
TCEP-d12 10.06 261 213 N/A 
Tris(2-chloroethyl) phosphate TCEP 10.16 249 251 0.2 
Tris(2-chloroisopropyl) 
phosphate 
TCIPP 10.37 277 
279, 
201 
1.1 
Tris(1,3-
dichloroisopropyl)phosphate 
d15* 
TDCIPP-
d15 
14.88 394 197 N/A 
Tris(1,3-
dichloroisopropyl)phosphate 
TDCIPP 15.02 381 
379, 
191 
0.03 
Tris(2-butoxy-[13C2]-ethyl) 
phosphate* 
M6TBOEP 15.49 303 
231, 
157 
N/A 
Tris(2-butoxyethyl) phosphate TBOEP 15.49 199 299 0.1 
Tris(phenyl) phosphate d15 * TPHP-d15 15.64 341 239 N/A 
Tris(phenyl) phosphate TPHP 15.72 326 
325, 
215 
0.2 
2-Ethylhexyldiphenyl 
phosphate 
EHDPP 15.78 251 
250, 
362 
0.1 
* = chemical used as an internal standard  
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5.2.5 QA/QC  
To investigate the extraction efficiency and the blank levels, i) MilliQ water was 
fortified with 50 µL internal standard solution (concentration ~1600 µg/L) and ii) 
MilliQ water was fortified with 50 µL internal standard and native PFRs 
(concentration ~1600 µg/L), then these were extracted, concentrated and analysed 
as outlined above. The observed blank levels are given in Table S- 9 and ranged 
from 0.01 to 0.21 µg/L for EHDPP, TPhP, TBOEP, TCEP, TCIPP, TDCIPP. 
Somewhat higher blank levels were observed for TIBP and TNBP with averages of 
0.29 and 1.0 and µg/L, respectively. Average recovery of the PFRs in the spiked 
MilliQ water ranged from 76 – 114%. In addition, a wastewater sample consisting of 
wastewater from 5 of the STPs was homogenised, split into four aliquots, two of 
which were fortified only with PFR internal standards, the other two with both internal 
standards and native OPEs. These samples were extracted to check extraction 
efficiency and for matrix effects. The average recovery for the spiked wastewater 
was comparable with the spiked MilliQ water and ranged between 70 – 112% with 
the exception of TIBP (50%) and TNBP (53%). All the analysed wastewater samples 
were corrected for the blank values and labelled internal standards, however not for 
the recovery standards. The limit of detection (LOD) for the PFR method is defined 
as three times the concentration measured in the blank (Table 11).  
 
5.3  Results and Discussion 
5.3.1 Concentration of PFRs in wastewater 
Table S- 7 gives the concentrations of the various PFRs detected in wastewater 
samples collected from around Australia. TBOEP, TCIPP and TDCIPP were 
detected in all samples. TCEP was detected in all but one sample. TIBP was 
detected in six samples while EHDPP was detected in five. TPHP was only detected 
in one sample. TNBP was not detected in any of the samples.  
TBOEP had the highest concentrations which ranged from 0.4 to 6.6 μg/L with a 
median of 4.4 μg/L followed by TCIPP, (0.5 to 4.1 μg/L, median = 2.5 μg/L), TIBP 
(1.1 to 1.6 μg/L with a median of 1.4 μg/L), TCEP (0.2 to 0.6 μg/L with a median of 
0.3 μg/L) and TDCIPP (0.05 to .3 μg/L with a median of 0.1 μg/L. In the most recent 
US EPA survey, production volumes for TBOEP, TNBP and TCEP were listed as 
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high production volume chemicals with individual production volumes of between 1 
and 10 million pounds annually (Environmental Protection Agency 2010).  
 
5.3.2 PFR load in wastewater of different Australian catchments 
The daily load of the PFRs coming into each STP was calculated by multiplying the 
concentration measured in the sample by the total volume (estimated from flow) of 
wastewater entering each treatment plant for the sampled 24 hour period.  
A linear regression was performed for daily mass loads of TBOEP, TCEP, ∑TCIPP 
and TDCIPP entering wastewater treatment plants against the population size as 
these were the most frequently detected compounds and were found in samples 
from all sites, except for TCEP which couldn’t be detected at Site 2. The population 
data is considered accurate as the samples were collected either on or within two 
days of the 2011 Census. This data indicates that the mass load entering 
wastewater for these compounds correlates strongly with the population size with r2 
≥ 0.87 which may indicate that Australians, regardless of location, use similar 
products containing OPEs. As the samples are from a range of catchments and 
population sizes, it is therefore assumed they have different sewer networks 
comprising of gravity sewers, rising mains and pumping stations, the strong 
correlations for linear regressions between population size and mass load for these 
PFRs may be indicative that the PFRs are not significantly degraded in the sewer. 
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Figure 11 Population versus daily mass load of PFRs which were measured at the majority of sites. The black line is the 
line of best fit. The grey lines indicate the 90% confidence interval of the regression line. 
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 In order to compare the level of PFR discharge into the sewer system among 
different STPs, we determined daily per capita PFR input into wastewater by dividing 
the mass load of each PFR by the population size. A comparison of the individual 
PFR to the sum of the detected PFR (referred to here as a PFR profile) is shown in 
Figure 12. This data indicates that the input of ΣOPE per capita input into 
wastewater is between approximately 0.85 and 2.6 mg/person/day with a mean of 
2.1 mg/person/day. Data <LOD were excluded. Statistical analysis suggests that 
there are no significant outliers in this data set (Grubbs’ test, significance level: 0.05 
two sided).  
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Figure 12 Daily per capita input of PFR mass loads into wastewater for eleven STP catchments in Australia. For STPs 6 
and 7, the mean of two consecutive days sampling are reported. For STP 9, the mean of three consecutive days is 
reported (coefficient of variation for TDCIPP = 0.17, TCEP = 0.26, ∑TCIPP = 0.16, TBOEP = 0.58). 
5.3.3 Comparison of PFRs in wastewater between Australia and other 
countries 
For comparison between the data from this study and other countries we have to 
revert to the concentrations in the influent water samples acknowledging that water 
use and associated dilution may vary substantially between treatment plants and 
sampling periods. Overall we find similar (within an order of magnitude) 
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concentrations to those observed in other studies. For example, the concentration of 
TBOEP in Australian wastewater influent (median = 4.4 μg/L) is similar to those 
observed in Sweden (median = 9.1 μg/L) (Marklund et al. 2005b). For TCIPP the 
median concentration in Australia (2.5 μg/L) is similar to both Sweden and United 
States medians (2.0 and 1.2 μg/L respectively). TCEP concentrations in our study 
(median = 0.3 μg/L) were also similar to those reported in Swedish and US studies 
(median = 0.5 and 0.7 μg/L respectively). The concentration of TDCIPP in Australia 
(median = 0.1 μg/L) was similar to that of Sweden (median = 0.3 μg/L) but much 
lower than the United States influent (median = 1.9 μg/L). TIBP was not measured in 
either the Swedish or United States influent. Overall there is reasonably good 
agreement in the concentrations and associated profiles of PFRs entering 
wastewater among the few studies available (Figure 14). 
 
Figure 13 Country comparison of concentration of PFRs in wastewater influent as well as dust. Australian influent data 
(STPs=11). Sweden influent data (STPs=7) is from Marklund et al. (2005b). United States influent data (STPs=2) is from 
Schreder and La Guardia (2014). Australia dust data (n=238) is from Brommer (2014). Bars indicate the median. Lines 
indicate the maximum. < indicate that the median was below the detection limit. ⋆ indicate that the compound 
matching that colour was not analysed. 
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5.3.4 Annual Australian PFR discharge into STPs and the aquatic environment 
On Australian Census Day 2011 when the samples were collected, the population 
was 21.5 million. Given this population size and that the daily load of PFRs in 
wastewater is approximately 2.1 mg/person/day, the yearly load of PFRs input into 
Australian wastewater is approximately 16 tonnes. As a third of this load is 
chlorinated PFRs, this may be an environmental issue as chlorinated PFRs are 
considered resistant to microbial degradation and there is no significant removal 
from wastewater (Meyer and Bester 2004). It is therefore estimated that the load of 
PFRs entering STPs in Australia is likely to be similar to that entering the aquatic 
environment. However, it is important to note that this is an estimate only and without 
further study on the removal efficiencies of the PFRs in the STPs assessed, we 
cannot be certain of the PFR loads entering the Australian aquatic environment. 
Additionally, the amount of PFR discharged into the Australian aquatic environment 
may be slightly under-estimated in this study because we did not include a small 
proportion of PFR mass that could adsorb onto the particulate phase of the 
wastewater. Recently both Marklund et al. (2005b) and Schreder and La Guardia 
(2014) suggested that between 1 – 5 % of the PFRs that are in use enter the 
wastewater stream annually. Based on the annual load estimated from the sampling 
during the census period (16 tonnes) and the above estimate that 1 – 5 % of the in-
use PFRs we come up with a ball park estimate of 320 – 1600 tonnes of PFRs were 
in use at the time of this study (ie. 2011). NICNAS (2001) estimated that the import 
of TCEP and TCIPP in 2001 was about 410 tonnes which is similar to the total 
amount of 100 – 500 tonnes that is estimated from our study using the Marklund et 
al. (2005b) and Schreder and La Guardia (2014) approach.  However continuous 
import must have resulted in a much higher total amount of these chemicals being in 
circulation hence we estimate that the release into wastewater is probably well below 
1 % of the PFRs that are in use within Australia at the time. These data indicate that 
TDCIPP, which hadn’t been imported into Australia before 2001 (NICNAS 2001), has 
been imported into Australia and suggest that in 2011 somewhere between 6 and 30 
tonne per were in use. It is noteworthy that TBOEP was found at higher loads than 
when compared for example with TCEP, TCIPP and TDCIPP which are priority 
existing chemicals – and thus our data may suggest that it could be considered for 
inclusion into the list of priority existing chemicals. 
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If we consider the annual load of PFRs entering STPs and the individual removal 
efficiencies of STPs for each PFR (Table 12), the combined annual load of PFRs 
discharged to the environment from all STPs in Australia is approximately 6.7 
tonnes. ∑TCIPP is the largest contributor to this load (69%) whereas TBOEP, which 
had the highest input into wastewater, only contributes about 13% to the annual 
Australian STPs discharge load.   
 
 
Table 12 Estimated annual loads of PFRs in Australian effluent based on the influent data and STP removal efficiencies. a 
removal estimate is from Olofsson (2012). b removal estimate is from Meyer and Bester (2004). TCEP, ∑TCIPP and 
TDCIPP are considered not significantly removed (Meyer and Bester 2004). 
  EHDPP  TPHP TBOEP TCEP ∑TCIPP TDCIPP TIBP TNBP ∑OPEs 
STP 
Removal 
Efficiency 
81%a 58%b 89%b 
not  
removedb 
not  
removedb 
not  
removedb 
84%b 54%b   
Effluent 
Load 
(tonne.year-
1) 
0.02 0.2 0.9 0.5 4.6 0.3 0.3 NA 6.7 
 
5.3.5 Comparison with data from other sources  
Schreder and La Guardia (2014) determined that laundry wastewater may be the 
primary source for PFRs entering STPs, possibly as a result of household dust 
accumulating on clothing and transferring to the laundry wastewater (Schreder and 
La Guardia 2014). Currently there is only one study which measured PFRs in 
Australian dust (Brommer 2014). This study focused on the OPEs: TNBP, TCEP, 
TCIPP, TPHP, EHDPP, TDCIPP and TMPP in five indoor microenvironments: living 
rooms, bedrooms, cars, couches and mattresses (Brommer 2014). In order to 
establish whether or not the profile of PFRs in the dust are reflective of what is in the 
wastewater influent, the median concentration from all dust microenvironments were 
averaged to give a single value for each PFR and graphed with the Australian 
wastewater influent (Figure 3, right part of figure using the secondary y axis). 
Although TBOEP had the highest concentration and mass load in Australian 
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wastewater influent, it was not measured in the dust samples. EHDP and TIBP were 
also not measured in the dust. However, the profile for the dust appears to agree 
with the wastewater influent in that the order of highest to lowest is TCIPP, then 
TCEP and then TDCIPP. Therefore, inclusion of TBOEP in future analysis of dust 
samples may provide further evidence for whether or not indoor dust is the dominant 
source of PFRs in wastewater in addition to giving a better estimate of the sum of 
PFRs in dust.  
5.4 Conclusion: 
To our knowledge this is the first study to investigate PFRs in Australian wastewater. 
The data indicate that TBOEP has the highest concentration followed by TCIPP, 
TDCIPP and TCEP. Using accurate census population, it is estimated that on 
average a load of 2.1 mg/person/day PFRs enter Australian wastewater. 
Additionally, good correlation was observed for the four main contributors (TBOEP, 
TCIPP, TDCIPP and TCEP) to the PFR load and the population size (r2 ≥ 0.87). The 
concentration of PFRs in Australian wastewater influent is similar to U.S. and 
European wastewater influents. This study also confirms that TDCIPP has been 
imported into Australia and that expected PFR usage and observed usage are 
similar. Approximately 6.7 tonnes of PFRs are estimated to be discharged to the 
Australian aquatic environment every year. This dataset may be useful for further 
evaluation of time and spatial trends in Australia and suggests that wastewater 
analysis may be a useful tool for assessing PFR usage in other countries. 
 
5. Acknowledgements 
We would like to thank the operators of the STPs for providing wastewater samples 
for this study. Additionally we would like to thank Sandra Brommer and Stuart Harrad 
for sharing their PFR in Australian dust data. This project was conducted as part of a 
secondment between the VU University Amsterdam and The University of 
Queensland as part of the INTERFLAME project, supported by the European Union 
Seventh Framework Programme FP7/2007-2013 under grant agreement 295138. 
We would like to thank the IVM for hosting and for the training provided by Jacco 
Koekoek and Martin van Velzen. Jake O’Brien receives an APA PhD scholarship. 
Phong Thai is funded by a UQ Postdoctoral Research Fellowship. Jochen Mueller is 
114 
 
funded by an ARC Future Fellowship (FF 120100546). Entox is a joint venture of The 
University of Queensland and Queensland Health. 
 
 
  
115 
 
_________________________________________________________ 
Chapter 6: Conclusion: key findings, final discussion and future 
research 
_________________________________________________________ 
 
6.1 Conclusion 
The field of WBE has received much attention particularly for its ability to objectively 
measure illicit drug consumption with even the European Monitoring Centre including 
wastewater analysis in its Perspectives on Drugs report (EMCDDA 2016). In 
Australia, a national WBE drug monitoring strategy has been developed as WBE is 
recognised as providing a comprehensive picture of illicit drug markets and an 
effective way to measure the response of law enforcement to the illicit drug market 
((ACC) 2016). 
 
While the applications of WBE are becoming broader and the number of target 
analytes are increasing, the core principle remains the same. The approach relies on 
the principle that any substance when ingested, is excreted as the active parent 
compound and/or their metabolites and that these ultimately enter the urban sewer 
networks. The concentrations measured in the wastewater itself is thus 
representative of consumption of a particular chemical by the population served by 
the sewer network. Therefore, by measuring concentrations of target compounds (𝐶𝐶𝑖𝑖) 
in wastewater samples which are representative of whole days, multiplying by the 
daily flow (𝐹𝐹), correcting for excretion factors (𝑅𝑅𝑖𝑖
𝐸𝐸𝑖𝑖
) and dividing by the population (𝑃𝑃) 
we calculate the amount of a chemical consumed on a per capita basis. This is 
outlined by the equation in Zuccato et al. (Zuccato et al. 2008) where consumption of 
a target chemical (𝐷𝐷) is normalized to per 1000 people: 
𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷 𝑐𝑐ℎ𝑒𝑒𝑒𝑒𝐷𝐷𝑐𝑐𝐷𝐷𝐷𝐷 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑒𝑒𝑐𝑐𝑐𝑐𝐷𝐷𝑐𝑐𝑐𝑐𝑖𝑖 � 𝑒𝑒𝑚𝑚𝑑𝑑𝐷𝐷𝐷𝐷1000 𝑐𝑐𝑒𝑒𝑐𝑐𝑐𝑐𝐷𝐷𝑒𝑒� =  𝐶𝐶𝑖𝑖 + 𝐹𝐹 + 𝑅𝑅𝑖𝑖𝐸𝐸𝑖𝑖𝑃𝑃  
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Figure 14 Wastewater-based epidemiology required elements and associated uncertainties. Uncertainty assessments 
based on Castiglioni et al. (2013) (Castiglioni et al. 2013) and Lai et al. (2011) (Lai et al. 2011). 𝑭𝑭 = total daily flow. 𝑺𝑺 = 
sampling. 𝑬𝑬 = excretion factor.  𝑪𝑪 = concentration of chemical. 𝑷𝑷 = population. 𝑷𝑷 = population. * = based on cocaine. 
 
The accuracy of this estimate is dependent on accuracy of each of the parameters in 
the equation. Each of these parameters has its own uncertainties associated with it. 
An assessment of the uncertainties of WBE conducted by Castiglioni et al (2013) 
(Castiglioni et al. 2013) found that even using best practice methods, uncertainties 
still remained high. In an international interlaboratory study using real samples, it 
was found that the uncertainty of chemical analysis as expressed by relative 
standard deviation, RSD was 1 – 34% even when using analyte specific labelled 
internal standards and internal quality controls. The uncertainty of the sampling 
method can be reduced to between 5 and 10% using best practice sampling 
methods such as continuous flow-proportional sampling but is still dependent on the 
concentration variation of the target chemicals, population size, number of users, 
pharmacokinetics, operation of pump stations, in addition to the characteristics of the 
catchment such as exfiltration, special events and layout of the sewer catchment. In 
addition, there’s uncertainty from the degradation of the target analytes both within 
the collected samples and within the sewer network which is estimated at 
flow
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approximately 10%. The consumption estimate also relies on excretion data which in 
some cases may not exist or may be based on very small sample sizes. As an 
example, the uncertainty of the cocaine excretion profile is approximately 26%. The 
largest uncertainty however was identified for the estimation of population size with 
the uncertainty of population size estimated as between 7 and 55%.  
 
As the uncertainty of population size was identified as the largest uncertainty, the 
overall aim of this thesis was to evaluate and propose an approach to reduce this 
uncertainty. The novelty of this PhD thesis lies in the unique wastewater sample set 
which were collected during a population census thus allowing for accurate head 
counts of the de facto population who contributed to each sample to be obtained. 
This sample set was then used to identify markers of de facto population size and to 
accurately calibrate per capita mass loads of potential population markers for 
inclusion in a population size model. Through identifying population size markers 
within wastewater samples and including them in a model, both the uncertainty of 
population size and flow were able to be reduced and thus overall improving upon 
the uncertainty of WBE.  
  
6.2 Key Findings 
In Chapter 2 a method was developed to accurately quantify creatinine concentration 
in wastewater influent using LC-MS/MS. Creatinine is a previously used marker of 
population size. Using laboratory-scale sewer reactors with conditions representative 
of both gravity sewers (GS) and rising main (RM) (pressure) sewers, we found that 
creatinine, while stable in collected samples, is unstable under sewer conditions and 
that this is likely due to the presence of sewer biofilms. The degradation followed first 
order kinetics and the degradation rate was significantly higher under RM conditions 
than when under GS conditions. Using samples collected from 10 different WWTP 
catchments during the 2011 Australian census for which accurate population data 
were obtained, an assessment between population size and creatinine daily mass 
load was made but no correlation was found. Therefore it can be concluded that 
creatinine is an unsuitable marker for estimating de facto population size.  
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In Chapter 3 a method was developed to accurately quantify 96 chemicals in 
wastewater influent using LC-MS/MS. Wastewater influent samples were collected 
from 10 different WWTP catchments during the 2011 Australian census for which 
accurate population data was obtained. These samples were analysed using the 
developed LC-MS/MS method. An assessment between population size and the 
daily mass load of the fourteen chemicals detected in all samples was made. 
Thirteen of these fourteen chemicals were found to have good correlation between 
daily mass load and population size (R2 > 0.8). The good correlation between 
population and daily mass load suggested that these chemicals are suitable markers 
to estimate population size. Bayesian inference was then used to incorporate the 
correlation between mass load and population size for all fourteen chemicals into a 
single population size estimation model. The predictive capability of the model was 
validated using a leave-one-out approach for all sites which could then be compared 
to the census population sizes. It was found that Bayesian updating using all 
fourteen chemicals resulted in a significant improvement over the uncertainty of 
population size estimates provided by WWTP operators (width of the posterior for 
small WWTP catchments became 1.1 and 2.4 times narrower, but for the large 
WWTP catchments this was between 5.0 and 40 times narrower). It was also found 
that the width of the posterior was dependent on the number of chemicals included in 
the model with all fourteen providing the narrowest posterior and thus the most 
confident population estimate. Another finding from this study was that when 
estimating the population size using a single compound only, significant 
under/overestimation could be observed even for large WWTP catchments. This 
demonstrates that the aggregate consumption of an individual substance does not 
necessarily tend towards a nation-wide average.  
 
In Chapter 4 we evaluated the impact of in-sewer degradation on the suitable 
population markers identified in Chapter 3. Additionally we assessed whether or not 
degradation of these chemicals impacts the population model. Using the same 
laboratory-scale sewer reactors used in Chapter 2, i.e. conditions representative of 
both RM and GS, it was determined that five of the markers were stable under all 
conditions over the 12 hour study period while the others were not. For the 
chemicals which were unstable, this ranged from very little degradation over the 
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study period and only under certain conditions to rapid degradation regardless of 
sewer conditions.  
We applied the population model using only the chemicals which met the following 
four criteria: (1) measurable via direct injection on LC-MSMS; (2) have mass loads 
which correlate well with population size (R2 > 0.8); (3) have negligible degradation 
in wastewater to ensure the stability of chemicals during wastewater collection; and 
(4) less than 10% in-sewer degradation could occur during the mean residence time 
in the WWTP sewer network. It was determined that the precision of the estimates 
did not improve and thus the combination of uncertainties associated with other 
factors such as variation in excretion and homogeneity of consumption may have 
greater influence on the uncertainty of the model. Regardless, to ensure that 
degradation does not influence the uncertainty of a population model, core chemicals 
to be used within the model should be chosen based on the 4 criteria outlined above. 
 
By combining the knowledge gained from Chapters 2 to 4, a framework can be 
defined that can be applied to assess suitability of potential markers of population 
size. This is shown in Figure 16. 
 
 
Figure 15 Framework to assess suitability of potential markers of population size. 
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In Chapter 5, to assess whether WBE can be expanded to chemicals other than 
those previously assessed (illicit drugs, alcohol and tobacco), a method was 
developed to analyse PFRs in wastewater influent to determine per capita loads of 
PFRs entering WWTPs in Australia. It was estimated that 2.1 mg person-1 day-1 of 
PFRs enter Australian wastewater and that there is a good correlation between the 
loads of the four main contributors (TBOEP, TCIPP, TDCIPP and TCEP) and 
population size (r2 ≥ 0.87). This study also confirmed that TDCIPP had been 
imported into Australia, a fact which was not previously known. Additionally, it was 
estimated that 6.7 tonnes of PFRs are discharged to the Australian aquatic 
environment every year.  
 
 
6.3 Final discussion 
6.3.1 Degradation of chemicals in the sewer 
While the laboratory-scale sewer reactors used in Chapters 2 and 4 have been 
shown to provide conditions similar to real sewers, the area to volume (A/V) ratio 
was much higher than real sewers and thus observed degradation may not be 
representative. Additionally, we only monitored the degradation of the parent 
compounds and did not do an assessment of transformation products which may be 
useful in determining whether or not observed changes of mass loads in collected 
samples are a result of lower consumption or degradation in the sewer. Since 
conducting the sewer degradation experiments, new methods for analysing some 
metabolites/transformation products have been developed. One such method is for 
paraxanthine which is a major metabolite of caffeine. Thus for future in-sewer 
degradation paraxanthine could be a useful marker for indicating that caffeine is 
metabolised within the sewer. Additionally, since conducting the sewer degradation 
experiments (Chapters 2 and 4) a pilot sewer has been built onsite at a nearby 
WWTP which can be directly fed with fresh wastewater influent. This particular pilot 
sewer comprises of both rising main (RM) and gravity sewer (GS) pipes of similar 
dimensions to those within the sewer catchment. As the A/V ratio of the pilot sewer 
will be similar to those within actual sewer networks, it can be used to better 
understand in-sewer degradation/transformation. In addition, as the sewer can be 
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directly fed with fresh wastewater from the catchment, the biofilms are expected to 
be more reflective of those in the actual sewers within the catchment.  
 
6.3.2 Expansion of wastewater-based epidemiology to assessing per capita 
input of organophosphorus flame retardants and plasticisers into wastewater 
 
While this particular study was the first to determine per capita loads of PFRs 
entering WWTPs, confirmation of human exposure was not possible as only the 
parent compounds were monitored. Since conducting the analysis for this study, 
other studies have evaluated PFR concentrations, in particular metabolites, in urine 
which can thus be used to confirm exposure (Van den Eede et al. 2014). Through 
evaluation of the concentrations of these metabolites in urine and the already low 
levels of PFRs detected in wastewater, we determined that using the current 
analytical methods we would not be able to quantify the metabolites in wastewater 
and that higher sample volume and or better limits of detection would be required.  
 
6.4 Future Research 
6.4.1 How far can we go with the model? 
Since publication, we have applied the population model developed in Chapter 3 to 
determine de facto population size for 311 daily wastewater influent samples from a 
large WWTP in South East Queensland (Lai et al. 2015). We found that the 
population uncertainty on average could be improved by a factor of 2. However, the 
relative day-to-day pattern of drug consumption was similar regardless of the type of 
normalization as daily illicit drug loads appeared to vary substantially more than the 
population. The time and effort put into calculating daily de facto population 
estimates using this method in this case then can probably not be justified.  
This raises the questions of when and where should we apply the model? When 
collecting the wastewater samples for the calibration data of the population model, 
we also asked the WWTP operators to provide population estimates which is the 
normal practice for WBE studies. In some cases large discrepancies were identified 
between census counts and the WWTP operator estimates and thus the model may 
be useful for providing a better estimate of the actual population. This is particularly 
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useful where per capita consumption of chemicals is to be compared between 
regions. 
  
6.4.2 Modelling of sub populations 
The accuracy and uncertainty of the population model is impacted by the 
homogeneity of consumption of chemicals within the population being investigated 
and within the calibration data populations. Some chemicals currently included in the 
population model, such as atenolol and hydrochlorothiazide, are only consumed by 
people with disease. Atenolol is a beta blocker and hydrochlorothiazide a diuretic 
hence both are used primarily for the treatment of cardiovascular disease. In 
Australia, cardiovascular disease affects one in six people and is responsible for 
30% of deaths. Moreover, the processes leading to cardiovascular disease increase 
with age. While consumption of these chemicals is thought to be relatively 
homogenous in the population overall, depending on demographic factors within a 
particular community (e.g. where the average age is higher), the model may not 
accurately estimate the population size for this community using these chemicals in 
the model. However, while this is a limitation of the model, the monitoring and 
modelling of these specific chemicals may reveal domestic migration patterns of 
people with cardiovascular disease.  
Additionally, where other chemicals are identified which are representative of other 
subpopulations, then these also may be used to determine specific demographics of 
communities and/or their migration patterns. Such examples include chemicals only 
consumed and or excreted by females (gender specific hormones may be useful for 
this), chemicals only consumed/excreted by younger people and so on.  
For this to become a reality, a model needs to be calibrated where accurate 
demographic data can be correlated with mass loads of chemicals. This may be 
possible during the likes of the Australian Census where in addition to accurate head 
counts, demographic data such as age, ethnicity, gender, internal migration, income, 
level of education and occupation are collected ((ABS) 2015).   
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6.4.3 Using the population model for other countries 
To assess the applicability of the population model in other countries, we analysed 
the same suite of chemicals in wastewater samples from China and applied our 
calibration data to estimate the population for each site based on this (Appendix 5) 
(Gao et al. 2016). It was in general observed that consumption of these chemicals 
was higher in Australia which would lead to underestimation of population sizes if 
used to estimate populations for China. In this case, we chose to recalibrate the 
model using WWTP operator population estimates and the mass loads of chemicals 
calculated from these samples. Therefore, in future studies to identify markers of 
population size it would be beneficial to focus on detecting endogenous markers in 
order to develop a universal population size model.   
 
 
6.4.5 When to recalibrate the population model? 
Ideally the best time to calibrate is when representative samples can be collected 
from populations of known size such as during census. Additionally, the model can 
be recalibrated if new exogenous population markers are identified which can then 
be analysed in previously collected samples with associated accurate head count 
data. The best case scenario is that markers are identified that are human specific, 
excreted homogenously, are uninfluenced by demographic (i.e. no age, gender or 
ethnic differences) and are stable within wastewater. In this scenario, calibration data 
could be collected once from multiple catchments for which accurate head counts 
can be obtained and used universally without site specific calibration. As mentioned 
in Chapter 3, the model is not limited to using only relationships between chemical 
mass loads and population size but other parameters such as mobile phone usage 
data (Charles-Edwards 2016) can be incorporated.  
 
6.4.6 What other uncertainties of WBE should be addressed? 
As shown in this thesis, the uncertainty of population size for WBE can be reduced. 
Further work is still required however to identify universal markers which can be 
used to provide better per capita chemical consumption comparisons between cities 
and countries. Other uncertainties should also be reduced to improve WBE data. For 
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example, Ort et al. (2010) (Ort et al. 2010b) reduced the uncertainty of sampling 
through use of a continuous flow-proportional sampling method whereby sampling 
uncertainties of <10% can be achieved (Castiglioni et al. 2013). As the quality of 
WBE also relies on the quality of the measured flow data, using a population model 
as described in this thesis to determine population size, the uncertainty from 
systematic flow measurement errors can be cancelled out. The quality and 
uncertainty of chemical analysis can be improved through following quality guidelines 
such as use of matched internal standards and use of quality assurance/quality 
controls. The stability of target compounds in wastewater and within the sewer for 
many target compounds is either limited or not known. This thesis produced some 
stability data for certain target chemicals both in wastewater and within the sewer. 
Further research however is required as stability is chemical dependant. Through 
identifying both homogenously consumed and excreted chemicals which are stable 
under certain conditions and others which are not, it may be possible to better 
understand the degradation processes occurring in individual catchments and back-
calculate mean residence times based on these profiles.  
 
Another uncertainty which is also compound dependant is that of excretion and the 
excretion profile. Excretion profiles can depend on many factors such as route of 
administration, frequency of use, and weight, age and ethnicity of the consumer. In 
addition, the profile of a chemical may change when consumed alongside other 
substances. Such studies are limited, or may be hampered by ethical issues where 
toxic substances such as illicit drugs are involved, and typically such studies use 
small sample sizes. Therefore the uncertainty inherent in excretion profiles remains 
largely unknown for many compounds. One alternative may be using the wastewater 
itself to refine the excretion factors by combining the available pharmacokinetic data 
with wastewater analysis data. Such a study has recently been applied for refining 
the excretion factors for both codeine and methadone and showed promising results 
(Thai et al. 2016).  
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Table S- 1 Measured and estimated values of creatinine loads in different WWTPs. 
WWTP 
ID 
Sampling 
date 
Sampling 
mode 
WWTP 
estimated 
population  
Census 
population  
Daily 
flow (ML) 
Creatinine 
load (g/d) 
Estimated 
creatinine 
excreted (g/d) 
a 
Percentage 
measured 
(%)b 
WWTP 1 9/08/2011 Volume proportional 345,000 342,459 80.3 21624 489716 4.42 
WWTP 2 10/08/2011 Time proportional 40,000 43,513 10.2 412 62224 0.66 
WWTP 3 9/08/2011 
Continuous 
flow 
proportional 
330,000 230,117 57.1 476 329067 0.14 
WWTP 4 11/08/2011 Volume proportional 643,000 495,027 127.4 2235 707889 0.32 
WWTP 5 10/08/2011 Volume proportional 96,000 92,104 15.6 2901 131709 2.20 
WWTP 6 10/08/2011 Volume proportional 100,000 86,882 21.4 19447 124241 15.65 
WWTP 7 9/08/2011 Volume proportional 26,600 38,005 4.1  39 54347 0.07 
WWTP 8 10/08/2011 Time proportional 3,500 3,682 1.6 11 5265 0.21 
WWTP 9 10/08/2011 Time proportional 10,000 8,995 3.8 16 12863 0.12 
WWTP 
10 11/08/2011 
Volume 
proportional 28,000 25,698 12.6 9875 36748 26.87 
aUsing the average excretion value of 1.1 L of urine/person/day with average creatinine concentration of 1.3 g/L (Brewer et al. 
2012) 
bPercentage of the measured load vs the estimated excreted load by method proposed by Brewer et al. (2012) (Brewer et al. 2012). 
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Figure S- 1 Chromatograms of creatinine in a standard and in a real sample. 
 
 
 
 
 
146 
 
_________________________________________________________ 
Appendix 2: Supplemental Information – A model to estimate the 
population contributing to the wastewater using samples collected 
on census day 
_________________________________________________________ 
 
Supporting Information for 
A model to estimate the population contributing to the wastewater using samples 
collected on census day 
 
 
Jake W. O’Brien*a, Phong K. Thaia, Geoff Eagleshama, Christoph Ortb,c, Andreas 
Scheideggerc, Steve Carterd, Foon Yin Laia, Jochen F. Muellera 
 
aThe University of Queensland, The National Research Centre for Environmental 
Toxicology (Entox), 39 Kessels Road, Coopers Plains, QLD 4108, Australia 
bThe University of Queensland, Advanced Water Management Centre (AWMC), St. 
Lucia, QLD 4072, Australia 
cEawag, Swiss Federal Institute of Aquatic Science and Technology, CH 8600 
Dübendorf, Switzerland 
dQueensland Health Forensic and Scientific Services, 39 Kessels Road, Coopers 
Plains, QLD 4108, Australia 
 
*j.obrien2@uq.edu.au 
* Tel. +61 (0)7 3274 9120, Fax +61 (0)7 3274 9003 
 
 
 
Number of pages: 4 
Number of figures: 2 
Number of tables: 2 
 
147 
 
 SI 1. Total daily wastewater volume versus population 
As no rainfall occurred during the sampling period at any of the STPs, the 
relationship between the total daily volume of wastewater and the census population 
was assessed with a linear regression (Figure 1). This indicated a strong correlation 
with an R2 = 0.99 and that each person within a catchment contributes 250 ± 10 L of 
wastewater per day. However, this method for population estimation is fraught with 
uncertainties such as the daily variability of water consumption, infiltration/exfiltration 
of water into/out of the sewer, seasonal variations in water consumption, commercial 
inputs of wastewater and so on (Editorial 2009, Russo 2009). Discussion with STP 
operators, however, identified that most of their population estimates are based 
solely on wastewater volume where a certain volume of water is assigned as a 
Population Equivalent. Our continuous flow monitoring data from three STPs indicate 
that wastewater entering the plant during rain events may increase more than 100% 
and thus this method for assessing population size is not applicable during such 
events.  
 
Figure S- 2 Population versus daily wastewater volume for 10 different STPs. The black line is the best fit. Dotted lines 
represent the 95% confidence interval while continuous grey lines represent the 95% prediction interval. 
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SI 2. Chemical mass loads for each wastewater catchment 
 
Table S- 2 Chemical mass loads [kg/day] as measured in wastewater samples for each site 
STP 
ID 
Date 
Sampled 
(D/M/Y) 
ABS 
Census 
Count 
STP 
Estimat
e 
Chemical Mass Load [kg/day] 
acesulfa
me 
atenolol caffeine 
carbamaza
-epine 
codeine 
frusemid
e 
gabapent
in 
hydrochlor
o-thiazide 
ibuprofen 
iopromid
e 
naproxe
n 
norfloxaci
n 
paracetam
ol 
salicylic 
acid 
1 10/08/2011 3,682 3,500 0.039428 0.001639 0.055338 0.000233 0.002076 0.001194 0.000468 0.001321 0.002359 0.000753 0.003912 >LOQ 0.267309 0.01939 
2 10/08/2011 8,995 10,000 0.049357 0.002168 0.105225 0.000464 0.003291 0.00102 0.010612 0.001553 0.003017 0.000095 0.005254 0.000087 0.358312 0.020684 
3 11/08/2011 25,698 28,000 0.146538 0.006955 0.296942 0.002876 0.011609 0.001208 0.084193 0.008862 0.027454 0.002933 0.019417 >LOQ 0.09544 0.098915 
4 9/08/2011 38,005 26,600 0.182351 0.006873 0.174698 0.003145 0.00858 0.001619 0.023679 0.005057 0.022425 0.00046 0.009813 0.000857 0.589109 0.082088 
5 10/08/2011 43,513 40,000 0.380131 0.012263 0.356932 0.006511 0.021369 0.008245 0.061619 0.010272 0.029262 0.073007 0.017849 0.006816 1.909864 0.1898 
6 10/08/2011 86,882 100,000 0.600508 0.043017 1.146587 0.012416 0.043472 0.00328 0.114064 0.024677 0.108056 0.00087 0.045204 0.011923 5.194477 0.355467 
6 11/08/2011 86,882 100,000 0.657787 0.043889 1.231807 0.013945 0.042969 0.006051 0.126283 0.026686 0.09267 0.001987 0.050478 0.012604 5.536418 0.36758 
7 10/08/2011 92,104 96,000 0.58329 0.028419 0.827786 0.018982 0.029133 0.004335 0.110573 0.020193 0.054892 0.104583 0.025682 0.010298 3.409843 0.341526 
7 11/08/2011 92,104 96,000 0.548421 0.045585 0.774905 0.014109 0.038778 0.019386 0.125745 0.021256 0.060503 0.208049 0.022012 0.012997 2.486486 0.279354 
8 9/08/2011 230,117 330,000 1.758618 0.087608 1.446619 0.01559 0.084374 0.037025 0.204962 0.054616 0.272773 0.099348 0.116704 0.018165 3.947295 1.715018 
8 10/08/2011 230,117 330,000 1.7346 0.079808 1.297264 0.015044 0.080473 0.031916 0.209544 0.056044 0.208183 0.259809 0.109074 0.01958 3.799039 1.339204 
8 11/08/2011 230,117 330,000 1.766367 0.082253 1.419766 0.017014 0.089104 0.033944 0.21941 0.060906 0.30746 0.283755 0.12504 0.01647 4.170054 1.348881 
9 9/08/2011 342,459 345,000 2.415554 0.048005 4.041362 0.035875 0.197219 0.021713 0.364385 0.078877 0.300027 0.094578 0.162816 0.024872 14.905437 1.260942 
10 11/08/2011 495,027 643,000 3.832751 0.153654 7.05338 0.038653 0.175966 0.063137 0.459909 0.086249 0.397188 1.559894* 0.165895 0.043566 17.267569 2.692283 
* measurement considered to be an outlier 
LOQ = limit of quantification 
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SI 3. Population versus daily mass load of iopromide outlier 
Linear regressions were plotted for the measured mass loads of all potential 
chemical population size biomarkers against the population size; it appears that 
iopromide contains an outlier. Including this outlier changed the slope of the 
regression from y = 5.95 e-7 to y = 2.22e-6 (Figure 2). We therefore decided to 
exclude this value from our calibration data. 
 
 
Figure S- 3 Population versus daily mass load of iopromide with and without the outlying value. The black line is the line 
of best fit. The grey lines indicate the 90% prediction interval. 
 
 
 
SI 4. Instrumental parameters for analysis of pharmaceutical and personal care 
products 
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_________________________________________________________ 
MRM (Q1 > Q3) DP EP CE CXP MRM (Q1 > Q3) DP EP CE CXP
ESI + 3,4-Dichloroaniline 7.7 162>127 55 10 30 10 162>74 55 10 70 10 Sigma-Aldrich Australia
Acetyl-Sulfamethoxazole-d4  3.4 300.099>138.1 66 10 37 10 300.099>69.1 66 10 67 10 Dr Ehrenstorfer 
Acetyl-Sulfamethoxazole-d5 3.4 302.3>202.1 60 10 26 9 302.3>138.1 60 10 36 9 Toronto Research Chemicals
Ametryn 5.85 228.2>186 70 10 28 10 228.2>116 70 10 38 10 Restek
Atenolol 2.47 267.2>190 60 10 27 9 267.2>145 60 10 38 9 Cerilliant
Atenolol-d7 2.47 274.1>145.1 70 10 37 10 274.1>190.1 70 10 28 8 Toronto Research Chemicals
Atorvastatin 8.85 559.5>440.3 70 10 31 10 559.5>250.2 70 10 62 10 Cerilliant
Atrazine 7.42 216.1>174 71 10 27 14 216.1>96 71 10 36 12 Restek
Atrazine-d5  7.4 221.1>101 60 10 36 6 221.1>179 60 10 27 6 Dr Ehrenstorfer
Bromacil 6.03 261.2>205 40 10 23 10 263.2>207 40 10 23 10 Restek
Caffeine 3.09 195.1>138.1 71 10 28 8 195.1>110.1 71 10 32 8 Cerilliant
Caffeine-d3  3.08 198.1>138 60 10 27 8 198.1>110 60 10 35 8 CDN Isotopes
Carbamazepine 6.35 237.2>194 96 10 31 16 237.2>193 96 10 47 12 Cerilliant
Carbamazepine-d10 6.3 247.2>204.1 65 10 30 8 247.2>202.1 65 10 51 8 CDN Isotopes
Carbaryl 7.19 202.1>145.1 25 10 13 7 202.1>127.1 25 10 41 7 Restek
Cephalexin 3.75 348.3>158 45 10 15 10 348.3>140 45 10 38 10 Dr Ehrenstorfer
Chlorpyriphos 11.56 350.1>198 70 10 27 4 350.1>97 70 10 55 4 Restek
Ciprofloxacin 2.81 332.3>231.1 61 10 54 12 332.3>288.2 61 10 24 16 Sigma-Aldrich Australia
Ciprofloxacin-d8 2.81 340.3>235.2 65 10 55 15 340.3>296.2 65 10 28 20 CDN Isotopes
Citalopram 4.1 325.3>109 70 10 38 4 325.3>262.2 70 10 28 4 Cerilliant
Codeine 2.61 300.2>215.1 60 10 37 12 300.2>165.1 60 10 57 10 Cerilliant
Cyclophosphamide 4.91 261.1>106 70 10 28 10 261.1>120 70 10 33 10 Dr Ehrenstorfer
Dapsone 4.16 249.2>156 60 10 22 7 249.2>92 60 10 34 14 Dr Ehrenstorfer
DEET 7.5 192.1>119 86 10 26 10 192.1>91 90 10 44 6 Restek
Desethyl-Atrazine 4.46 188>146 70 10 26 10 188>104 70 10 37 10 Restek
Desisopropyl-Atrazine 3.56 174>104 70 10 34 10 174>132 70 10 27 10 Restek
Desmethyl-Citalopram 4.01 311.3>109 60 10 35 8 311.3>262.2 60 10 25 15 Cerilliant
Desmethyl-Diazepam 7.05 271.2>140.1 70 10 41 15 271.2>165.1 70 10 41 15 Cerilliant
Diazepam 8.13 285.2>154.1 76 10 36 12 285.2>193.2 76 10 42 14 Cerilliant
Diazinon 10.45 305.3>169.1 50 10 35 8 305.3>249.1 50 10 27 8 Restek
Diclofenac 9.03 296.2>214 40 10 50 10 296.2>250.1 40 10 21 10 Cerilliant
Diclofenac-d4 9.01 300.1>219.1 45 10 30 8 300.1>218.1 45 10 46 8 Dr Ehrenstorfer
Diuron 7.51 235.2>72 70 10 40 10 235.2>46 70 10 38 10 Restek
Doxylamine 2.74 271.2>182 40 10 24 8 271.2>167.1 40 10 45 7 United States Pharmacopeial Convention
Erythromycin 4.23 734.7>576.4 50 10 27 8 734.7>158.1 50 10 45 8 Cambridge Isotope Laboratories
Erythromycin-Hydrate 5 716.7>558.5 66 10 21 18 716.7>158.1 66 10 46 8 Sigma-Aldrich Australia
Flumeturon 7.25 233.1>72 70 10 38 10 233.1>46 70 10 38 10 Restek
Fluoxetine 5.41 310.1>44 40 10 42 15 310.1>148 40 10 13 7 Cerilliant
Fluoxetine-d5  5.4 315.2>153.1 45 10 14 10 315.2>44 45 10 42 5 Isotec Stable Isotopes
Gabapentin 2.65 172.1>154 45 10 21 8 172.1>137 45 10 25 8 Cerilliant
Haloxyfop-Etoyl 11.01 434>316.1 65 10 26 17 434>91 65 10 57 7 Dr Ehrenstorfer
Haloxyfop-Methly 10.62 376>91 60 10 48 7 376>316.1 60 10 24 17 Accustandard
Hexazinone 5.73 253.2>171 70 10 24 10 253.2>71 70 10 50 10 Restek
Ifosfamide 4.71 261.1>92 70 10 37 10 261.1>63 70 10 64 10 Dr Ehrenstorfer
Indomethacin 9.02 358.3>138.9 66 10 31 10 358.3>75 66 10 107 12 Dr Ehrenstorfer
Iopromide 2.7 792>573.1 80 10 35 13 792>559.1 80 10 41 13 Dr Ehrenstorfer
Lincomycin 2.67 407.3>126.1 60 10 44 8 407.3>359.3 60 10 28 20 Dr Ehrenstorfer
Metolachlor 9.57 284.2>252 76 10 22 18 284.2>176 76 10 38 18 Restek
Metoprolol 3.07 268.2>116.1 70 10 28 7 268.2>191.1 70 10 27 10 Cerilliant
Naproxen +ve 7.77 231.2>185.1 64 10 23 10 231.2>170.1 64 10 33 12 Cerilliant
Norfloxacin 2.78 320.3>276.2 70 10 26 14 320.3>233.2 70 10 35 14 Sigma-Aldrich Australia
Norfloxacin-d5 2.78 325.2>281.2 70 10 28 15 325.2>238.2 70 10 36 15 Sigma-Aldrich Australia
Oxazepam 6.71 287.2>241.2 60 10 32 10 287.2>104 60 10 52 10 Cerilliant
Oxycodone 2.68 316.2>298.2 65 10 26 16 316.2>241.2 65 10 42 16 Cerilliant
Paracetamol 2.83 152.1>110 56 10 24 8 152.1>65.1 56 10 42 6 Cerilliant
Phenytoin 6.37 253.2>182 60 10 26 14 253.2>104 60 10 48 14 Cerilliant
Praziquantel 7.85 313.3>203.2 70 10 25 10 313.3>55 70 10 72 8 Dr Ehrenstorfer
Primidone 3.76 219.2>162.1 50 10 18 10 219.2>91 50 10 40 14 Cerilliant
Prometryn 6.95 242.2>158 70 10 35 10 242.2>200.1 70 10 28 10 Restek
Propoxur 6.85 210.1>168.1 25 10 12 8 210.1>111 25 10 20 8 Restek
Propranolol 3.71 260.2>116.1 70 10 28 8 260.2>183.1 70 10 28 8 Cerilliant
Ranitidine 2.5 315.3>176.1 50 10 26 10 315.3>98.1 50 10 33 10 Cerilliant
Ranitidine-d6 2.51 321.2>176.1 55 10 26 8 321.2>130.1 55 10 38 8 Toronto Research Chemicals
Roxithromycin 5.63 837.6>679.5 10 10 32 9 837.6>158 10 10 52 5 Dr Ehrenstorfer
Sertraline 5.46 306.3>275.2 35 10 18 12 306.3>159.1 35 10 35 12 Cerilliant
Simazine 6.28 202.1>132 70 10 29 10 202.1>124 70 10 27 10 Restek
Simazine-d10 6.2 212>137 60 10 40 10 212>134 60 10 38 10 Dr Ehrenstorfer
Sulfsalazine 7.07 399.3>223.1 30 10 43 11 399.3>119.1 30 10 63 7 Sigma-Aldrich Australia
Sulphadiazine 3.16 251.2>92 71 10 37 14 251.2>65 71 10 61 10 Dr Ehrenstorfer
Sulphamethoxazole 4.6 254.2>92.1 51 10 38 8 254.2>156 51 10 23 8 Cambridge Isotope Laboratories
Sulphathiazole 3.17 256.2>156.1 51 10 22 10 256.2>92.1 51 10 40 8 Dr Ehrenstorfer
Tebuthiuron 5.61 229.2>172 70 10 27 10 229.2>116 70 10 40 10 Restek
Temazepam 7.54 301.2>255.1 55 10 32 8 301.2>283.1 55 10 21 8 Cerilliant
Temazepam-d5 7.51 306.2>260.1 56 10 31 14 306.2>288.1 56 10 21 14 Cerilliant
Terbutryn 6.99 242.2>91.2 46 10 39 6 242.2>71.1 46 10 45 4 Restek
Tramadol 3.08 264.2>58 45 10 44 8 264.2>42 45 10 125 3 Cerilliant
Trimethoprim 2.78 291.2>230.1 85 10 35 14 291.2>123.1 85 10 35 8 Dr Ehrenstorfer
Tylosin 4.66 916.7>174.1 8 10 58 5 916.7>101.1 8 10 72 12 Dr Ehrenstorfer
Venlafaxine 3.45 278.2>58 45 10 50 7 278.2>121 45 10 40 10 Cerilliant
ESI - Amoxicilin -ve 1.5 364.1>223 -55 -5 -15 -8 364.1>206 -55 -5 -25 -8 Sigma-Aldrich Australia
2,4,5-T 8.55 252.9>194.1 -58 -4 -18 -9 254.9>196.1 -58 -4 -18 -9 Restek
2,4,5-TP 8.8 266.9>194.9 -58 -4 -18 -9 268.9>196.9 -58 -4 -18 -9 Restek
2,4-D 7.7 219>161 -36 -10 -21 -7 221>163 -36 -10 -22 -7 Restek
2,4-D 13C6 7.7 225>167 -36 -10 -21 -10 227>169 -36 -10 -21 -10 Restek
2,4-DB 8.7 247>161 -27 -10 -13 -7 249>163 -27 -10 -13 -7 Restek
2,4-DP 8.4 233>161 -35 -10 -21 -7 235>163 -35 -10 -21 -7 Restek
Acesulfame 3.3 162>82 -45 -10 -22 -5 162>78 -45 -10 -45 -5 Dr Ehrenstorfer
Acesulfame-d4 3.3 166>86 -45 -10 -22 -5 166>78 -45 -10 -45 -7 Toronto Research Chemicals
Acetylsalicylic Acid 4.7 178.9>136.9 -35 -10 -9 -11 178.9>92.9 -35 -10 -30 -5 Dr Ehrenstorfer
Atorvastatin 9.1 557.4>397.2 -70 -10 -39 -16 557.4>278.1 -70 -10 -60 -13 Cerilliant
Chloramphenicol 5.2 321.9>153 -70 -10 -24 -13 321.9>257.9 -70 -10 -16 -13 Cambridge Isotope Laboratories
Clopyralid 4 190>146 -47 -4 -13 -6 192>148 -47 -4 -13 -6 Sigma-Aldrich Australia
Dalapon 3.9 140.9>97 -43 -10 -11 -7 140.9>105 -43 -10 -12 -7 Restek
DCPA (internal standard) 7.56 205>161 -25 -10 -10 -10 203>159 -25 -10 -10 -7 ChemServices
Dicamba 6.9 219>175 -25 -10 -10 -7 221>177 -25 -10 -10 -10 Restek
Diclofenac 9.3 294.1>250.1 -53 -10 -17 -12 294.1>214 -53 -10 -28 -12 Cerilliant
Diclofenac-d4 9.3 302.1>258 -50 -10 -16 -8 300.1>256 -50 -10 -16 -8 CDN Isotopes
Fluroxypyr 6.3 253>195 -35 -10 -17 -10 255>197 -35 -10 -17 -10 Restek
Fluvastatin 9.1 410.3>348.1 -10 -10 -22 -26 410.3>210.1 -10 -10 -42 -11 United States Pharmacopeial Convention
Furosemide 6.46 329>285 -57 -10 -21 -13 329>205 -57 -10 -33 -13 Cerilliant
Gemfibrozol 10.2 249.1>121 -60 -10 -18 -8 249.1>127 -60 -10 -15 -9 Cerilliant
Haloxyfop 9.6 360>288 -50 -10 -21 -5 362>290 -50 -10 -21 -5 Accustandard
Hydrochlorothiazide 3.26 296>269 -85 -10 -28 -20 296>205 -85 -10 -34 -12 Cerilliant
Hydrochlorothiazide-C13d2 3.24 299>270.1 -85 -10 -28 -12 299>206.1 -85 -10 -35 -12 Toronto Research Chemicals
Ibuprofen 9.56 205.1>161 -52 -10 -12 -10 205.1>159 -52 -10 -11 -10 Sigma-Aldrich Australia
Iopromide 2.66 790.001>127 -80 -10 -55 -7 790>127 -80 -10 -55 -7 Dr Ehrenstorfer
MCPA 7.73 199>141 -45 -10 -22 -7 201>143 -45 -10 -19 -7 Dr Ehrenstorfer
MCPB 8.73 227>141 -30 -10 -13 -7 229>143 -30 -10 -20 -7 Restek
Mecoprop 8.4 213>141 -45 -10 -21 -7 215>143 -45 -10 -17 -7 Restek
Naproxen 8 229.2>185.1 -53 -10 -11 -10 229.2>170.1 -53 -10 -22 -10 Cerilliant
Picloram 4.4 239>195 -24 -10 -13 -7 241>197 -24 -10 -13 -7 Restek
Salicylic Acid 5.6 137>93 -45 -10 -24 -6 137>65 -45 -10 -40 -6 Cerilliant
Triclopyr 8.1 254>196 -35 -10 -19 -7 256>198 -35 -10 -21 -7 Restek
Triclosan 10.7 287>35 -50 -10 -30 -3 289>35 -50 -10 -30 -3 Sigma-Aldrich Australia
Warfarin 8.6 307>161 -170 -10 -28 -11 307.01>250 -170 -10 -30 -9 Cerilliant
                ESI = Electrospray Ionisation
Notes:  MRM = Multiple Reaction Monitoring, DP = Declustering Potential, EP = Entrance Potential, CE = Collision Cell Energy, CXP = Collision Cell Exit Potential
Quantitation Ion/Transition Confirmation Ion/Transition
Source Compound
Retention 
Time (RT)
Supplier
Table S- 3 LCMS/MS parameters using an AB/Sciex API 5500Q mass spectrometer (AB/Sciex, Concord, Ontario, Canada) 
with an electrospray ionization (ESI) interface coupled to a Shimadzu Nexera HPLC system (Shimadzu Corp., Kyoto, 
Japan). Separation was achieved on a Luna C-18 (2) (3 µm 100 Å LC Column 150 mm x 3 mm, Phenomenex) column 
using a mobile phase gradient of 1 to 95 % acetonitrile with 0.1% formic acid. 
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S1. Comparison of sewer degradation of pharmaceutical and personal 
care product population markers observed in this study against other 
literature  
 
Acesulfame 
Acesulfame, an artificial sweetener, was considered stable under all sewer 
conditions as no significant difference from a slope of zero was observed over the 
study period. This is consistent with the Buerge et al. (2009) finding that acesulfame 
is not eliminated during wastewater treatment and appears to be stable in the 
aquatic environment. Acesulfame can thus be used as stable marker to assess the 
degradation of other chemicals in the environment.  
Atenolol 
Atenolol, a beta blocker used primarily to treat angina and high blood pressure, was 
considered stable under all sewer conditions as no significant difference from a slope 
of zero was observed over the study period. While there are no other studies on 
aerobic degradation of atenolol, the available data for atenolol degradation under 
anaerobic pressurized sewer conditions indicate less than 20% removal during a 24 
hour pass through the sewer pipe (Jelic et al. 2014).    
Caffeine 
Under control conditions caffeine, a stimulant, remained stable over the 12 hour 
study period. However, under gravity sewer conditions, caffeine degraded rapidly 
fitting the first-order kinetics model with a half-life of 4 hours resulting in only 13% 
remaining after 12 hours. In the rising main degradation also fitted the first-order 
kinetics model with a half-life of 1.8 hours and only 1% remaining after the 12 hour 
study period. For control conditions, our data agree with others that caffeine is stable 
(Senta et al. 2015). Other studies indicate that caffeine is readily degraded under 
microbial conditions such as when exposed to activated sludge leading to almost 
100% removal during wastewater treatment (Blair et al. 2015).  
Carbamazepine 
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Carbamazepine, an anticonvulsant, was considered stable under all sewer 
conditions as no significant difference from a slope of zero was observed over the 
study period. This is consistent with findings that carbamazepine is not removed 
during wastewater treatment (Jelic et al. 2014, Ryu et al. 2014). Additionally, in some 
cases effluent concentrations of carbamazepine were noticeably higher than the 
influent concentrations. Carbamazepine is highly soluble thus it is thought that 
desorption from solids alone cannot account for the increase and the increase may 
be a result of metabolites retransforming back to the parent compound (Blair et al. 
2015, Rodayan et al. 2014).  
Codeine 
In wastewater codeine, an opiate analgesic, remained stable with a slight increase 
(slope = 1.02) over the 12 hour study period. While in gravity and rising main 
reactors and in the presence of biofilm codeine degraded rapidly fitting the first-order 
kinetics models better and half-lives of 3.8 and 2.1 hours respectively which meant 
by 12 hours only 11% remained in the gravity sewer and less than 2% remained in 
the rising main.  
This is contrary to Jelic et al. (2014) who only observed a small amount of formation 
of codeine during the pass through their pressurised sewer. This is also contrary to 
other studies which found that removal of codeine during biological treatment was 
only 13% after 10 hours (Rodayan et al. 2014) however this may not be 
representative of sewer systems. 
Furosemide 
Furosemide, a strong diuretic, degraded under all sewer conditions and first-order 
kinetic models were the best fit for all conditions. Half-lives were consistent between 
the control and the gravity sewer with 5.7 and 5.8 hours. Under rising main 
conditions the half-life reduced to 1.9 hours. As a result less than 24% remained in 
the control and gravity sewers over the 12 hour study period and approximately only 
1% remained in the rising main sewer. Jelic et al.(2014) didn’t see any removal of 
furosemide during a pass through a pressurised sewer and their data indicate that a 
small amount of furosemide formation may have occurred. Our results however 
indicate that furosemide undergoes both aerobic and anaerobic degradation. Data 
for removal during wastewater treatment is in the range of 40 and 80% (Kasprzyk-
Hordern et al. 2010). 
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Gabapentin 
Gabapentin, an anticonvulsant, was considered stable under all sewer conditions as 
no significant difference from a slope of zero was observed over the study period. 
During wastewater treatment removal, trickling filters resulted in minimal removal of 
gabapentin but activated sludge resulted in 84% removal in one study (Kasprzyk-
Hordern et al. 2010) however only 6.4% in another (Gurke et al. 2015).  
Hydrochlorothiazide 
Hydrochlorothiazide, a diuretic, was stable in the control with a small increase (linear 
regression slope = 1.39) and no significant deviation from zero in the gravity sewer. 
In the gravity sewer no significant difference from zero was observed over the 12 
hour study period. In the rising main there was only limited degradation and neither 
linear regression nor first-order kinetic models fitted the data well. Elimination during 
wastewater treatment shows little to no removal of hydrochlorothiazide in some 
studies (Radjenovic et al. 2009, Schroder et al. 2010) but up to 85% in others with no 
explanation for such large differences in results (Radjenovic et al. 2007). 
Ibuprofen 
Ibuprofen, a non-steroidal anti-inflammatory, was considered stable under all sewer 
conditions as no significant difference from a slope of zero was observed over the 
study period. This is consistent with the finding of Jelic et al. (2014) who found 
approximately only 5% removal during a single pass through a 7.6 km long 
pressurised sewer. During wastewater treatment it has been observed that ibuprofen 
is effectively eliminated through bio-degradation processes in the range of 85 - 95% 
(Kasprzyk-Hordern et al. 2010). 
Iopromide 
Iopromide, an imaging contrast agent, degraded under all conditions over the study 
period with first-order kinetics the best fitting model for all scenarios. In the control 
the half-life was about 16.8 hours where as in the gravity sewer and rising main it 
was 10.0 and 10.7 hours respectively. Elimination of iopromide in a conventional 
treatment plant has been observed at greater than 80% (Kormos et al. 2011). 
Naproxen 
Naproxen, an analgesic, was found to only be stable in the control reactor with no 
significant deviation from zero during the study period. Both the gravity sewer and 
rising main showed linear decay with slopes of -3.15 and -3.26 respectively. This 
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finding is inconsistent with that of Jelic et al. (2014) who on average saw no removal 
through a single pass through their 7.6km long sewer pipe, however, their data 
indicate removal at between -20 and 10%. Removal during wastewater treatment 
has been observed at more than 90% (Ryu et al. 2014). 
Norfloxacin 
Norfloxacin, a chemotherapeutic antibacterial agent, remained stable under control 
conditions with no significant deviation from zero during the 12 hour study period. In 
the gravity and rising main sewers, norfloxacin rapidly degraded with first-order 
kinetics indicating half-lives of 0.6. However, a non-zero plateau was observed for 
norfloxacin at approximately 16% of the initial concentration in the gravity sewer and 
13% in the rising main and thus the half-lives given this plateau were 0.3 and 0.4 
hours respectively. Data for removal of norfloxacin during wastewater treatment 
indicate 87-100% removal (Blair et al. 2015, Lindberg et al. 2005, Vieno et al. 2006) 
with sorption rather than degradation thought responsible for the removal. This may 
be a potential reason for the plateau observed if the liquid fraction has reached 
equilibrium with the solids.  
Paracetamol 
Paracetamol, an analgesic also called acetaminophen, was found to be stable under 
control conditions with no significant deviation from zero during the 12 hour study 
period. However, under gravity sewer and rising main conditions first-order kinetic 
models fitted well with half-lives of 1.5 hours 0.8 hours respectively. This is 
consistent with removal during wastewater treatment indicating that even though 
influent concentrations of paracetamol are high, removal in most cases is 100% 
(Ratola et al. 2012).  
Salicylic acid 
Salicylic acid, a metabolite of acetyl salicylic acid which is an anti-inflammatory, was 
unstable under all conditions. For the control linear regression degradation was the 
best fit with a slope of -8.26 but for the gravity sewer and rising main first-order 
kinetic models fitted better with halves of 2.6 and 1.3 hours respectively. Studies on 
salicylic acid removal during wastewater treatment indicates that it is completely 
eliminated (Lee et al. 2005, Ternes 1998).   
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Table S- 4 LCMS/MS parameters using an Sciex API 6500Q mass spectrometer (AB/Sciex, Concord, Ontario, Canada) with an electrospray ionization (ESI) interface coupled to a Shimadzu 
Nexera HPLC system (Shimadzu Corp., Kyoto, Japan). Separation was achieved on a Luna C-18 (2) (3 µm 100 Å LC Column 150 mm x 3 mm, Phenomenex) column using a mobile phase 
gradient of 1 to 95 % methanol with 0.1% acetic acid. 
 
 
Source Compound 
Retention 
Time (RT) 
Quantitation Ion/Transition Confirmation Ion/Transition 
Supplier 
MRM (Q1 > Q3) DP EP CE CXP MRM (Q1 > Q3) DP EP CE CXP 
ESI - Acesulfame  3.3 162>82 -45 -10 -22 -5 162>78 -45 -10 -45 -5 Dr Ehrenstorfer 
ESI - Acesulfame-d4  3.3 166>86 -45 -10 -22 -5 166>78 -45 -10 -45 -7 Toronto Research Chemicals 
ESI + Atenolol  2.47 267.2>190 60 10 27 9 267.2>145 60 10 38 9 Cerilliant 
ESI + Atenolol-d7  2.47 274.1>145.1 70 10 37 10 274.1>190.1 70 10 28 8 Toronto Research Chemicals 
ESI + Caffeine  3.09 195.1>138.1 71 10 28 8 195.1>110.1 71 10 32 8 Cerilliant 
ESI + Caffeine-d3  3.08 198.1>138 60 10 27 8 198.1>110 60 10 35 8 CDN Isotopes 
ESI + Carbamazepine  6.35 237.2>194 96 10 31 16 237.2>193 96 10 47 12 Cerilliant 
ESI + Carbamazepine-d10  6.3 >247.2>204.1 65 10 30 8 >247.2>202.1 65 10 51 8 CDN Isotopes 
ESI + Codeine  2.61 300.2>215.1 60 10 37 12 300.2>165.1 60 10 57 10 Cerilliant 
ESI - Furosemide  6.46 329>285 -57 -10 -21 -13 329>205 -57 -10 -33 -13 Cerilliant 
ESI + Gabapentin  2.65 172.1>154 45 10 21 8 172.1>137 45 10 25 8 Cerilliant 
ESI - Hydrochlorothiazide  3.26 296>269 -85 -10 -28 -20 296>205 -85 -10 -34 -12 Cerilliant 
ESI - Hydrochlorothiazide-C13d2  3.>24 299>270.1 -85 -10 -28 -12 299>206.1 -85 -10 -35 -12 Toronto Research Chemicals 
ESI - Ibuprofen  9.56 205.1>161 -52 -10 -12 -10 205.1>159 -52 -10 -11 -10 Sigma-Aldrich Australia 
ESI - Iopromide  2.66 790.001>127 -80 -10 -55 -7 790>127 -80 -10 -55 -7 Dr Ehrenstorfer 
ESI - Naproxen  8 229.2>185.1 -53 -10 -11 -10 229.2>170.1 -53 -10 -22 -10 Cerilliant 
ESI + Norfloxacin  2.78 320.3>276.2 70 10 26 14 320.3>233.2 70 10 35 14 Sigma-Aldrich Australia 
ESI + Norfloxacin-d5 2.78 325.2>281.2 70 10 28 15 325.2>238.2 70 10 36 15 Sigma-Aldrich Australia 
ESI + Paracetamol  2.83 152.1>110 56 10 >24 8 152.1>65.1 56 10 42 6 Cerilliant 
ESI - Salicylic Acid  5.6 137>93 -45 -10 ->24 -6 137>65 -45 -10 -40 -6 Cerilliant 
Notes: MRM = Multiple Reaction Monitoring, DP = Declustering Potential, EP = Entrance Potential, CE = Collision Cell Energy, CXP = Collision Cell Exit Potential, ESI = Electrospray Ionisation 
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Table S- 5 Octanol/water partition coefficients both calculated using Episuite v4.11 and from experimental database matches. 
 
Chemical pKa 
Log KOW 
Calculated 
Experimental database 
match Log Kow 
Reference 
acesulfame 5.67 -1.33     
atenolol 9.6 -0.03 0.16 (Hansch et al. 1995) 
caffeine 0.7 and 14 0.16 -0.07  (Hansch et al. 1995) 
carbamazepine 13.9 2.25 2.45 (Dal Pozzo et al. 1989) 
codeine 10.6 1.28 1.19 (Avdeef et al. 1996) 
furosemide 3.8 and 7.5 2.32 2.03 (Sangster 1993) 
gabapentin 3.68 and 10.70 -1.37 -1.1 (Sangster 1994) 
hydrochlorothiazide 7.9 and 9.2 -0.1 -0.07 (Hansch et al. 1995) 
ibuprofen 4.91 3.79 3.97 (Avdeef et al. 1998) 
iopromide  <2 and >13 -2.49 -2.05 (Hansch et al. 1995) 
naproxen 4.15 3.1 3.18 (Hansch et al. 1995) 
norfloxacin 6.32 and 8.47 -0.31 -1.03 (Hansch et al. 1995) 
paracetamol 9.38 0.27 0.46 (Sangster 1994) 
salicylic acid 2.98 2.>24 2.26 (Hansch et al. 1995) 
Log KOW values reported for neutral molecule form and were calculated using the US EPA EPI Suite version 4.11 with 
KOWWIN version 1.68 (EPA 2012). 
pKa values were from SPARC (http://ibmlc2.chem.uga.edu/sparc); values given for -OH, -COOH, or highest NHx groups. 
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 Table S- 6 Pearson correlation analysis between the R2 for the correlation between mass load and population size from O’Brien et al. 
(2014) and the time before 10% loss in each of the sewer reactors. 
 
Chemical 
Correlation 
between mass load 
and population size 
R2 (O’Brien et al. 
2014) 
Time before 10% loss (h) 
Control Gravity Sewer Rising Main 
Acesulfame 0.995 >24.00 >24.00 >24.00 
Atenolol 0.823 >24.00 >24.00 >24.00 
Caffeine 0.869 >24.00 0.61 0.28 
carbamazepine 0.849 >24.00 >24.00 >24.00 
Codeine 0.908 >24.00 0.57 0.32 
furosemide 0.839 0.87 0.88 0.29 
gabapentin 0.968 >24.00 >24.00 >24.00 
hydrochlorothiazide 0.944 >24.00 >24.00 9.01 
ibuprofen 0.919 >24.00 >24.00 >24.00 
iopromide 0.377 2.55 1.52 1.63 
naproxen 0.912 >24.00 3.17 3.07 
norfloxacin 0.929 >24.00 0.09 0.09 
paracetamol 0.811 >24.00 0.22 0.12 
salicylic acid 0.922 1.21 0.40 0.20 
Pearson r Correlation 
R  0.5127 0.3161 0.2721 
95% confidence 
interval  
-0.02456 to 
0.8202 
-0.2577 to 
0.7251 -0.3021 to 0 
R squared  0.2629 0.9994 0.07404 
P value     
P (two-tailed)  0.0608 0.2708 0.3466 
P value summary  ns ns ns 
Significant? (alpha 
= 0.05)  No No No 
Number of XY 
Pairs  14 14 14 
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Figure S- 4 Mean residence time versus population size from Ort et al. 2014 
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Figure S- 5 Individual substance distributions for estim
ating population size for all Large W
W
TPs from
 (O
'Brien et al. 2014). 
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Table S- 7 Daily concentration (μg/L) of OPEs in wastewater collected from 11 different Australian STPs 
Site  
(2011) 
EHD
PP  
(μg/L) 
TPHP  
(μg/L) 
TBOE
P  
(μg/L) 
TCEP  
(μg/L) 
∑TCI
PP  
(μg/L) 
TDCIP
P  
(μg/L) 
TIBP  
(μg/L) 
TNBP  
(μg/L) 
∑OP
Es  
(μg/L) 
STP 1  
10th Aug <LOD <LOD 0.4 0.2 1.2 0.1 <LOD <LOD 2.0 
STP 2  
10th Aug <LOD <LOD 4.1 <LOD 1.3 0.05 <LOD <LOD 5.5 
STP 3  
11th Aug <LOD <LOD 3.6 0.2 1.3 0.1 <LOD <LOD 5.2 
STP 4  
9th Aug <LOD <LOD 4.8 0.3 4.1 0.2 1.2 <LOD 10.6 
STP 5  
10th Aug <LOD <LOD 5.1 0.6 2.6 0.2 1.6 <LOD 10.2 
STP 6  
10th Aug <LOD <LOD 4.2 0.3 3.7 0.3 1.1 <LOD 9.5 
STP 6  
11th Aug <LOD <LOD 4.4 0.5 3.2 0.2 1.4 <LOD 9.7 
STP 7  
10th Aug 0.1 <LOD 5.7 0.4 3.0 0.2 1.4 <LOD 10.7 
STP 8  
10th Aug <LOD <LOD 6.6 0.3 3.0 0.2 <LOD <LOD 10.1 
STP 8  
11th Aug <LOD <LOD 5.4 0.3 2.6 0.2 <LOD <LOD 8.4 
STP 9  
9th Aug <LOD <LOD 1.7 0.2 1.8 0.1 <LOD <LOD 3.8 
STP 9  
10th Aug <LOD <LOD 3.8 0.2 2.5 0.1 <LOD <LOD 6.6 
STP 9  
11th Aug <LOD <LOD 6.2 0.3 2.0 0.1 <LOD <LOD 8.7 
STP 10  
9th Aug <LOD <LOD 4.2 0.2 2.3 0.1 <LOD <LOD 6.9 
STP 11  
11th Aug <LOD <LOD 5.8 0.2 2.4 0.1 <LOD <LOD 8.5 
Median <LOD <LOD 4.4 0.3 2.5 0.1 1.4 <LOD 8.6 
Limit of 
Detection 
(LOD) 
0.1 0.2 0.1 0.2 1.1 0.03 0.8 3.0   
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Table S- 8 Per capita mass load of OPFRs across different catchments and days for eleven Australian STPs 
Site  
(2011) 
EHDPP  
(μg/person/d
ay) 
 
TPHP 
(μg/person/d
ay) 
 
TBOEP 
(μg/person/d
ay) 
 
TCEP 
(μg/person/d
ay) 
 
∑TCIPP 
(μg/person/d
ay) 
 
TDCIPP 
(μg/person/d
ay) 
 
TIBP 
(μg/person/d
ay) 
 
TNBP 
(μg/person/d
ay) 
∑OPFRs 
(μg/person/d
ay) 
 
STP 1  
10th Aug NA NA 187 102 501 60 NA NA 850 
STP 2  
10th Aug NA NA 1704 NA 559 21 NA NA 2283 
STP 3  
11th Aug NA NA 1778 94 654 40 NA NA 2567 
STP 4  
9th Aug 6 NA 514 35 444 24 133 NA 1157 
STP 5  
10th Aug 14 46 1198 151 614 48 371 NA 2442 
STP 6  
10th Aug 12 NA 1042 62 902 70 263 NA 2350 
STP 6  
11th Aug 12 NA 1067 110 773 59 343 NA 2364 
STP 7  
10th Aug 12 NA 969 62 510 31 231 NA 1815 
STP 8  
10th Aug NA NA 1343 69 601 45 123 NA 2186 
STP 8  
11th Aug NA NA 1091 58 534 35 NA NA 1719 
STP 9  
9th Aug NA NA 427 47 436 24 NA NA 934 
STP 9  
10th Aug NA NA 928 57 603 33 NA NA 1620 
STP 9  
11th Aug NA NA 1567 77 503 33 NA NA 2181 
STP 10  
9th Aug NA NA 997 53 540 34 NA NA 1624 
STP 11  
11th Aug NA NA 1504 53 611 32 NA NA 2200 
NA = Mass loads could not be calculated as the concentration within the sample was below the limit of detection (LOD) 
 
 
 
Table S- 9 Average procedural blank concentration of each OPE measured by GC/MS in EI mode 
  
EHDPP  
(μg/L) 
TPHP 
(μg/L) 
TBOE
P 
(μg/L) 
TCEP 
(μg/L) 
∑TCIPP 
(μg/L) 
TDCIP
P 
(μg/L) 
TIBP 
(μg/L) 
TNBP 
(μg/L) 
Blank 0.02 0.08 0.03 0.06 0.37 0.01 0.29 1.0 
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 Table S- 10 Coefficient of variation for daily per capita input of each OPE mass load into wastewater for eleven STP 
catchments in Australia. 
 
 
 
 
 
 
 
 
  
TBOEP ΣTCIPP TIBP TCEP TDCIPP EHDPP TPHP
Number of Values 11 11 5 10 11 4 1
Minimum 0.187 0.444 0.123 0.034 0.02 0.005 0.046
25% Percentile 0.969 0.51 0.1275 0.052 0.03 0.0065 0.046
Median 1.054 0.558 0.23 0.062 0.033 0.0115 0.046
75% Percentile 1.504 0.614 0.336 0.096 0.047 0.0135 0.046
Maximum 1.778 0.837 0.37 0.151 0.064 0.014 0.046
Mean 1.099 0.5772 0.2314 0.0755 0.0381 0.0105 0.046
Std. Deviation 0.4726 0.1048 0.107 0.0338 0.0138 0.0039 0
Std. Error of Mean 0.1425 0.0316 0.0479 0.0107 0.0042 0.0019 0
Coefficient of Variation (%) 43.003 18.157 46.24 44.781 36.335 36.886 0
Lower 95% CI of mean 0.7818 0.5068 0.0985 0.0513 0.0288 0.0043 0
Upper 95% CI of mean 1.417 0.6476 0.3643 0.0997 0.0474 0.0167 0
Sum 12.09 6.349 1.157 0.755 0.419 0.042 0.046
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App. 5 Abstract 
Sampling and analysis of wastewater from municipal wastewater treatment plants 
(WWTPs) has become a useful tool for understanding exposure to chemicals. Both 
wastewater based studies and management and planning of the catchment require 
information on catchment population in the time of monitoring. Recently, a model has 
been developed and calibrated using selected pharmaceutical and personal care 
products (PPCPs) measured in influent wastewater for estimating population in 
different catchments in Australia. The present study aimed at evaluating the 
feasibility of utilizing this population estimation approach in China. Twenty-four hour 
composite influent samples were collected from 31WWTPs in 17 cities with 
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catchment sizes from 200,000–3,450,000 people representing all seven regions of 
China. The samples were analyzed for 19 PPCPs using liquid chromatography 
coupled to tandem mass spectrometry in direct injection mode. Eight chemicals were 
detected in more than 50% of the samples. Significant positive correlations were 
found between individual PPCP mass loads and population estimates provided by 
WWTP operators. Using the PPCP mass load modeling approach calibrated with 
WWTP operator data, we estimated the population size of each catchment with good 
agreement with WWTP operator values (between 50–200% for all sites and 75–
125% for 23 of the 31 sites). Overall, despite much lower detection and relatively 
high heterogeneity in PPCP consumption across China the model provided a good 
estimate of the population contributing to a given wastewater sample. Wastewater 
analysis could also provide objective PPCP consumption status in China. 
 
Keywords: PPCP consumption, population estimation, wastewater treatment plant, 
LC-MS/MS 
 
Graphical Abstract 
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Highlights 
• Large scale monitoring of selected PPCPs in 17 cities across China 
• Model using selected PPCPs to estimate population provided reasonably good 
result. 
• More accurate population data are needed to calibrate the model to be used in China. 
• Consumption of some popular PPCPs varied across different regions of China. 
App. 5 Introduction 
Wastewater analysis (WWA), or wastewater-based epidemiology, is a valuable 
approach to evaluate chemical consumption and exposure in the population and 
complements other consumption data such as surveys and production/sales 
statistics. For chemicals that are both excreted and measurable in the wastewater, 
WWA can provide objective and quick estimation about their use in a given 
wastewater treatment plant (WWTP) catchment. Until now, one of the largest 
sources of uncertainty of WWA is the estimation of de facto population during the 
monitoring period (Castiglioni et al. 2013). 
 
Accurate estimation of de facto population is of great importance not only for 
management and planning purposes, but also for reliable back-estimation of per 
capita chemical consumption using WWA in a given wastewater catchment because 
population may change due to commuting, events, tourism, and migrating labor 
forces in a given catchment (Castiglioni et al. 2013). For a given WWTP catchment, 
population estimates could be obtained from direct methods such as Census or 
indirect methods such as daily flow or biological oxygen demand. Census data 
however are only accurate for the day on which they were collected and are 
extremely high cost limiting the frequency in which they can be carried out. Indirect 
methods could be more representative of the population on a given day potentially 
cost effective, but so far the most commonly used indirect methods, such as flow, 
have relatively large uncertainties, e.g. the fluctuation of flow due to rainfall. 
Alternative approaches have been proposed to estimate the de facto population 
including the use of several biomarkers to estimate the population contributing to a 
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wastewater treatment plant for a given period (Been et al. 2014, Chen et al. 2013, 
Daughton 2012a). But until now only a set of commonly consumed pharmaceuticals 
and personal care products (PPCPs) have been evaluated as useful to estimate the 
population in different catchments in Australia (Lai et al. 2011, O'Brien et al. 2014). 
To date, the model was calibrated using samples collected during the Australian 
census which allowed accurate head counts to be obtained. This model was applied 
and proved able to provide more robust population normalized drug consumption in 
a WWA study in Australia (Lai et al. 2015). 
 
China is the world’s largest producer and consumer of PPCPs (Liu and Wong 2013). 
The rapid economic growth and the increasing number of aging population in the 
society contribute to the rising consumption of PPCPs. The increased consumption 
of PPCPS in China provides a good opportunity to apply population estimation model 
with PPCPs mass load in the influent of a catchment. 
 
Additionally, over-use and misuse of both prescribed and over-the-counter 
pharmaceuticals causes considerable harm to the community sustainability in China 
(Mao et al. 2015). There is thus a need for a tool to effectively monitor the 
consumption of PPCPs in the population to provide information for developing public 
health policies and evaluating their performance. Until now, WWA studies in China 
have focused only on estimating the consumption of recreational illicit drugs (Du et 
al. 2015, Khan et al. 2014, Li et al. 2014). Although many studies have monitored the 
occurrence of a wide variety of PPCPs in wastewater and other environmental 
compartments (Bu et al. 2016, Chen et al. 2012b, Peng et al. 2008, Sim et al. 2010, 
Wang et al. 2015, Yu et al. 2011), few studies in China have attempted to link the 
load measured in the influent with consumption in the population (Sui et al. 2015). 
WWA has been used to assess the geographical consumption patterns of illicit drugs 
(Been et al. 2016) and has been proposed as a tool to assess consumption of 
PPCPs (Thomas and Reid 2011). Therefore WWA may be a useful tool to assess 
PPCPs consumption in China (Gao et al. 2015). 
 
The aims of the present study were to investigate the feasibility of utilizing a 
previously established model for de facto population estimation using daily PPCPs 
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mass loads in wastewater influent from multiple WWTPs in China and to assess the 
consumption of these PPCPs. 
 
App. 5.2 Materials and Methods 
App. 5.2.1 Sampling 
A sampling campaign was carried out in 31 WWTPs from 17 cities including densely 
populated and developed cities like Beijing, Shanghai and Shenzhen across seven 
regions of China (Du et al. 2015). Details about the samples and sampling sites are 
provided in Table S- 13. Briefly, twenty-four hour composite influent samples were 
collected from early July to early October 2014. The treatment capacity of the 
investigated WWTPs range from 25,000 m3/day to 910,000 m3/day and the total 
estimated population in the investigated catchment area is 32.9 million. All the 
samples were acidified to pH 2 on site using 2M hydrochloric acid immediately after 
the sampling. The samples were then immediately frozen before being shipped to 
Peking University on ice in thermal insulation boxes, and then stored frozen (at -20 
℃). All the samples were aliquoted (~60 ml) to small clean bottles, re-frozen and 
shipped on ice to The University of Queensland by air within 20 hours and kept at -
20 ℃ until analysis. 
 
App. 5.2.2 Standards and Reagents 
Analytical grade formic acid was purchased from Sigma Aldrich (Castle Hill, 
Australia). Analytical standards were purchased from various suppliers ((O'Brien et 
al. 2014)-SI). Water was purified with a Milli-Q system (Millipore, 0.2 μm filtered, 18.2 
MΩ cm-1). Liquid chromatography grade acetonitrile was purchased from Merck 
(Darmstadt, Germany). Mobile phases were filtered using Sartorius Stedim 0.45 μm 
RC filters (Goettingen, Germany).  
 
App. 5.2.3 Instrumental Analysis 
The analytical method was previously described by O’Brien et al. (2014)(O'Brien et 
al. 2014). We focused on PPCPs which could be directly measured in filtered 
wastewater using LC-MS/MS without the need for solid phase extraction.  
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 In brief, wastewater samples were thawed and filtered through 0.45 μm reconstituted 
cellulose filter disk followed by internal standards spiking. An AB Sciex 5500 QTrap 
mass spectrometer (AB Sciex, Concord, Ontario, Canada) with an electrospray 
ionization (ESI) interface coupled to a Shimadzu Nexera HPLC system (Shimadzu 
Corp., Kyoto, Japan) was used to analyze target chemicals. A Luna C-18 column (3 
μm, 100 Å, LC Column 150 × 3 mm, Phenomenex) was used with 1-95% acetonitrile 
(0.1% formic acid) as mobile phase. Both positive and negative ionization mode was 
applied to analyze the selected PPCPs (see Table S- 14). Quantitation was 
performed using the isotope dilution method. The most abundant transition ion for 
each compound was used as the quantification ion with the less abundant transition 
as the qualifier ion. An acceptable threshold of 30% for the ratio between 
quantification ion to qualifier ion was used to confirm results.  
 
App. 5.2.4 Quality assurance and quality control 
Rigorous quality assurance and quality control (QA/QC) was implemented to ensure 
the accurate quantification of the selected PPCPs. All the standards and samples 
were analyzed in duplicate and the relative difference of all replicated samples was 
less than 15%. Three MilliQ water laboratory blanks were analyzed identically to the 
wastewater samples. No analytes were detected above the limit of detection in any 
of the blank samples. A calibration standard curve was run at the beginning and the 
end of the sequence with additional calibration standards after every tenth sample. 
Deuterated internal standards were used to minimize the influence of matrix effects.  
 
App. 5.2.5 Population estimation using PPCPs mass load in the influent 
To estimate the de facto population for each WWTP catchment during the sampling 
period, the model developed by O’Brien et al. (2014)(O'Brien et al. 2014) was used. 
This model uses Bayesian inference to estimate de facto population based on linear 
regressions of daily chemical mass loads of high use PPCPs against population size. 
We used the best estimates that considered the mass load of selected PPCPs of 
significant correlation with population. To estimate the population for each WWTP 
catchment, the model was calibrated with the measured mass loads of PPCPs and 
172 
 
the population provided by the WWTP operators of 30 catchments, the 31st 
catchment population was estimated by the model (the leave-one-out approach). 
These estimates were then compared with the estimates provided by WWTP 
operators for each catchment. To the best of our knowledge the population estimates 
provided by WWTP operators were based on catchment characteristics and the most 
recent census data (2010). To assess whether regional consumption of PPCPs 
could be differentiated, the model was also applied using a North-South split where 
only calibration data for catchments in the North were used to estimate the 
population for WWTP catchments in the North and only calibration data for 
catchments in the South were used to estimate the population for WWTP 
catchments in the South.   
 
App. 5.2.6 Estimation of PPCPs consumption 
As is standard practice in WWA studies for illicit drug consumption, the population 
normalized consumption of PPCPs was calculated from the equation: 
 
Consumption of PPCPs � mg1000 inhday � = 𝐶𝐶𝑖𝑖 ∗ FP ∗ 𝐸𝐸𝑖𝑖 ∗ MWparMWmet 
 
where 𝐶𝐶𝑖𝑖 is the concentration of a chemical 𝐷𝐷 in the sample (mg/L), 𝐹𝐹 is the daily flow 
on the sampling day (L), 𝑃𝑃 is the population size in the catchment area of the WWTP 
provided by the operator (1000 inhabitants) and 𝐸𝐸𝑖𝑖is the excretion factor of the 
selected biomarker (%), 𝑀𝑀𝑀𝑀𝑃𝑃𝑝𝑝𝑝𝑝 is the molecular weight of the parent compound, 
𝑀𝑀𝑀𝑀𝑚𝑚𝑚𝑚𝑚𝑚 is the molecular weight of metabolites. In the present study, we only used the 
parent compound to back-calculate the consumption.  
 
 
App. 5.3 Results and discussion 
To the best of our knowledge, this study is the first attempt to measure selected 
PPCPs in influent wastewater from all the seven regions of China. The utilization of 
these monitoring data for population estimation and the consumption of five PPCPs 
representing different indicators are discussed in the following sections.  
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App. 5.3.1 PPCPs profiles in Chinese wastewater 
Fourteen out of 19 chemicals included in the analysis were detected in the 
wastewater samples. Salicylic acid, acesulfame, caffeine, ibuprofen and paracetamol 
were detected in more than 95% of the samples. Frequent detection of these 
compounds is in good agreement with previous studies that reported the widespread 
occurrence of these compounds in wastewater and environmental matrices in China 
(Bu et al. 2013, Duan et al. 2013, Sun et al. 2016, Zhao et al. 2011). 
Hydrochlorothiazide, iopromide and gabapentin were detected in more than half of 
the samples. Carbamazepine, citalopram, naproxen, tramadol, atenolol and 
temazepam were detected in less than 20 % of the samples and five compounds 
were not detected (i.e. venlafaxine, atorvastatin, furosemide, fluoxetine and 
norfloxacin). Previous studies have identified that the occurrence of PPCPs could 
have significant geographical patterns. The analyte concentrations in the present 
study are comparable with data reported in other studies with different geographical 
pattern (Beijing, Xiamen and Shanghai, data not shown) (Sui et al. 2010, Sui et al. 
2015, Sun et al. 2016). 
 
App. 5.3.2 Population estimation using PPCPs mass loads in the influent 
Concentration of PPCPs were converted to daily mass loads by multiplying by the 
daily flow (Table S- 13). Ten PPCPs recommended by O’Brien et al (2014)(O'Brien 
et al. 2014) were evaluated for the correlation between their daily mass loads and 
the population estimates provided by the WWTP operators. All the PPCPs except 
carbamazepine demonstrated significant statistical correlation with population 
estimates (P< 0.01, see Table S- 14).  
 
Using the data from the 31 WWTPs across China to calibrate the model, we 
obtained estimates of the de facto population for the sampling period in each 
catchment. For 21 out of 31 WWTPs the modelled population was within 20 % of the 
population estimate provided by the WWTP operators and the remaining 10 WWTPs 
estimates were consistently within a factor of 2 (see Table S- 12). The largest 
variations were found for BJ-1 (200%) and HZ-2 (51%). It appeared that the model 
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was biased towards overestimating populations for primarily catchments in the 
northern part of China and underestimating catchments mostly locate in the southern 
part of China. Since it is entirely feasible that systematic differences in PPCPs use 
exist between the northern and southern part of China we re-calibrated the model 
where we divided the WWTPs into Northern and Southern China catchments. 
However, the North-South grouping did not improve the estimation significantly (the 
ratio is from 54%-200% in north group and 65%-183% in the south group, see Table 
S- 16 and Table S- 17).  
 
App. 5.3.3 Consumption of selected PPCPs in China 
The population normalized mass load (PNML) and population normalized 
consumption (PNC) of selected PPCPs were also assessed (Table S- 11 and Table 
S- 15). Consumption was calculated by dividing the PNML by the excretion factor as 
shown in Table S- 14. Those PPCPs are commonly used substances that could be 
easily measured in wastewater and could also be associated with population life 
style, behavior and health status. Previous studies have observed geographical 
PPCPS consumption differences (Bu et al. 2013, Cox et al. 2003, Wangia and 
Shireman 2013). These differences were observed for some compounds in this 
study such as acesulfame and caffeine.  
 
App. 5.3.4 Consumption of acesulfame and caffeine  
Acesulfame, an artificial sweetener, and caffeine, a stimulant, are commonly found in 
soft drinks and snacks. Consumption of acesulfame and caffeine could reflect the 
expenditure on a wide range of soft drinks and snack food in the population similar to 
lifestyle markers. As can be seen in and Figure S- 10 and Figure S- 11, the 
consumption of caffeine is much higher than acesulfame. The difference could be 
even larger considering caffeine could degrade more significantly than acesulfame in 
different sewer conditions (Buerge et al. 2008, Seiler et al. 1999). The much higher 
use of caffeine to acesulfame is reasonable because caffeine is the key stimulant 
found in tea, coffee, energy drinks and lot of pharmaceuticals while there are several 
artificial sweeteners in addition to acesulfame, such as aspartame and saccharin in 
the food and beverage industry.  
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 Population in JN-1 had significantly higher PNC of caffeine than all the other sites 
investigated during the sampling period and two northwest sites YC-1 and XA-1 had 
relatively higher PNC of acesulfame than the remaining catchments. Population in 
SZ-1 and SZ-2 had considerable high PNC of both caffeine and acesulfame. As it is 
shown in Table S- 11 that population in the catchment of north China had higher 
PNC of acesulfame than south China population. Consumption of caffeine ranged 
from 840 mg/day/1000 inh in GY-2 to 42,000 mg/day/1000 inh in JN-1 with 18 sites 
lower than 10,000 mg/day/1000 inh and another 12 sites ranged from 10,000 to 
20,000 mg/day/1000 inh. Although significant geographical differences could be 
observed, most catchments investigated in the study have comparable consumption 
of caffeine. It is worthy to note that the most popular drink in China is tea, which 
could have lower and more variable content of caffeine than coffee (Barone and 
Roberts 1996). Previous studies have indicated that the economic status could 
influence the consumption behavior of PPCPS in different places (Bu et al. 2016, 
Hodges et al. 2012, Whelan et al. 2012). It was observed that caffeine and 
acesulfame consumption in China have good agreement with this hypothesis. For 
example, several developed catchments with more developed social-economical 
characteristics (SZ-1, SZ-2, HZ-1, 2, BJ-2 and SH-2) had considerable higher 
consumption of acesulfame and caffeine.  
 
App. 5.3.5 Consumption of paracetamol and ibuprofen  
Paracetamol, also known as acetaminophen, and ibuprofen are commonly used non-
narcotic analgesic and anti-inflammatory agents. These two drugs are highly 
metabolised by humans with only 2% of paracetamol and 9% of ibuprofen excreted 
as parent drugs (see Table S- 14). The highest paracetamol consumption was 
observed in HRB-1 with 18, 000 mg/day/1000 inh followed by JN-1 (16,000 
mg/day/1000 inh) and LZ-1(10,000 mg/day/1000 inh). Thirteen out of thirty-one sites 
are in the range of 1000-4000 mg/day/1000 inh with another thirteen sites from 4000 
to 8000 mg/day/1000 inh. The paracetamol concentrations in NJ-1 and GY-2 
samples were below the detection limit possibly due to the low consumption during 
the sampling period and high in sewer loss in the catchments.  
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The production of ibuprofen in China was reported to be approximately 8000 ton in 
2013 with 5600 ton exported. Assuming that the remaining 2,400 ton was all 
consumed, this equates to about 4700 mg/day/1000 inh of ibuprofen consumed in 
China ((MIIT) 2013). All the WWTPs but JN-1 and XA-1 had lower ibuprofen PNC 
compared with the national average based on production figures. This could possibly 
attribute to the large inter-individual variation regarding the excretion factor. Five 
sites had relatively low consumption (less than 1000 mg/day/1000 inh) with another 
eighteen sites with medium consumption between 1000 to 3000 mg/day/1000 inh, 
seven catchments had high consumption of ibuprofen (> 3000 mg/day/1000 inh). 
The coefficient of variance (CV) of ibuprofen consumption among all the investigated 
catchments was 141% while the CV of paracetamol consumption was 87%. It 
indicated that the consumption of paracetamol could have more geographic variance 
than ibuprofen across the country.  
 
App. 5.3.6 Consumption of iopromide  
Iopromide was detected in most samples except those from GY-1, SJZ-3, WH-1, 
WH-2, KM-2 and NN-1. It is noteworthy that the iopromide in SJZ-3 was below the 
method detection limit but it had relatively high PNC of other PPCPS investigated. 
Half of the investigated catchments consumed 50 to 500 mg/day/1000 inh of 
iopromide while eight catchments had higher consumption ranging from 500 to 3000 
mg/day/1000 inh. Considering that iopromide is not the sole contrast media in clinical 
practice, the observed geographical consumption variance could be attributed to the 
prescription habit and the iopromide producer’s marketing strategy. As shown in 
Figure S- 7, in general the iopromide consumption indicated that the Eastern China 
population had higher PNC than the Western population which may indicate that the 
Eastern population receives more radiographic checks than the Western population. 
The higher check rates could reveal the fact that population in the more developed 
East China with higher income and better health care insurance are highly likely to 
have more preventative and diagnostic health checks than the population in the 
developing western region. 
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App. 5.3.7 Comparison with Australia  
PPCPS consumption could correlate with demographic characteristics of a given 
population which was proposed in previous studies (Hodges et al. 2012, Whelan et 
al. 2012) and observed in China. It is interesting to compare the data from China with 
the data in Australia reported by O’Brien et al. (2014)(O'Brien et al. 2014) to verify 
whether demographic and economic characteristics affect the consumption behavior 
of PPCPS. 
 
In general the PNC/PNML of PPCPS in Australia is higher than the corresponding 
values in China (see Figure S- 8). Moreover, the Australian inter-WWTPs variation is 
smaller than the Chinese counterparts. The higher PNC in Australia supports the 
hypothesis that population with higher income is more likely to consume more 
PPCPS in daily life. The inter-WWTPs variation of PNC of selected PPCPS in 
Australia is relatively smaller than China, probably due to the more homogenous 
consumer behavior of the investigated PPCPS in Australia. Another noteworthy 
observation is that the PNML for the two anti-inflammatory drugs (ibuprofen and 
paracetamol) in Australia are much higher than in China. The observation could be 
explained by the fact that Chinese population use considerable amount of traditional 
herbal medicines and other substitute therapies whereas the Australian population 
could possibly tend to consume these two cheap over-the-counter drugs for many 
minor treatments. The per capita consumption of acesulfame for China and Australia 
is comparable. Caffeine consumption, however, was higher in Australia than in China 
which may indicate that the Australian population consume more caffeinated drinks 
(coffee mainly) than the Chinese population (green tea and black tea that have lower 
caffeine than coffee). 
 
App. 5.3.8 Uncertainties 
One of the main factors contributing to the uncertainty of the population model 
prediction in China is the quality of the population data provided by the WWTP 
operators that were used to calibrate the model. The accuracy of the model 
prediction not only relies on the accuracy of the measurement of selected PPCPS 
and accuracy of flow data, but also the accuracy of the population data for each of 
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the WWTP catchments in the calibration data. Therefore systematic overestimation 
or underestimation may happen with poor quality calibration data leading to relatively 
large uncertainties. The latest census in China was conducted 4 years before the 
sampling during which there could be significant catchment development, 
immigration and emigration. Due to a number of socio-economic reasons, the 
population in the big cities keep growing dramatically during the past ten years. This 
is in contrast with the Australian study where the population used in the model 
calibration was exceptionally reliable since the sampling was synchronized with the 
Census Day at which de facto population was obtained and mapped for geographical 
boundaries of WWTP catchments. The Chinese national census is only conducted at 
low frequency (approx. every 10 years), it therefore may be favorable to compare the 
PPCPS model estimation with other methods such as regional population survey or 
catchment cellphone signal (Ran et al. 2013) to evaluate the uncertainty of the 
method. 
 
The most abundant and homogenous consumed PPCPS could vary from region to 
region due to a number of factors including the population health status, prescription 
habits, availability and price. The PPCPS selected in the Australian model could be 
less popular and have more temporal fluctuation and geographical variation in China. 
Hence selection of more homogenous consumed PPCPS as potential population 
biomarkers could improve the reliability of model predictions. The possible 
contribution from industrial wastewater, especially pharmaceutical wastewater 
discharge from manufacturing and hospitals could also affect the model and 
associated population estimates in a given catchment, hence more detailed 
catchment survey could be considered in future studies. Variation of overuse and 
misuse of selected PPCPS could also contribute to the overall uncertainty in the 
population estimation. 
 
We acknowledge that the excretion factor identified in literature is from studies with 
limited numbers of participants which could compromise the accuracy of 
consumption estimation in WWA applications. Due to the limited resources, the 
present study only sampled WWTPs located in big cities over a short period of time. 
Future sampling campaigns should cover both urban and rural areas across the 
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country to provide better understanding of the distribution of PPCPS consumption in 
China. In addition, a longer period of sampling could also contribute to the insight of 
the temporal consumption pattern of PPCPS.   
 
App. 5.4 Conclusion 
The population estimation model utilizing the PPCPS mass loads in the influent 
produced reasonable results in China considering the uncertainty related to the 
calibration data. Further calibration and validation of the model is needed with 
samples from WWTPs with different characteristics (sub-rural and rural areas) during 
the census period ideally to improve on the accuracy of the calibration population. 
Wastewater analysis could also reveal the consumption status of PPCPS in the 
population. Per capita consumption of the PPCPS included in this study was lower in 
China than in Australia. Within China, East China has higher consumption than the 
West and the catchments in North China have larger per capita consumption than 
South China. Multiple factors including but not limited to socio-economical 
characteristics of the catchment, life style, population health status, prescription 
habits, availability and price need to be further evaluated to better understand the 
PPCPS consumption behavior in the population.  
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App. 5 Figures: 
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Figure S- 6 Estimated consumption of paracetamol and ibuprofen in China 
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Figure S- 7 Iopromide consumption in China. 
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Figure S- 8 PNC of selected PPCPs in China and Australia 
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App. 5 Tables: 
Table S- 11 Consumption estimation of selected PPCP in China (mg/day/1000 inh) (the human excretion factor 
accounted) 
WWTP Acesulfame Caffeine Ibuprofen Iopromide Paracetamol 
BJ-1 5534 132250 3150 2097 5353 
BJ-2 3393 132723 3456 697 3720 
SJZ-1 5520 66961 3527 435 4562 
SJZ-2 3995 37832 2800 163 2767 
SJZ-3 2727 61502 1990 <28 3842 
HRB-1 6967 142390 2607 1521 17991 
SY-1 5754 59116 2741 87 6587 
SY-2 4368 49846 1869 105 4128 
SH-1 1442 107254 1367 865 7392 
SH-2 1350 161759 1241 65 5898 
NJ-1 1009 12738 567 <30 <2900 
NJ-2 1687 78572 1125 442 2815 
XM-1 2262 85177 567 1169 1171 
XM-2 2633 86082 1757 174 2363 
JN-1 7734 424232 6078 9315 15560 
HZ-1 3411 125819 1504 54 2494 
HZ-2 2288 131642 1138 243 1970 
WH-1 2619 29358 870 <62 1330 
WH-2 1170 19567 346 <34 1092 
LY-1 4128 88748 1256 265 2175 
LY-2 5190 105220 1487 2871 7640 
KM-1 2335 78533 2353 481 6431 
KM-2 2241 66132 1747 <47 4634 
GY-1 740 23283 438 <9 1519 
GY-2 337 841 <200 53 <1838 
XA-1 17941 157744 20113 649 1405 
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XA-2 4310 94902 2323 192 6677 
LZ-1 5689 115757 3253 295 10444 
YC-2 14719 157906 3759 696 7993 
SZ-1 2724 186244 1250 28 4125 
SZ-2 3510 179257 1939 73 4783 
184 
 
 Table S- 12 Population estimation from WWTP operators and PPCP model 
WWTP WWTP est. Model Est. 
Model/WWTP 
% 
BJ-1 2420000 4840000 200 
BJ-2 3450000 2798795 81 
SJZ-1 1600000 2236145 140 
SJZ-2 600000 592771 99 
SJZ-3 760000 494458 65 
HRB-1 550000 1033735 188 
SY-1 800000 963855 120 
SY-2 1200000 1445783 120 
SH-1 200000 205622 103 
SH-2 320000 336707 105 
NJ-1 200000 197590 99 
NJ-2 1560000 1491084 96 
XM-1 1200000 1137349 95 
XM-2 1200000 1214458 101 
JN-1 410000 678394 165 
HZ-1 2890000 2506988 87 
HZ-2 2740000 1386506 51 
WH-1 510000 499759 98 
WH-2 740000 624096 84 
LY-1 600000 616868 103 
LY-2 670000 909478 136 
KM-1 690000 786988 114 
KM-2 670000 667309 100 
GY-1 300000 291566 97 
GY-2 1360000 1026827 76 
XA-1 290000 321446 111 
XA-2 1000000 1172691 117 
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LZ-1 600000 746988 124 
YC-1 250000 259036 104 
SZ-1 1500000 1192771 80 
SZ-2 2000000 1044177 52 
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Table S- 13 Sewage treatment plants and sampling information 
City WWTP 
Population 
served (million) 
Sampling dates 
Wastewater flow 
(m3/d) (average 
flow) 
Harbin HRB-1 0.55 
2014-10-12 (-3-
 
200000 
2014-10-13 (-2-
 
Shenyan
g 
SY-1 0.8 
2014-07-13 (18-
 
400000 
2014-07-14 (17-
 
SY-2 1.2 
2014-07-12 (18-
 
385000 
2014-07-14 (17-
 
Yinchuan YC-1 0.25 
2014-08-03 (22-
 
100400 
2014-08-04 (18-
 
Xi’an 
XA-1 0.29 2014-09-12 (19-
 
170000 
XA-2 1 
2014-09-14 (15-
 
380000 
2014-09-16 (15-
 
Lanzhou LZ-1 0.6 
2014-09-10 (16-
 
160000 
2014-09-11 (15-
 
Beijing 
BJ-1 2.42 
2014-07-22 (26-
 
650000 
2014-07-27 (25-
 
BJ-2 3.45 
2014-07-27 (25-
35℃) 
910000 
Shijiazhu
ang 
SJZ-1 1.6 
2014-08-24 (21-
 
493700 
2014-08-25 (21-
 
SJZ-2 0.6 
2014-08-24 (21-
 
157800 
2014-08-25 (21-
 
SJZ-3 0.76 
2014-08-24 (21-
 
202100 
2014-08-25 (21-
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City WWTP 
Population 
served (million) 
Sampling dates 
Wastewater flow 
(m3/d) (average 
flow) 
Wuhan 
WH-1 0.51 
2014-08-03 (25-
 
300000 
2014-08-04 (25-
 
WH-2 0.74 
2014-08-05 (27-
 
240000 
2014-08-11(21-
 
Luoyang 
LY-1 0.6 
2014-09-11 (16-
 
164300 
2014-09-13 (17-
 
LY-2 0.67 
2014-09-09 (20-
 
190550 
2014-09-10 (18-
 
Jinan JN-1 0.41 
2014-09-18 (13-
 
341100 
2014-09-20 (17-
 
Nanjing 
NJ-1 0.2 
2014-08-10 (23-
 
58000 
2014-08-11 (23-
 
NJ-2 1.56 
2014-08-10 (23-
 
640000 
2014-08-11 (23-
 
Hangzho
u 
HZ-1  2.89 2014-08-04 (26-
 
 600000 
HZ-2 2.74 
2014-08-03 (26-
 
570000 
2014-08-04 (26-
 
Shanghai 
SH-1 0.2 
2014-09-05 (23-
 
52200 
2014-09-06 (24-
 
SH-2 0.32 
2014-09-05 (23-
 
75000 
2014-09-06 (24-
 
Xiamen 
XM-1 1.2 
2014-08-06 (26-
 
262600 
2014-08-08 (26-
 
XM-2 1.2 
2014-08-06 (26-
 
190000 
2014-08-08 (26-
 Shenzhe
n 
SZ-1 1.5 
2014-09-21 (25-
 
288500 
2014-09-22 (24-
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City WWTP 
Population 
served (million) 
Sampling dates 
Wastewater flow 
(m3/d) (average 
flow) 
SZ-2 2 
2014-09-24 (25-
 752000 2014-09-29 (26-
 2014-10-04 (21-
 
Kunming 
KM-1 0.69 2014-08-26 (17-
 
210000 
KM-2 0.67 2014-08-27 (16-
 
300000 
Guiyang 
GY-1 0.3 2014-08-31 (20-
 
25000 
GY-2 1.36 2014-08-31 (20-
 
250000 
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Table S- 14 Characteristics of selected PPCP 
PPCP Class EF IM LOR (ppb) 
DF 
(%) 
CP P value 
with 
population 
Acesulfame Artificial sweetener more than 99% (Buerge et al. 2009) Neg 0.05 100 0.63 <0.0001 
Atenolol Antagonist 88% (Reeves et al. 1978) Pos 0.05 1.5 NA NA 
Atorvastatin Antihyperlipidemic agent less than 2% (Jernal et al. 1999) Pos 0.1 0 NA NA 
Caffeine Stimulant 2.4% (Blanchard et al. 1985) Pos 0.1 100 0.77 <0.0001 
Carbamazepin
e Anticonvulsant  
less than 1% 
(Morselli and 
Frigerio 1975) 
Pos 0.05 14 -0.36 0.1182 
Citalopram Antidepressant 12% (Dalgaard and Larsen 1999) Pos 0.1 1.5 NA NA 
Fluoxetine Antidepressant 
less than 10% 
(Lemberger et al. 
1985)    
Pos 0.1 0 NA NA 
Furosemide Diuretic and antihypertensive agent 
90% (Beermann et 
al. 1975) Neg 0.2 0 NA NA 
Gabapentin Anticonvulsant and analgesic 
 86% - 99% 
(Vollmer et al. 
1986) 
Pos 0.1 55 0.73 <0.0001 
Hydrochlorthia
zide 
Diuretic and antihypertensive 
agent 
65-72% (Beermann 
and Groschinsky-
Grind 1977) 
Neg 0.1 88 0.48 <0.0001 
Ibuprofen Analgesic and Anti-inflammatory 
9% (Mills et al. 
1973) Neg 0.1  96 0.55 <0.0001 
Iopromide Contrast media higher than 95% Neg 0.1 73 0.06 0.0019 
Naproxen Anti-inflammatory and analgesic antipyretic agent 10% (Segre 1975) Neg 0.1 14 0.92 <0.0001 
Norfloxacin Antibiotic 26-32% (R.Wise 1984) Pos 0.2 0 NA NA 
Paracetamol Antipyretic 2% (Davis et al. 1976) Pos 0.2 95 0.40 <0.0001 
Salicylic Acid Metabolite 3%(Lehmann et al. 1973) Neg 0.1 100 0.31 <0.0001 
Temazepam Antianxiety/hypnotic drug 1.5% (Schwarz 1979) Pos 0.15 1.5 NA NA 
Tramadol Narcotic analgesic 29% (Lintz et al. 1981) Pos 0.1 9 NA NA 
Venlafaxine Antidepressant 5% (Muth et al. 1991) Pos 0.1 0 NA NA 
 
EF: Excretion Factor; IM: Ionization Mode; DF: Detection Frequency; Pos: Positive; 
Neg: Negative; CP: Correlation with Population (R2); NA: Not Applicable 
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Table S- 15 Population normalized mass load (mg/day/1000 inhabitant) of selected PPCPs in the influent 
WWTP Acesulfame Caffeine Carbamazepine Gabapentin Hydrochlorothiazide Ibuprofen Iopromide Naproxen Paracetamol SA Tramadol 
BJ-1 5479 3174 18 78 142 283 2076 ＜LOD 2677 6013 ＜LOD 
BJ-2 3359 3185 15 59 132 311 697 28 1860 4138 ＜LOD 
SJZ-1 5464 1607 79 56 170 317 430 39 2281 2578 181 
SJZ-2 3955 908 35 33 113 252 161 ＜LOD 1384 1353 45 
SJZ-3 2700 1476 ＜LOD 16 77 179 ＜LOD 14 1921 37812 51 
HRB-1 6897 3417 ＜LOD ＜LOD 181 235 1506 ＜LOD 8996 6058 ＜LOD 
SY-1 5696 1419 ＜LOD 31 133 247 86 ＜LOD 3294 4228 ＜LOD 
SY-2 4324 1196 ＜LOD 44 93 168 104 ＜LOD 2064 3259 ＜LOD 
SH-1 1428 2574 ＜LOD 115 168 123 857 20 3696 4520 ＜LOD 
SH-2 1337 3882 ＜LOD 87 132 112 65 ＜LOD 2949 2311 ＜LOD 
NJ-1 999 306 ＜LOD ＜LOD ＜LOD 51 ＜LOD ＜LOD ＜LOD 224 ＜LOD 
NJ-2 1670 1886 ＜LOD 46 98 101 437 ＜LOD 1407 1674 ＜LOD 
XM-1 2240 2044 ＜LOD ＜LOD 29 51 1157 ＜LOD 585 100 ＜LOD 
XM-2 2607 2066 ＜LOD ＜LOD 9 158 172 ＜LOD 1182 2419 ＜LOD 
JN-1 7657 10182 ＜LOD 236 260 547 9222 47 7780 3885 ＜LOD 
HZ-1 3377 3020 ＜LOD 54 45 135 53 ＜LOD 1247 8338 ＜LOD 
HZ-2 2265 3159 6 53 40 102 241 ＜LOD 985 2058 ＜LOD 
WH-1 2592 705 ＜LOD ＜LOD ＜LOD 78 ＜LOD ＜LOD 665 755 ＜LOD 
WH-2 1158 470 ＜LOD ＜LOD 20 31 ＜LOD ＜LOD 546 1199 ＜LOD 
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WWTP Acesulfame Caffeine Carbamazepine Gabapentin Hydrochlorothiazide Ibuprofen Iopromide Naproxen Paracetamol SA Tramadol 
LY-1 4087 2130 ＜LOD ＜LOD 104 113 263 ＜LOD 1087 1176 ＜LOD 
LY-2 5138 2525 ＜LOD 34 124 134 2842 ＜LOD 3820 2983 ＜LOD 
KM-1 2312 1885 ＜LOD 74 100 212 476 ＜LOD 3215 4345 ＜LOD 
KM-2 2219 1587 ＜LOD 46 114 157 ＜LOD ＜LOD 2317 2542 ＜LOD 
GY-1 733 559 ＜LOD ＜LOD 14 39 ＜LOD ＜LOD 759 1054 ＜LOD 
GY-2 333 20 ＜LOD ＜LOD ＜LOD ＜LOD 52 ＜LOD ＜LOD 42 ＜LOD 
XA-1 17762 3786 ＜LOD ＜LOD 126 1810 643 ＜LOD 702 15432 ＜LOD 
XA-2 4267 2278 ＜LOD ＜LOD 72 209 191 ＜LOD 3338 1410 ＜LOD 
LZ-1 5632 2778 ＜LOD 61 133 293 292 41 5222 4427 ＜LOD 
YC-2 14572 3790 ＜LOD 51 179 338 689 ＜LOD 3996 10049 ＜LOD 
SZ-1 2697 4470 ＜LOD ＜LOD 24 112 27 ＜LOD 2063 3004 ＜LOD 
SZ-2 3475 4302 ＜LOD 13 26 175 73 ＜LOD 2392 4997 ＜LOD 
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 Table S- 16 Population estimates with North China group calibration 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S- 17 Population estimates with South China group calibration 
WWTP WWTP est. Model est. 
Model/WWTP 
% 
BJ-2 3450000 1856627 54 
SJZ-3 760000 494458 65 
SJZ-2 600000 515663 86 
LY-1 600000 520482 87 
XA-2 1000000 867470 87 
SY-1 800000 777510 97 
LZ-1 600000 597590 100 
YC-1 250000 251004 100 
XA-1 290000 333092 115 
LY-2 670000 791084 118 
SJZ-1 1600000 1940562 121 
JN-1 410000 655341 160 
BJ-1 2420000 4315181 178 
SY-2 1200000 2361446 197 
HRB-1 550000 1100000 200 
WWTP WWTP est. Model est. 
Model/WWTP 
% 
SZ-2 2000000 1301205 65 
GY-2 1360000 1015904 75 
SZ-1 1500000 1337349 89 
WH-2 740000 659759 89 
HZ-2 2740000 2684980 98 
GY-1 300000 296386 99 
NJ-1 200000 199197 100 
SH-1 200000 212048 106 
WH-1 510000 540723 106 
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Table S- 18 Instrumental parameters for analysis of selected PPCP 
ESI Positive 
    Quantification Transition Confirmation Transition 
Compound 
Retent
ion 
time 
Q1 Q3 DP EP CE CXP Q1 Q3 DP EP CE CXP 
Tebuconazole 6.46 308 70 50 10 45 10 308 125 50 10 55 15 
Fluroxypyr 5.08 255 209 50 10 22 20 255 181 50 10 31 17 
Pendimethalin 7.3 282.1 212.1 25 10 15 25 282.1 194.1 25 10 26 22 
Trifluralin 7.14 336.3 220.1 30 10 23 27 336.3 206.1 30 10 25 27 
Fluazipop 6.12 328.2 282.2 70 10 27 28 328.2 254.1 70 10 35 27 
Paraxanthine 3.85 181 124 40 10 27 14 181 69 40 10 42 8 
3,4 DiCl Aniline 5.39 162 127 55 10 28 12 162 74 55 10 68 12 
5-HIAA 3.2 192.1 146.1 40 10 21 13 192.1 117.1 40 10 48 13 
Ametryn 5.9 228.2 186 70 10 26 16 228.2 116 70 10 36 14 
Asulam 3.65 231 156 65 10 14 13 231 108 65 10 27 10 
Atenolol 3.13 267.2 190 50 10 25 17 267.2 145 50 10 36 12 
Atorvastatin 6.6 559.5 440.3 70 10 27 30 559.5 250.2 70 10 58 24 
Atrazine 5.66 216.1 174 71 10 25 16 216.1 96 71 10 34 12 
Bromacil 5.31 261.2 205 35 10 21 18 263.2 207 35 10 21 18 
Caffeine 4.58 195.1 138.1 71 10 26 16 195.1 110.1 71 10 30 14 
Carbamazepine 5.88 237.2 194 86 10 29 14 237.2 193 86 10 45 12 
Carbofuran 5.65 222.1 165.2 50 10 15 6 222.1 123 50 10 27 6 
Chlorpyriphos 7.16 350.1 198 70 10 23 18 350.1 97 70 10 51 11 
Citalopram 5.4 325.3 109 70 10 36 14 325.3 262.2 70 10 26 24 
Clopyralid 2.25 192 110 75 10 45 10 192 146 75 10 27 16 
Codeine 4.02 300.2 215.1 60 10 35 19 300.2 165.1 60 10 57 16 
Cotinine 3.66 177.1 80 90 10 33 12 177.1 98 90 10 28 12 
DEET 6.04 192.1 119 86 10 24 14 192.1 91 90 10 42 11 
Desethyl Atrazine 4.6 188 146 70 10 24 17 188 104 70 10 35 12 
SH-2 320000 354699 111 
KM-2 670000 791084 118 
XM-1 1200000 1455422 121 
HZ-1 2890000 3597992 124 
NJ-2 1560000 2343133 150 
KM-1 690000 1219277 177 
XM-2 1200000 2197590 183 
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ESI Positive 
    Quantification Transition Confirmation Transition 
Desisopropyl 
Atrazine 
3.87 174 104 70 10 32 10 174 96 70 10 25 9 
Desmethyl 
Citalopram 
5.4 311.3 109 60 10 33 10 311.3 262.2 60 10 23 22 
Desmethyl 
Diazepam 
6.34 271.2 140.1 70 10 39 16 271.2 165.1 70 10 37 18 
Diazinon 6.65 305.3 169.1 50 10 27 15 305.3 249.1 50 10 25 22 
Dichlorvos 5.3 221 109 50 10 19 10 221 127 50 10 18 12 
Diuron 5.65 233.1 72 70 10 40 12 233.1 46 70 10 38 12 
Fenamiphos 6.49 304.2 217.1 86 5.5 31 18 304.2 202.1 86 5.5 45 18 
Flumeturon 5.37 233.1 72 70 10 36 12 233.1 46 70 10 36 8 
Fluoxetine 5.6 310.1 44 40 10 42 12 310.1 148 40 10 11 15 
Gabapentin 3.26 172.1 154 45 10 19 14 172.1 137 45 10 23 14 
Hexazinone 5.86 253.2 171 70 10 22 16 253.2 71 70 10 40 8 
Imazapic 5.12 276.1 231.1 80 10 26 22 276.1 163 80 10 33 16 
Imazethapyr 5.5 290.1 177.1 80 10 35 20 290.1 106 80 10 57 14 
Imidacloprid 5 256.1 209.1 60 10 23 14 256.1 175 60 10 23 12 
Iopromide 4.02 792 573.1 80 10 33 34 792 559.1 80 10 43 34 
Malathion 6.47 331.1 99 40 10 30 12 331.1 127 40 10 18 17 
Methiocarb 6.17 226.1 169.2 45 10 14 12 226.1 121 45 10 23 11 
Methomyl 4.18 163.1 88.1 35 10 11 10 163.1 106 35 10 13 10 
Metolachlor 6.65 284.2 252 76 10 20 18 284.2 176 76 10 36 15 
Metribuzin 5.49 215.1 187 70 10 23 16 215.1 47 70 10 70 6 
Metsulfuron-
Methyl 
6.05 382.1 167 50 10 26 15 382.1 199 50 10 25 17 
Naproxen +ve 6.17 231.2 185.1 64 10 21 15 231.2 170.1 64 10 35 11 
Paracetamol 1.45 152.1 110 56 10 22 14 152.1 65.1 56 10 40 8 
Picloram 3.31 243 197 80 10 31 13 243 143 80 10 59 17 
Prometryn 6.25 242.2 158 70 10 33 18 242.2 200.1 70 10 26 20 
Propiconazole 6.79 342 159 100 10 37 14 342 41 100 10 58 6 
Propoxur 5.5 210.1 168.1 25 10 10 18 210.1 111 25 10 18 14 
Simazine 5.33 202.1 132 70 10 25 15 202.1 124 70 10 25 14 
Tebuthiuron 5.48 229.2 172 70 10 25 18 229.2 116 70 10 38 14 
Temazepam 6.47 301.2 255.1 55 10 30 24 301.2 283.1 55 10 19 24 
Terbuthylazine 6 230.1 174 80 10 23 16 230.1 104 80 10 45 13 
Terbuthylazine 
Des ethyl 
5.3 202 146 40 10 21 15 202 104 40 10 37 12 
Terbutryn 6.31 242.2 91.2 46 10 37 8 242.2 71.1 46 10 43 10 
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ESI Positive 
    Quantification Transition Confirmation Transition 
Tramadol 4.78 264.2 58 40 10 42 8 264.2 42 40 10 
12
3 
5 
Venlafaxine 5.17 278.2 58 40 10 48 9 278.2 121 40 10 38 14 
Atenolol D7 3.06 274.1 145.1 60 10 35 12 274.1 190.1 60 10 26 17 
Caffeine 13C3 4.6 198.3 140.1 60 10 24 17 198.3 112.1 60 10 33 14 
D2 5HIAA 3.16 194.1 148 60 10 21 17 194.1 120 60 10 38 14 
Codeine D3 4.04 303.3 152 96 10 89 15 303.3 115 96 10 
10
3 
14 
Cotinine-D4 3.36 181.2 84 85 10 32 10 181.2 98 85 10 28 10 
D4 Acetyl 
Sulfamethoxazole 
4.91 300.1 138.1 61 10 35 17 300.1 69.1 61 10 65 8 
D5 Atrazine 5.64 221.1 179 60 10 25 14 221.1 101 60 10 34 12 
D10 
Carbamazepine 
5.85 247.2 204.1 65 10 28 18 247.2 202.1 65 10 49 17 
D6 Fluoxetine 5.6 316.2 44 46 10 40 12 316.2 154.2 46 10 11 16 
D10Simazine 5.29 212 137 60 10 30 14 212 134 60 10 28 14 
Temazepam D5 6.45 306.2 260.1 56 10 29 22 306.2 288.1 56 10 19 26 
Tadalafil 6.38 390.2 268.1 90 10 16 25 390.2 204 90 10 78 19 
Sildenafil 5.73 475.2 58 130 10 110 8 475.2 283.1 130 10 50 26 
Simazine hydroxy 3.66 184.1 114 50 10 27 12 184.1 69 50 10 37 10 
Simazine amine 4.14 183.1 113 50 10 27 12 183.1 68 50 10 42 10 
mCPDMU 5.35 199.0 72 45 10 32 10 199.0 46 45 10 29 9 
DCPU 5.25 
205.0
3 
127 45 10 38 13 
205.0
1 
162 45 10 21 15 
DCPMU 5.44 
219.0
1 
127 45 10 35 13 
219.0
2 
162 45 10 20 15 
Hexazinone oxy 4.88 267.1 171 50 10 27 16 267.1 71 50 10 42 8 
Hexazinone 
hydroxy 
5.12 269.1 171 50 10 27 16 269.1 71 50 10 42 8 
Hexazinone 
desmethyl 
5.59 239.1 157 50 10 27 16 239.1 71 50 10 42 8 
Ametryn desethyl 5.26 200.1 158 50 10 27 12 200.1 68 50 10 50 12 
Ametryn 
desisopropyl 
4.76 186.1 144 50 10 27 14 186.1 116 50 10 32 10 
Ametryn hydroxy 4.2 198.1 156 50 10 25 14 198.1 86 50 10 32 10 
Norfloxacin 4.27 320.3 276.2 70 10 24 24 320.3 233.2 70 10 33 18 
Norfloxacin D5 4.25 325.2 281.2 70 10 26 25 325.2 238.2 70 10 34 24 
ESI Negative 
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ESI Positive 
    Quantification Transition Confirmation Transition 
    Quantification Transition Confirmation Transition 
Compund 
Retent
ion 
time 
Q1 Q3 DP EP CE CXP Q1 Q3 DP EP CE CXP 
Salicylic acid 4.11 137 93 -25 -10 -22 -8 137 65 -25 -10 -38 -8 
Acesulfame 0.87 162 82 -25 -10 -18 -9 162 78 -25 -10 -43 -9 
MCPA 5.72 199 141 -25 -10 -18 -12 201 143 -25 -10 -17 -12 
Ibuprofen 6.33 205.1 161 -32 -10 -9.5 -15 205.1 159 -32 -10 -9 -15 
Mecoprop 5.95 213 141 -25 -10 -17 -9 215 143 -25 -10 -15 -9 
24 D 5.63 219 161 -16 -10 -19 -12 221 163 -16 -10 -15 -12 
Dicamba 4.79 219 175 -25 -10 -10 -7 221 177 -15 -10 -8 -12 
245T 5.97 252.9 194.9 -30 -10 -16 -17 254.9 196.9 -30 -10 -16 -17 
Triclopyr 6.02 254 196 -15 -10 -12 -17 256 198 -15 -10 -14 -17 
Bromoxynil 5.65 273.8 78.9 -60 -5 -48 -6 275.8 78.9 -70 -5 -54 -6 
Triclosan 6.74 287 35 -30 -10 -33 -15 289 35 -30 -10 -30 -15 
Hydrochlorthiazide 2.6 296 269 -90 -10 -26 -20 296 205 -90 -10 -31 -18 
Furosemide 5.5 329 285 -37 -10 -19 -23 329 205 -37 -10 -29 -25 
Haloxyfop 6.45 360 288 -30 -10 -19 -25 362 290 -30 -10 -19 -25 
Acesulfame D4 0.86 166 86 -25 -10 -20 -9 166 78 -25 -10 -43 -9 
13C6 24D 5.63 225 167 -16 -10 -19 -15 227 169 -16 -10 -16 -15 
DCPA  5.75 203 159 -20 -10 -10 -7 205 161 -15 -10 -8 -7 
Hydrochlorthiazide 
13CD2 
2.55 298.9 269.9 -115 -10 -27 -21 298.9 205.9 -115 -10 -32 -15 
Ibuprofen D3 6.3 208.1 164 -30 -10 -10 -15 208.1 161 -30 -10 -9 -13 
Isoxaflutole 5.14 358.2 79 -60 -10 -21 -8 358.2 64 -60 -10 -75 -10 
Fluroxypyr 5.07 253 195 -40 -10 -11 -17 253 233 -40 -10 -21 -22 
2,4 DB 6.27 247 161 -35 -10 -20 -15 249 163 -35 -10 -21 -15 
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Figure S- 9 Official population versus daily mass load of selected PPCP. The black line is the line of best fit. The gray lines indicates the 90% 
prediction interval 
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Figure S- 10 Caffeine consumption in selected STP catchment area 
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Figure S- 11 Acesulfame consumption in China 
 
 
 
Figure S- 12 Map of investigated WWTPs 
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Abstract: Population size is crucial when estimating population- normalized drug consumption 
(PNDC) from wastewater-based drug epidemiology (WBDE). Three conceptually diﬀerent 
population estimates can be used: de jure (common census, residence), de facto (all persons 
within a sewer catchment), and chemical loads (contributors to the sampled wastewater). De facto 
and chemical loads will be the same where all households contribute to a central sewer system 
without wastewater loss. This study explored the feasibility of determining a de facto population 
and its eﬀect on estimating PNDC in an urban community over an extended period. Drugs and 
other chemicals were analyzed in 311 daily composite wastewater samples. The daily estimated 
de facto population (using chemical loads) was on average 32% higher than the de jure 
population. Consequently, using the latter would systemically overestimate PNDC by 22%. 
However, the relative day-to-day pattern of drug consumption was similar regardless of the type of 
normalization as daily illicit drug loads appeared to vary substantially more than the population. 
Using chemical loads population, we objectively quantiﬁed the total methodological uncertainty of 
PNDC and reduced it by a factor of 2. Our study illustrated the potential beneﬁts of using chemical 
loads population for obtaining more robust PNDC data in WBDE.
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 Abstract Art: 
 
 
 
 
 
App. 6.1 Introduction: 
Measuring drug residues in raw sewage−subsequently referred to as wastewater-based drug 
epidemiology (WBDE) has become an important tool to estimate illicit drug use worldwide. The 
ﬁnal estimate is typically presented on a basis of per capita consumption (i.e., consumed mass of 
a drug per capita per day). The back-estimation methodology of WBDE relies on a number of 
parameters, including concentrations of drug residues, wastewater volumes, excretion fractions, 
and population size.(Zuccato et al. 2008) There is uncertainty in each of these parameters. One 
key component concerns the number of people in a catchment, which can substantially aﬀect the 
accuracy of the ﬁnal estimate and comparisons of data across diﬀerent communities.(Castiglioni 
et al. 2014, Zuccato et al. 2008) The variability and accuracy of this parameter cannot be easily 
estimated. In most WBDE studies, the population parameter has been obtained either from the 
design capacity of wastewater treatment plants (WWTPs) or the most recently available census 
data.(van Nuijs et al. 2011a) Design capacity usually refers to population equivalents including 
industrial pollutant loads and also refers to a certain (long-term) planning horizon. For these two 
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reasons, usually less people contribute to the wastewater than indicated by design capacity. In 
exceptional circumstances, WWTPs may also operate above design capacity to receive 
wastewater from more people than expected. However, this is diﬃcult to assess and quantify 
objectively. Census data, taken on a speciﬁc day, provide only a single estimate of a population 
size; typically, it refers to a de jure population, which is counted according to home address, but 
does not provide important information on whether people are actually within the WWTP 
catchment under investigation or elsewhere on a speciﬁc day. Relying on such a ﬁxed population 
size may not be practical to WBDE.(Zuccato et al. 2008) 
Researchers have recommended that attempts should be made to estimate the number of people 
eﬀectively contributing to a wastewater sample; e.g., see refs (Zuccato et al. 2008), (van Nuijs et 
al. 2011a) and (Daughton 2012a). A few indicators have been proposed to estimate de facto 
populations by means of chemical loads measured in wastewater. Theoretically, if all households 
in the catchment of a WWTP are connected to a central sewer system, and assuming that no 
wastewater losses occur - e.g., leaky sewers, wastewater bypassing the WWTP during rainy 
periods, or abnormal operational situations - the population estimated from chemical loads in 
wastewater is a fair approximation of de facto population. Therefore, de facto subsequently refers 
to both de facto population and population estimated from chemical loads.(Daughton 2012a) For 
practical applicability in WBDE it appears important that (i) selected chemicals are human-
speciﬁc; (ii) the method is applied over an extended period of consecutive days (to reveal day-to-
day variation); (iii) methodological uncertainties can be quantiﬁed objectively; and (iv) the 
relevance of the parameter populations size is determined in the context of the overall 
methodological uncertainty of WBDE. Human-speciﬁc chemicals were proposed but not validated 
in ﬁve studies, namely, creatinine,(Chiaia et al. 2008),(Brewer et al. 2012) coprostanol,(Daughton 
2012a) cholesterol, cotinine, and a neurotransmitter metabolite, 5- hydroxyindoleacetic acid,(Chen 
et al. 2013) and commonly prescribed pharmaceuticals and artiﬁcial sweeteners.(Lai et al. 2011) 
Only two studies were found in which the measurement was over an extended period: one 
covered 235 days in a 1 year period using hydrochemical parameters (nitrogen, phosphorus, 
biological oxygen demand, and chemical oxygen demand), and another one covered 13 days in 
an 8 month period using ammonium;(van Nuijs et al. 2011c),(Been et al. 2014) those selected 
chemicals are not human-exclusive. Only one recent publication provides an approach to quantify 
objectively the methodological uncertainty of the population estimates.(O'Brien et al. 2014) Lastly, 
the two studies addressing population size estimation in the context of overall uncertainty were 
review-type reports that did not provide new methods.(Castiglioni et al. 2014),(Castiglioni et al. 
2013) In summary, to the best of our knowledge, no study to date has addressed all four aspects 
listed previously in a comprehensive manner that is pertinent to their applicability in WBDE. 
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Furthermore, most studies rely on a day-speciﬁc excretion fraction by one person, which does not 
allow an objective quantiﬁcation of associated uncertainty if these values are either missing or 
unreliable. 
Recently, a multisubstance model to estimate de facto population was developed and calibrated 
with wastewater samples collected on a Census Day.(O'Brien et al. 2014) Applying this model 
facilitates the examination of the variation in daily de facto populations over time in large 
catchments and consequently its eﬀect on the estimation of population-normalized illicit drug 
loads in WBDE particularly when compared to using a constant population number such as that 
from census data. The aims of our study were to (a) estimate a day-speciﬁc de facto population 
using the recently developed model in a large catchment on consecutive days over an extended 
period, (b) compare the estimated de facto populations with the de jure population and the eﬀects 
of using the diﬀerent population estimates on temporal patterns and levels of illicit drug use, and 
(c) evaluate whether the overall methodological uncertainty of WBDE can be reduced and better 
quantiﬁed using day-speciﬁc estimated de facto populations. 
 
App. 6.2 Materials and Methods 
App. 6.2.1 Wastewater Sampling.  
The sampling was set up at the inlet of a wastewater treatment plant that served a mainly urban 
catchment in South East Queensland (Australia) with a de jure population of 211,340 people and 
a de facto population of 230,117 on Census Day (Aug. 11, 2011) according to the Australian 
Bureau of Statistics.(Australian Bureau of Statistics (ABS) 2012) Samples were collected between 
June 2011 and June 2012 (n = 311 days; see Table S- 20 in the Supporting Information for 
missing data (n = 33 days) due to logistical or technical reasons). A continuous ﬂow- proportional 
sampling technique was applied to ensure collection of representative daily composite samples 
(from 6 AM to 6 AM the next day).(Ort et al. 2010b),(Ort et al. 2010a) The samples were 
refrigerated at 4 °C during collection, acidiﬁed on site to pH 2 using 2 M hydrochloric acid, and 
then frozen until analysis. This preservation method has been commonly used and can stabilize 
the targeted residues of illicit drugs in wastewater during storage; e.g., see refs (Chiaia et al. 
2008) and (van Nuijs et al. 2012). Data on daily wastewater volumes were recorded by the 
WWTP. 
 
App. 6.2.2 Analysis of Targeted Compounds.  
Samples were analyzed for the targeted illicit drug residues and high-use chemicals using liquid 
chromatography (Shimadzu, Nexera UHPLC system, Kyoto, Japan) coupled with tandem mass 
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spectrometry (AB SCIEX QTRAP5500, Ontario, Canada) (LC-MS/MS). The analytical method 
applied in this study has 
been validated and described previously.(Lai et al. 2011),(O'Brien et al. 2014) Brieﬂy, an 
electronic robot (Tecan Genesis Workstation 200, Australia) was used to transfer ﬁltered samples 
into a vial which were then spiked with mixtures of carbon-labelled and deuterium-labelled 
chemical standards (Table S- 21 of the Supporting Information) for compensating potential 
instrumental variability and matrix eﬀects during analysis. Separation of the targeted analytes was 
performed on a C18 LC analytical column using gradient mobile phases (Table S- 21 of the 
Supporting Information). Together with the calibration standards, concentrations of the targeted 
analytes were measured using mass spectrometry with a multireaction monitoring (MRM) 
scheme. Two MRM transitions were used for identiﬁcation and quantiﬁcation of each analyte. (Lai 
et al. 2011),(O'Brien et al. 2014) Concentrations of the targeted analytes have taken the recovery 
of the spiked mass-labelled standards into account (i.e., isotope dilution method). In every batch 
of analysis, Milli-Q water samples (i.e., procedural blanks), duplicate samples, and samples 
spiked with native chemicals were included as quality assurance and control (QA/QC) of the 
analysis. The QA/QC results are summarized in Table S- 22 of the Supporting Information. Brieﬂy, 
no contamination was found in the blank samples. The diﬀerence (coeﬃcient of variance, CV (%)) 
between duplicate samples was on average 4.8−7.9% for the illicit drug residues and 4.2− 9.4% 
for the high-use chemicals. Recovery of the native chemicals spiked in the samples was 75−81% 
for the illicit drug residues and 99−113% for the high-use chemicals. Interday variation across 3 
days was 2.3−11% for the illicit drug residues and 4.7−21% for the high-use chemicals. 
 
App. 6.2.3 Estimating Daily de Facto Populations.  
Day-speciﬁc de facto populations and conﬁdence intervals were estimated with the 
multisubstance model.(O'Brien et al. 2014) Details on the calculation (calibration, Bayesian 
inference, and validation) can be found in O’Brien et al.(O'Brien et al. 2014) Brieﬂy, we calibrated 
the model with mass loads of 14 chemicals in the inﬂuent of 10 WWTPs catchment sizes ranging 
from approximately 3,500 to 500,000 people) and de facto populations, both determined on or 
around the last Australian Census Day. It should be noted that normally census data refer to de 
jure populations; however, in Australia, de facto populations are also determined on Census 
Day.(O'Brien et al. 2014) In this study, we only used eight chemicals that can be readily measured 
in the samples without pre-concentration, consistent with the measurement of the targeted illicit 
drug residues. These eight high-use chemicals included acesulfame, atenolol, caﬀeine, 
carbamazepine, codeine, hydrochlorothiazide, naproxen, and salicylic acid. Model calculations 
indicated that the use of eight chemicals provided de facto population estimates consistent with 
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using 14 chemicals (Table S- 23 of the Supporting Information). It should be noted that any 
variability that is unknown or cannot be quantiﬁed explicitly was implicitly accounted for when 
calibrating the model with mass loads of the high-use chemicals in wastewater from various 
catchments and accurate population sizes. The uncertainties encompass systematic or random 
eﬀects due to, e.g., disposals of unused chemicals, unknown absolute excretion rates, day-to-day 
variations of actual consumption, and transformations of chemicals in sewer systems, sampling, 
and storage (see O’Brien et al. for more explanation).(O'Brien et al. 2014) It is a fair assumption 
that the system under investigation (e.g., catchment and sewers), and the relevant processes 
(e.g., average consumption habits, pharmacokinetics, and transformation in sewers) did not 
change substantially between the Census Day and our monitoring period. 
App. 6.2.4 Population-Normalized Drug Consumption.  
The back-estimation method follows the previously proposed equation (see Supporting 
Information).(Zuccato et al. 2008) Brieﬂy, the estimation involves three main steps: (a) the mass 
loads (mg/day) of drug residues are obtained by multiplying concentrations (μg/L) with total 
wastewater ﬂow (ML/day); (b) the estimated mass loads are then extrapolated to the consumed 
amount with a correction factor taking the average excretion rate and the ratio of molecular weight 
between the parent drug to its metabolite into account (Table S- 24 of the Supporting Information); 
and (c) the consumed amount is normalized to a population size to result in the collective 
consumption of the population ((mg/ day)/(1000 people)). We chose, when analytically possible, 
two drug residues (i.e., dual tracers, the unchanged parent drug and metabolite) to back-estimate 
consumption of the parent drug (Table S- 22 of the Supporting Information): cocaine and 
benzoylecgonine, respectively, for estimation of cocaine; methamphetamine and amphetamine, 
respectively, for estimation of methamphetamine (as illicit amphetamine use is rare in 
Australia);((ACC) 2013) and only MDMA (3,4-(methylenedioxy)-methamphetamine) itself for 
estimation of MDMA. These targeted residues have been demonstrated to be adequate for back-
estimating consumption of the corresponding parent drug; see, e.g., refs (Zuccato et al. 2008), 
(van Nuijs et al. 2011a), and (Khan and Nicell 2011, 2012, Zuccato et al. 2011). Consistent 
patterns and consumption rates obtained from the two residues allow veriﬁcation of the reliability 
of the estimate of the parent drug.(Lai et al. 2011) 
App. 6.2.5 Uncertainty Analysis.  
Previous studies have revealed the uncertainty components associated with the back- estimation 
methodology of WBDE.(Castiglioni et al. 2014),(Lai et al. 2011) Five components were considered 
for contribution to the overall uncertainty (Utot) for the ﬁnal estimate of population-normalized drug 
consumption (PNDC; (mg/day)/(1000 people)); we refer to the Utot(de jure) as the total uncertainty 
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of the de jure-PNDC and Utot(de facto) as the total uncertainty of the de facto-PNDC. These 
encompass uncertainties related to sampling (US), chemical analysis (UC), ﬂow measurements 
(UF), excretion rates (UE), and population size (UP). The magnitude of each uncertainty 
component is presented as relative standard deviations (RSD, %)8 as determined from modelling 
results for US and UP, interday variability of instrumental analysis for UC, literature data for UE, and 
estimates from WWTP operators for UF (Table S- 19). These uncertainty components are 
independent from each other, because they arise from individual aspects of studies and the 
methods of calculating them. As the primary metabolite chosen for back-estimating consumption 
of the three illicit drugs is relatively stable under typical sewer conditions,(Thai et al. 2014a) we 
therefore consider the uncertainty of in-sewer chemical biodegradation as negligible. This study 
used Monte Carlo simulation to estimate Utot as described previously.(Jones et al. 2014, Ort et al. 
2014a) Linear error propagation as suggested earlier, see, e.g., ref (Lai et al. 2011), only provides 
a good approximation of Utot if UP is small and also other uncertainty components do not exceed a 
certain value. Otherwise the linear error propagation tends to systematically underestimate Utot. 
App. 6.2.6 Statistics.  
Nonparametric Mann−Whitney tests (unpaired) were used to examine signiﬁcant diﬀerences 
between weekdays and weekends for the estimated de facto populations and for illicit drug 
consumption. Nonparametric Wilcoxon tests (paired) were used to assess signiﬁcant diﬀerences 
between population-normalized consumption based on de jure and de facto populations. The 
statistics were performed using GraphPad Prism (version 6.00, GraphPad Software Inc.). 
 
App. 6.3 Results and Discussion 
App. 6.3.1 Estimated Day-Speciﬁc de Facto Populations.  
The de facto population for individual days was estimated in a range between 96,400 and 466,000 
(minimum−maximum; 90% interquantile, 96,400−304,000 (25% of all days were outside this 
range)), with an average of 280,000 persons and a variation (CV) of 15.6% throughout 311 
monitoring days (Figure S- 13A). The variation of our data is similar to that reported in Brussels 
over 235 days (CV, 18%; 90% interquantile, 495,000− 1,040,000 (25% of all days outside this 
range)).(van Nuijs et al. 2011c) We observed a mild seasonal variation in the estimated de facto 
population in the catchment: it gradually increased from approximately 264,000 to 284,000 
persons (monthly average; Table S- 25 of the Supporting Information) between July and 
September, remained at about 300,000 persons from October to December 2011, was recorded 
as the highest estimate of 310,000 persons in January 2012, and then slowly decreased from 
294,000 persons in February to 243,000 persons in June 2012. The yearly average de facto 
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population on the weekends (∼280,000 persons) was similar to that during the weekdays 
(∼278,000 persons) over the study period, as were most of the months (Figure S- 13A). The 
variation (CV) of the estimated de facto population among individual week days was relatively 
lower for Monday (13%), Friday (14%), and Sunday (13%) but slightly higher for Saturday (18%) 
and from Tuesday to Thursday (16−17%). There was also a signiﬁcant diﬀerence in the estimated 
de facto populations between Sundays and Wednesdays−Saturdays (p = 0.005−0.03) and 
between Mondays and Tuesdays−Saturdays (p < 0.0001−0.005). 
 
App. 6.3.2 Comparison between Two Diﬀerent Population Estimates.  
The estimated de facto population (∼280,000 people) is on average about 32% higher than the de 
jure population (i.e., ∼211,000 people on the Census Day) (Figure S- 13B). For almost all days, 
the estimated de facto population was higher than the de jure population (Figure S- 13A). The 
diﬀerence ranged from +2.1 to +120% (Figure S- 13B). On only 17 days was the estimated de 
facto population lower than the de jure population, ranging from −2.8 to −54% (Figure S- 13B). 
The overall diﬀerences between the estimated de facto population and the de jure population 
appear reasonable because the studied catchment is one of the most urbanised areas in South 
East Queensland and it is a popular destination for domestic and international visitors with many 
resorts, music festivals, theme parks, and tourist attractions that operate throughout the year. 
High commuting ﬂow is thus common in the catchment area. While the diﬀerence between the 
estimated de facto population and the de jure population is in a range of 22− 44% (25−75 
percentile) for half of the monitoring days (Figure S- 16 of the Supporting Information), there were 
some days on which there was a substantial increase or decrease in the estimated de facto 
population compared to the de jure population (Figure S- 13B). For example, an elevated de facto 
population was estimated on Nov. 28, 2011 (+101%, Figure S- 13B), Jan. 26, 2012 (+120%, 
Figure S- 13B) and Jan. 30, 2012 (+94%, Figure S- 13B). We noticed a coincidence between a 
high rainfall level recorded from Jan. 23, 2012 to Jan. 30, 2012 (peak rainfall on Jan. 25, 2012 
with ∼230 mm)(Government) and an increase in the de facto population on Jan. 26, 2012 and 
Jan. 30, 2012. However, it should be noted that the de facto population, estimated based on the 
daily mass loads of the high-use chemicals, cannot be driven by the increase in wastewater 
volumes and is independent of the dilution factor, as long as the lowered concentrations of the 
chemicals are still above the quantiﬁcation limits. This can be seen from the data, for example, on 
Mar. 4, 2012 and Mar. 29, 2012, when increased wastewater volumes due to rainfall around these 
days (Figure S- 17A) did not result in an increase in estimated de facto population (Figure S- 
13A,B). Higher de facto population estimates may reﬂect either an increase in per capita 
consumption of the high-use chemicals or more people being present who consume the usual per 
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capita amount of the chemicals. The observed elevated de facto population appears reasonable 
because (a) every November is a special period when young teenagers gather in this urban 
catchment to celebrate their completion of secondary school and (b) the 26th of January is the 
Australia Day public holiday, so the catchment attracts a lot of people for holidays and celebration 
activities. On some of the monitoring days, the estimated de facto population was substantially 
lower than the de jure population (Figure S- 13A), for example, the data on Jan. 24, 2012 (−48%, 
Figure S- 13B) and Apr. 28, 2012 (−54%, Figure S- 13B). Heavy rainfall events were recorded in 
the catchment around those 2 days. This may have led to a diversion of wastewater (combined 
sewer overﬂows), resulting in substantially decreased mass loads of high-use chemicals entering 
the WWTP. However, PNDC is still thought to be unbiased as explained at the end of the next 
section. 
App. 6.3.3 Eﬀects on PNDC Using Diﬀerent Population Estimates.  
The deviation between the de facto-PNDC and the de jure-PNDC is calculated as the following: 
deviation/% = drug loads𝑑𝑑𝑒𝑒 𝑓𝑓𝐷𝐷𝑐𝑐𝑐𝑐𝑐𝑐 population −  drug loads𝑑𝑑𝑒𝑒 𝑗𝑗𝑐𝑐𝑒𝑒𝑒𝑒 population
𝑑𝑑𝑒𝑒𝑐𝑐𝑚𝑚 𝐷𝐷𝑐𝑐𝐷𝐷𝑑𝑑𝑐𝑐
𝑑𝑑𝑒𝑒 𝑗𝑗𝑐𝑐𝑒𝑒𝑒𝑒 population  = � 𝑑𝑑𝑒𝑒 𝑗𝑗𝑐𝑐𝑒𝑒𝑒𝑒 population
𝑑𝑑𝑒𝑒 𝑓𝑓𝐷𝐷𝑐𝑐𝑐𝑐𝑐𝑐 population − 1� × 100 
This gives negative deviations (−2 to −54.6%) for most of the monitoring days (Figure S- 13C) 
since the PNDC is reduced when the drug load is normalized to the estimated de facto population 
which is greater than the de jure population. By contrast, the deviation becomes positive (+2.9 to 
+119%) when the drug load is normalized to an estimated de facto population that is smaller than 
the de jure population (Figure S- 13C). There were significant differences (p < 10−4) between the 
de facto population normalized and de jure population normalized consumption of the three illicit 
drugs. Over the monitoring period, the PNDC based on the estimated de facto populations was 
systematically lower by 22% (Figure S- 13C) because the average de facto population was 32% 
higher than the de jure population (Figure S- 13B). This indicates that the model of estimating the 
de facto populations allows for the assessment of how systematic differences in the population 
drug consumption are related to changes in the number of people who contributed in the sampled 
wastewaters in the studied catchment. While there were absolute differences in the PNDC 
estimated using the two different population estimates, the relative day-to-day pattern of 
consumption for the three illicit drugs did not significantly change over the monitoring period 
(Figure S- 19 of the Supporting Information). The variation of PNDC was very similar, regardless 
of whether one used the estimated de facto or de jure population (de facto/de jure: for cocaine, 
55%/59%; for methamphetamine, 38%/37%; for MDMA, 132%/138%) (CV, in Table S- 26 of the 
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Supporting Information). The same was true for variations between weekdays and weekends over 
the year (Table S- 26 of the Supporting Information). Our data are in line with those of a recent 
study(Ort et al. 2014a) which summarized and reported that only a small variation in a PNDC was 
observed between estimates made using de jure and de facto populations. For example, in 
Brussels, using hydrochemical parameters for de facto populations and census for de jure 
populations (census = 1.1 million people), the CVs for PNDC differed only slightly (de facto/de 
jure: for cocaine, 33%/31%; for methamphetamine, 40%/41%; for MDMA, 180%/186%).(van Nuijs 
et al. 2011c) Our data also follow the result of another recent study which revealed consistent 
patterns of per capita illicit drug use between using census data (de jure 220,000 persons) and 
estimated population numbers using ammonium ions in the urban area of Lausanne, 
Switzerland.(Been et al. 2014) These coherent findings among international studies in large 
catchments indicate that the consumed mass of illicit drugs varies more substantially than the 
population, and consequently, relative temporal changes of population drug consumption usually 
persist irrespective of the type of population estimates used for normalization. This may not be the 
case for small catchments and days with special events. Despite the absence of large variations 
in the overall day-today patterns, we observed 19 days with substantially higher or lower 
differences between the population’s drug consumption using the two different population 
estimates (Figure S- 20 of the Supporting Information). Those exceptional days indicate that a 
day-specific de facto population estimate is essential when estimating a PNDC on a single day. 
Our data suggest that it is hard to predict when substantial variations in de facto populations 
happen since those exceptional days were randomly detected and not simply related to specific 
events in the catchment. The deviations in population drug consumption on these 19 days may 
have been due to (a) the “normal number” of people increasing or decreasing their overall 
consumption of the eight high-use chemicals, (b) a substantial increase or a decrease in the 
number of people consuming the “average per capita amount” of the high-use chemicals, or (c) 
unusual operational conditions in the sewer network affecting influent loads in the WWTP. 
Unfortunately, it is not possible to differentiate reasons (a) and (b). However, the values observed 
outside the “normal range of de facto population” indicate that the results of these few days should 
be interpreted cautiously. When using the de jure population, such “caution indicators” are 
missing. An example for reason (c) with “unusual operational conditions” was observed by van 
Nuijs et al.:(van Nuijs et al. 2011c) a de facto population which was less than 10% of the “normal” 
de facto population was estimated because an unreported amount of wastewater did not enter the 
influent of the WWTP where samples were taken. This does not imply that only 10% of the 
population were in the catchment but simply that only 10% of the normal wastewater volume was 
sampled and used to calculate a de facto population. Since the illicit drug loads were also 
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quantified for 10% of the wastewater only, the PNDC was not affected. However, if the de jure 
population had been used, a substantial underestimation during the days with unusual operational 
conditions would have resulted; unless one had corrected for the missing wastewater volume, 
assuming that the non-sampled wastewater volumes showed similar concentrations (for both illicit 
drugs and substances to estimate de facto population). In a similar way, faulty flow measurements 
do not affect PNDC when the de facto population is estimated from chemical loads based on the 
same sample and wastewater volumes as illicit drug residues.(Lai et al. 2011) 
App. 6.4 Temporal Variations.  
App. 6.4.1 Cocaine.  
Both cocaine and its major urinary metabolite, benzoylecgonine, were measured in all samples 
and used to back-estimate cocaine consumption in the catchment. The yearly average 
consumption (25−75 percentile; median) of cocaine was estimated at 264 (mg/day)/(1000 people) 
(162−315; 230) using cocaine itself and 193 (mg/day)/(1000 people) (108−249; 167) using 
benzoylecgonine. This is equal to, on average, approximately two doses in a day among 1000 
people, assuming that the reference dose of cocaine is 100 mg.(Lai et al. 2013a) 
Benzoylecgonine has been recommended as the key biomarker for back-estimating cocaine 
consumption because it is exclusively excreted by humans and more persistent in wastewater 
than cocaine.(Castiglioni et al. 2011, Thai et al. 2014a, van Nuijs et al. 2009a, van Nuijs et al. 
2012) We thus used benzoylecgonine to assess the temporal pattern of cocaine consumption in 
the studied catchment. The overall variation of cocaine consumption in this study (55%, Table S- 
26 of the Supporting Information) was about twice that reported in Brussels.(van Nuijs et al. 
2011c) Cocaine consumption showed a gradual increasing pattern over the monitoring period 
(Figure S- 14A, Table S- 25 of the Supporting Information). Epidemiological indicators of cocaine 
use during this period are scant but generally suggest that there was limited use and stable 
markets since there was little change in hospital admissions, information calls, or self-reported 
substance use (among injecting drug and club drug consumers) in surveillance studies.(Hickey et 
al. 2011, McIlwraith et al. 2012a, McIlwraith et al. 2012b) However, analyses of the small number 
of cocaine seizures suggested that purity increased during April−June 2012 compared with 
previous months in this period.((ACC) 2013) The weekly pattern of cocaine consumption was 
consistent across the time period (Figure S- 14A). The average consumption of cocaine on the 
weekends (299 (mg/day)/(1000 people)) was approximately two times higher than that during the 
weekdays (149 (mg/day)/(1000 people)) (p < 10−4). This implies that, on the weekends, there was 
either a larger amount of cocaine consumed by the same number of regular users and/or an 
increase in the number of consumers who used a similar amount/dose within the catchment. Drug 
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purity was irrelevant to the weekly pattern because it is highly unlikely that there would be marked 
variations in drug purity within the week and the weekly pattern is clear regardless of the general 
level of consumption. Given the urban location of the studied site, there were a number of speciﬁc 
events, such as car races, sport competitions, music concerts/festivals and New Year 
celebrations, during the monitoring period. Elevated consumption of cocaine coincided with some 
of the major events in the catchment (Figure S- 14A). The eﬀect of the major events on cocaine 
consumption was more pronounced than the weekend eﬀect; for example, the level of cocaine 
use on the second-last weekend of October 2011 and on the 2012 New Year’s Day (Sunday) was 
well above the levels seen for weekends in most of the months (Figure S- 14A). This is also 
observed for another sampling day which was Sunday on the ﬁrst weekend of May 2012. It is 
noteworthy that the overall patterns of cocaine consumption estimated from cocaine itself and 
benzoylecgonine were very similar, except for a spike in cocaine consumption estimated from 
cocaine itself in one Thursday sample in February 2012 and one Tuesday sample in May 2012 
(Figure S- 21A of the Supporting Information). This suggests that there may have been direct 
release of cocaine into the wastewater system on these 2 days. Environmental inputs of cocaine 
can arise from, for example, disposal of cocaine, which provides amounts of cocaine in sewage 
systems well above those from human consumption and results in overestimation of cocaine 
consumption using wastewater samples.e.g.(Brewer et al. 2012),(Castiglioni et al. 2011) This can 
also potentially explain the observed diﬀerence (an average relative diﬀerence of 30%) between 
two estimates in this study (higher consumption when using cocaine itself rather than 
benzoylecgonine) and also slightly higher cocaine/benzoylecgonine ratio in the wastewater 
samples (an average of 0.34) than that in human pharmacokinetic data (0.21 from 7.5%/ 35%; 
see Table S- 24 of the Supporting Information). Variations in metabolism among individuals and 
mode of administration can also lead to changes in excretion proﬁles of cocaine, and therefore 
aﬀect the diﬀerence in the cocaine/benzoylecgonine ratio between the population in the studied 
catchment and that in pharmacokinetic studies; see, e.g., refs (van Nuijs et al. 2009b) and (van 
Nuijs et al. 2009c). As noted elsewhere,(Prichard et al. 2012) the use of such a dual tracer 
approach (i.e., both parent drugs and metabolites) gives additional conﬁdence in the results and 
may serve as a quality-control check providing information about potential 
breakdown/transformation of the compounds in the sewers (i.e., higher estimate from metabolites) 
or releases of unconsumed drugs (i.e., higher estimates using the parent compound).  
App. 6.4.2 Methamphetamine.  
As the primarily excreted metabolite, methamphetamine itself was chosen to back-estimate 
methamphetamine consumption. The average yearly consumption (25−75 percentile; median) of 
methamphetamine was estimated at 440 (mg/day)/(1000 people) (312− 549; 391).This is 
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equivalent to approximately 14 (doses/day)/(1000 people), assuming that a reference dose of 
methamphetamine of 30.5 mg.(Lai et al. 2013a) The use of methamphetamine appeared more 
prevalent than that of cocaine in the catchment, and the variation in methamphetamine 
consumption (38%) was smaller than that of cocaine consumption over the whole monitoring 
period (Table S- 26 of the Supporting Information). The yearly consumption pattern of 
methamphetamine (Figure S- 22A and Table S- 25 of the Supporting Information) was similar to 
that of cocaine (Figure S- 14A). Most epidemiological data in relation to methamphetamine are 
only compiled in annual aggregates but are generally in keeping with these trends: police seizures 
increased during 2011/-12 in both number and weight, as did the number of clandestine 
laboratories identiﬁed;((ACC) 2013) self-reported frequency of use among club drug consumers 
increased and so did the number of calls made about methamphetamine to information lines and 
hospital admissions.(Hickey et al. 2011, McIlwraith et al. 2012a) Analysis of police seizures 
demonstrated steady increases in purity over the ﬁrst three-quarters of the 2011/12 period. ((ACC) 
2013) There was higher consumption of methamphetamine on the weekends (average, 523 
(mg/day)/(1000 people)) than the 
weekdays (406 (mg/day)/(1000 people)) throughout the year (Figure S- 14B) (p < 10−4); the 
average diﬀerence was only about 1.3 times which is less than that for cocaine consumption. A 
few days of elevated methamphetamine consumption were captured around speciﬁc events in the 
catchment (Figure S- 22A of the Supporting Information). As for cocaine consumption, we also 
analyzed amphetamine as another drug residue for the estimation of methamphetamine 
consumption. Both amphetamine and methamphetamine itself estimated a similar pattern of 
methamphetamine consumption (an average relative diﬀerence of 17%) over the monitoring 
period (Figure S- 21B of the Supporting Information). The consistency of estimating 
methamphetamine consumption from both amphetamine and methamphetamine itself supports 
other evidence that illicit use of amphetamine is negligible in Australia;((ACC) 2013) hence, 
amphetamine measured in the samples was primarily from the metabolism of methamphetamine 
consumption. 
App. 6.4.3 MDMA.  
For MDMA, only one excreted residue can be analytically identiﬁed with conﬁdence; thus, 
estimating MDMA consumption relies solely on MDMA itself as described in the 
literature.e.g.(Thomas et al. 2012) The average consumption (25−75 percentile; median) of 
MDMA was estimated at about 229 (mg/day)/ (1000 people) (75−277; 145) over the year. This is 
equivalent to an average of three doses a day per 1000 people, assuming a reference dose of 
80.5 mg.(Lai et al. 2013a) Two discrete rising consumption periods of MDMA were observed: 
June 2011−January 2012 and February−May 2012 (Figure S- 22B and Table S- 25 of the 
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Supporting Information). Epidemiological indicators of MDMA consumption increased in this 
period, with self- reported frequency of use among club drug consumers increasing along with 
perceived purity.(Hickey et al. 2011, McIlwraith et al. 2012a) Analysis of police seizures 
demonstrated that purity increased between the third and fourth quarters of 2011, declining in the 
ﬁrst quarter of 2012 and increasing in the second quarter of 2012.((ACC) 2013) While these purity 
data are based on a restricted number of seizures, the general pattern is consistent with the 
ﬂuctuations detected in the wastewater samples in this study (Figure S- 22B of the Supporting 
Information). A strong weekend eﬀect was observed on MDMA consumption similar to that for 
cocaine. It was approximately two times higher on weekends (yearly average, 347 (mg/day)/ 
(1000 people); Table S- 25 of the Supporting Information) than on weekdays (181 (mg/day)/(1000 
people)) (p < 10−4). This pattern of use is consistent with trends reported in consumer studies. 
(Hickey et al. 2011, Hopper et al. 2006, McIlwraith et al. 2012a) A few spikes were identiﬁed in the 
quantities of MDMA consumed over the study period (Figure S- 22B of the Supporting 
Information). Some of these spikes coincided with major events in the catchment, conﬁrming 
previous ﬁndings of links between MDMA use and musical entertainment events.(Sindicich 2013, 
Van Havere et al. 2011)  
App. 6.5 Overall Methodological Uncertainty.  
Three diﬀerent evaluations were performed to calculate the total uncertainty (Utot) of PNDC (Table 
S- 19). First, the components UC, US, UF, and UE are typically considered for Utot. Often, UP is 
unfortunately excluded because it is unknown and obtaining a realistic, independent, and site-
speciﬁc estimate is diﬃcult. Applying Monte Carlo simulation, the average Utot was estimated at 
approximately 22% for the three illicit drugs over the monitoring period (see Table S- 19 for details 
and range), in which UF is the most dominant uncertainty component. This estimate was similar to 
our previous ﬁnding for this urban catchment.(Lai et al. 2011) Second, when considering a 
conservative value of 50% (range 7−55%, according to Castiglioni et al.)(Castiglioni et al. 2013) 
for UP-analogue to the uncertain knowledge of population (wide prior) used for Bayesian updating 
in the population estimation model(O'Brien et al. 2014)-Utot(de jure) would be approximately 57% 
for the three illicit drugs, in which UP becomes the dominating uncertainty factor. Third, as 
mentioned previously, the daily de facto population is estimated from chemical mass loads which 
are calculated with the same daily ﬂow data as the daily illicit drug loads. Thus, UF aﬀects both 
daily de facto population estimates and illicit drug loads in the same way and cancels out when 
calculating PNDC. For calculating de facto-PNDC, the Utot(de facto) is, therefore, based on US, 
UC, UE, and UP. For UP, the multi-substance model estimated an average of 3.5% over the 
monitoring period (posterior of population estimation(O'Brien et al. 2014)). The average Utot(de 
facto) is then estimated at approximately 10% for all compounds (Table S- 19). 
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There was a distinctive diﬀerence among a typical Utot, Utot(de jure), and Utot(de facto) for the 
three illicit drugs over the monitoring period (Figure S- 14 and Figure S- 23 and Figure S- 24 of 
the Supporting Information). The levels of Utot for estimating cocaine consumption was clearly 
diminished in a decreasing order as follows: Utot(de jure) (Figure S- 14C) > a typical Utot (Figure S- 
14B) > Utot(de facto) (Figure S- 14A). The same holds true for estimating methamphetamine and 
MDMA consumption (Figure S- 23 and Figure S- 24 of the Supporting Information). Our data 
clearly revealed a substantial reduction in the Utot when a dayspecific de facto population was 
estimated from chemicals in the same sample as used to measure illicit drug residues. A 
European-wide study estimated about 26% (a typical Utot) as the uncertainty of estimating cocaine 
consumption.(Castiglioni et al. 2013) A similar level was also estimated in our study, but our data 
reflected a much lower level when using the daily estimated de facto populations. This study 
showed an objective quantification of the total methodological uncertainty and achieved a 
substantial reduction thereof. In our case, the total uncertainty of the de facto-PNDC was reduced 
by a factor of 2 because of (i) eliminating the uncertainty of flow measurements and (ii) performing 
a unique assessment of uncertainty related to the population size. Whether or not the effort to 
reduce the total methodological uncertainty from about 20% to 10% for a daily value is justified, 
there remains an open discussion and it depends on the specific application and setting. 
However, it appears that avoiding a systematic over- or underestimation of PNDC - which 
normally remains undiscovered - is highly desirable, particularly when comparing consumption 
data across different locations. With a dataset that covers a much shorter duration and does not 
cover consecutive days, we could have not derived these findings and substantiated our 
conclusions. This also holds true for the identification of monitoring days that require more 
attention for interpretation. In combination with previously summarized long-term studies,(Ort et al. 
2014a) our study offers guidance to optimize future monitoring campaigns where financial or 
logistic reasons limit the numbers of sampling days for evaluation. A remaining challenge is to 
interpret an estimated population of, e.g., 100,000 people, as different settings could have led to 
this result: (1) 100,000 people all being present in a catchment over 24 h and having used the 
toilet an average of five times; or (2) 500,000 people in transit through the catchment area using 
the toilet an average of only once in the day, as an extreme opposite. Both situations would result 
in approximately 500,000 toilet flushes.  
 
App. 6.6 Supporting Information 
Text describing calculation information for back-estimation of illicit drug consumption, tables listing 
dates of missing representative samples, a summary of LC-MS/MS analysis data, quality 
assurance, and control samples for illicit drug residues and high-use chemicals, estimated de 
216 
 
facto populations, pharmacokinetic data of three conventional illicit drugs, population and 
consumption data for cocaine, methamphetamines, and MDMA, and CVs of consumption 
between de jure and estimated de facto populations, and figures showing Mann−Whitney test 
comparison between weekends and weekdays for estimated de facto populations and drug 
consumption, percentage differences between estimated de facto and de jure populations, daily 
concentrations of high-use chemicals for estimating de facto population and wastewater volume, 
high-use chemical concentrations vs flow rate, and various drug consumption comparisons. 
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App. 6. Figures: 
 
Figure S- 13 (A) Estimated daily de facto populations from the wastewater samples over the monitoring period (orange solid line, the de 
jure population of 211,340 persons). (B) Percentage diﬀerences between the daily de facto population and the de jure population (i.e., 
differences of the two estimates divided by the de jure population). (C) Deviations (percentage differences) of per capita consumption rates 
between normalization to the estimated de facto population and the de jure population. This panel is different from that of panel B due to 
the fact that the population estimate inﬂuences the population-normalized estimates by (de jure/de facto − 1) (see section 3.3 for details). 
Black bars along the X-axis = missing date (see Table S- 20 of the Supporting Information); triangles along the X-axis = days with special 
dates/events. Figure S- 15 of the Supporting Information shows a direct comparison of data between the weekends and weekdays for 
panel A (see Table S- 25 of the Supporting Information for the numerical data of the monthly average and the average over the entire 
monitoring period). 
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Figure S- 14 Estimated population-normalized consumption for cocaine considering diﬀerent population estimates and uncertainty 
components: (A) de facto population normalized consumption with Utot(de facto) = US + UC + UE + UP(de facto); (B) de jure population 
normalized consumption with a typical Utot = US + UC + UE + UF; (C) de jure population normalized consumption with Utot(de jure) = US + UC + 
UE + UF + UP(de jure). Black bars along the X-axis = missing dates (see Table S- 20 of the Supporting Information); triangles along the X-axis = 
days with special dates/events. Figure S- 15 of the Supporting Information shows a direct comparison of data between the weekends and 
weekdays for A (see Table S- 25 of the Supporting Information for the numerical data of the monthly average and the average over the 
entire monitoring period). 
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App. 6. Tables: 
 
Table S- 19 Evaluation of the Total Methodological Uncertainty (RSD %) for Estimating Illicit Drug Consumption between 
Normalization to the de Jure Population and the Estimated de Facto Population Using Monte Carlo Simulation 
 cocaine methamphetamine MDMA 
with de jure 
populations 
UP 
ignored 
UP 
considered 
UP 
ignored 
UP 
considered UP ignored 
UP 
considere
d 
US 5 5 5 5 5 5 
UC 7.1 7.1 5.1 5.1 9.8 9.8 
UF 20 20 20 20 20 20 
UE 1.9 1.9 0.82 0.82 2.3 2.3 
UP n.a. 50 n.a. 50 n.a. 50 
Utot 22 (22−23) 57 (54−61) 
21 
(21−22) 56 (53−62) 
23 
(23−24) 
57 
(55−62) 
with de facto 
populations             
US   5   5   5 
UC   7.1   5.1   9.8 
UF   −   −   − 
UE   1.9   0.82   2.3 
UP   3.5 (2.1−9.7)   
3.5 
(2.1−9.7)   
3.5 
(2.1−9.7) 
Utot   9.6 (9.1−13)   
8.0 
(7.5−12)   
12 
(11−15) 
an.a., not applicable; −, uncertainty of flow cancels out for population-normalized drug loads 
since de facto population estimate is affected in the same way as illicit drug loads. See Lai et 
al.8 for the details of quantifying the uncertainty components. 
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The equation of the back-estimation of illicit drug consumption (mg/day/1000p): 
 
 
Concentrations of drug residue in the samples are analysed using validated methods with LC-MS/MS.(Lai et al. 2011) Daily wastewater flow 
volume is measured and provided by the wastewater treatment plant. Correction factors are related to the average and molar excretion fraction 
of the parent drug or the metabolite (see details in Lai et al. (2013)(Lai et al. 2013a)). Day-specific populations are estimated through a multi-
substance model (see details in O’Brien et al. (2014)(O'Brien et al. 2014)). 
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Table S- 20 Dates of missing representative samples due to logistic or technical reasons 
 
15/07/2011 18/11/2011 
8/08/2011 19/11/2011 
9/08/2011 20/11/2011 
20/09/2011 21/11/2011 
2/11/2011 22/11/2011 
3/11/2011 29/11/2011 
4/11/2011 23/12/2011 
5/11/2011 9/01/2012 
6/11/2011 22/01/2012 
7/11/2011 12/02/2012 
8/11/2011 21/02/2012 
9/11/2011 6/03/2012 
10/11/2011 27/03/2012 
13/11/2011 31/03/2012 
14/11/2011 6/04/2012 
15/11/2011 15/05/2012 
16/11/2011 
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Table S- 21 Summary of LC-MS/MS information on analysing illicit drug residues and high-use chemicals 
 Illicit drug residues High-use chemicals 
LC system  Shimadzu, Nexera UHPLC system (Kyoto, Japan) 
LC columna Luna C18, 150X3 mm, 3 μm Kinetics C18, 100X4 mm, 2.6μm 
Mobile phase 
1% acetonitrile in 0.1% formic acid 
(A) 
95% acetonitrile in 0.1% formic acid 
(B) 
Milli-Q water in 0.1 % formic acid (A) 
95% acetonitrile in 0.1 % formic acid 
(B) 
Flow rate (mL/min) 0.3 0.7 
LC gradient 
 
Start at 8% B, 
ramped up to 35% at 3.5 min, 
increased to 100% B at 7 min, 
held 100% B for 4 mins, 
declined to 8% B, equilibrate for 3 
mins 
Start at 0.2% B, 
ramped up to 100% B at 5 min, 
held 100% B for 0.25 mins, 
declined to 0.2% B, equilibrate for 3 
mins 
Injection volume 
(µL)  
 
8 2 
Mass spectrometry AB SCIEX QTRAP®5500 (Ontario, Canada) 
Calibration 
standards 
0.05, 0.5, 1, 5, 10, 50 ng/mL 0.05, 0.1, 0.5, 1, 5, 10, 50 ng/mL 
Ionisation modes Positive ESI Switching positive and negative ESI 
Monitoring modes MRM with two transitions 
(Scheduled) 
MRM with two transitions (full scan) 
aPhenomenex, Torrance CA, USA. 
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Table S- 22 Quality assurance and control samples for analysis of illicit drug residues and high-use chemicals 
 Blank samplesa 
(n=15) 
  
 
Duplicate 
samples 
(n=29) 
Matrix spike recovery (%) (n=28) 
 
Inter-day 
variability (n=2, 3 
days) 
 Concentrations 
(μg/L) 
Average CV 
(%) 
Mean SD CV 
(%) 
CV (%) 
Illicit drug resides       
Cocaine <0.01 4.8 76 15 20 2.3 
Benzoylecgonine <0.01 5.7 75 16 21 7.1 
Amphetamine <0.01 7.9 81 10 13 11 
Methamphetamine <0.01 5.7 80 13 16 5.1 
MDMA <0.01 5.7 81 11 14 9.8 
 Blank samplesa 
(n=15) 
Duplicate 
samples 
(n=40) 
Matrix Spike recovery % (n=35) 
 
Inter-day 
variability (n=1, 3 
days) 
 Concentrations 
(μg/L) 
Average CV 
(%) 
Mean SD CV 
(%) 
CV (%) 
High-use 
chemicals 
      
Atenolol <0.1 9.4 108 17 16 8.6 
Codeine <0.5 8.6 103 15 15 7.6 
Caffeine <0.5 7.2 112 32 28 21 
Hydrochlorothiazid
e 
<1.0 9.4 103 13 13 9.0 
Acesulfame <5.0 5.9 113 26 23 4.7 
Salicylic acid <1.0 6.6 99 14 14 16 
Carbamazepine <0.05 4.2 99 6.8 6.8 6.8 
Naproxen <1.0 6.4 102 10 10 13 
a Milli-Q water as procedural blank samples; SD: standard deviation; CV: coefficient variation 
Internal standards used: cocaine-D3 (for cocaine), benzoylecgonine-D3 (for benzoylecgonine), 
amphetamine-D6 (for amphetamine), methamphetamine-D9 (for methamphetamine), MDMA-D5 
(for MDMA), atenolol-D7 (for atenolol), codeine- D3 (for codeine), caffeine-13C (for caffeine), 
hydrochlorothiazide-13C-D2 (for hydrochlorothiazide), acesulfame-D4 (for acesulfame), acetyl 
sulfamethoxazole-D4 (for salicylic acid and naproxen) and carbamazepine-D10 (for 
carbamazepine). 
 
 
 
 
 
 
225 
 
 Table S- 23 Estimated de facto populations using 8 chemicals or 14 chemicals. 
  8 chemicals   14 chemicals  
 Estimated 
population 
Standard 
derivation 
Relative standard 
deviation (%) 
Estimated 
l i  
Standard 
d i i  
Relative 
d d 
  
24/07/2011 280964 9541 3.40 280964 9437 3.36 
28/07/2011 169639 9441 5.57 169639 9411 5.55 
2/08/2011 198795 9465 4.76 198795 9484 4.77 
26/08/2011 280964 9398 3.35 280964 9446 3.36 
27/08/2011 214699 9427 4.39 214699 9462 4.41 
22/09/2011 280964 9535 3.39 280964 9576 3.41 
27/10/2011 196145 9431 4.81 196145 9404 4.79 
1/11/2011 196145 9422 4.80 196145 9470 4.83 
28/11/2011 426747 9461 2.22 426747 9590 2.25 
14/12/2011 137831 9355 6.79 137831 9305 6.75 
4/01/2012 180241 9444 5.24 180241 9402 5.22 
24/01/2012 111325 9308 8.36 111325 9324 8.38 
26/01/2012 463855 9508 2.05 463855 9407 2.03 
24/02/2012 180241 9397 5.21 180241 9487 5.26 
25/02/2012 164337 9335 5.68 164337 9336 5.68 
3/03/2012 169639 9442 5.57 169639 9340 5.51 
25/03/2012 182892 9384 5.13 182892 9478 5.18 
28/04/2012 95422 9234 9.68 95422 9239 9.68 
12/05/2012 206747 9416 4.55 206747 9520 4.60 
25/05/2012 172289 9329 5.41 172289 9449 5.48 
26/05/2012 217349 9366 4.31 217349 9422 4.33 
30/05/2012 164337 9424 5.73 164337 9276 5.64 
1/06/2012 182892 9521 5.21 182892 9352 5.11 
2/06/2012 198795 9427 4.74 198795 9483 4.77 
3/06/2012 214699 9407 4.38 214699 9532 4.44 
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 Table S- 24 Pharmacokinetic data of three conventional illicit drugs 
 
Parent drug Drug residue Average excretion 
 
Molecular weight 
 
Correction 
 Cocaine Cocaine Benzoylecgonine 7.5c–f 35c–f 1.0 
 
13 
 Methamphetamine   
 
 
39g–i 5.5g–i   
 
 
2.6 
 MDMA   
 
15j, k   
 
6.7 
aRatio of molecular weight of the parent drug to the drug residue; bMolecular mass ratio divided by average 
excretion; cAmbre 
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Table S- 25 Results (monthly average and average over entire period) of the estimated de facto population, population difference, 
consumption difference, cocaine consumption, methamphetamine consumption and MDMA consumption. Note: ‘mg’ in this table refers to 
the average amount per 1000 people per month and the average amount per 1000 people per the whole monitoring period. 
 Estimated de facto population  Cocaine consumption (mg) 
Monthly Monthly 
 
Monthly 
 
Monthly Monthly 
 
Monthly 
 2011 June 312,273 NA 312,273 2011 June 97 NA 97 
 July 263,983 271,601 260,174  July 158 235 120 
 August 263,237 260,547 264,261  August 173 293 127 
 Septembe
 
284,441 275,785 287,738  Septembe
 
180 295 137 
 October 299,501 303,133 297,771  October 193 305 139 
 November 290,628 296,259 288,516  November 113 186 86 
 December 286,098 295,609 282,022  December 192 284 152 
2012 January 309,942 310,636 309,678 2012 January 202 310 160 
 February 293,921 299,360 292,017  February 167 261 133 
 March 268,496 265,282 269,782  March 206 309 165 
 April 271,283 253,438 279,314  April 227 335 178 
 May 251,095 257,323 248,831  May 265 416 210 
 June 243,418 208,048 278,788  June 230 298 162 
 Entire 
 
279,522 278,286 280,026  Entire 
 
193 299 149 
 Population difference (%)  Methamphetamine consumption 
 
Monthly Monthly 
 
Monthly 
 
Monthly Monthly 
 
Monthly 
 2011 June 48 NA 48 2011 June 272 NA 272 
 July 25 29 23  July 360 445 317 
 August 25 23 25  August 389 481 354 
 Septembe
 
35 30 36  Septembe
 
393 487 358 
 October 42 43 41  October 373 469 328 
 November 38 40 37  November 290 344 270 
 December 35 40 33  December 325 396 294 
2012 January 47 47 47 2012 January 327 367 312 
 February 39 42 38  February 423 494 398 
 March 27 26 28  March 562 573 558 
 April 28 20 32  April 593 690 549 
 May 19 22 18  May 707 844 657 
 June 15 -2 32  June 684 799 568 
 Entire 
 
32 32 33  Entire 
 
440 523 406 
 Consumption difference (%)  MDMA consumption (mg) 
Monthly Monthly 
 
Monthly 
 
Monthly Monthly 
 
Monthly 
 2011 June -32 NA -32 2011 June 57 NA 57 
 July -19 -22 -18  July 92 135 71 
 August -19 -18 -19  August 129 242 86 
 Septembe
 
-25 -23 -26  Septembe
 
148 266 103 
 October -29 -30 -28  October 212 325 158 
 November -25 -28 -24  November 199 360 138 
 December -24 -28 -22  December 257 396 197 
2012 January -27 -32 -25 2012 January 393 398 391 
 February -25 -25 -25  February 161 301 112 
 March -19 -15 -21  March 214 367 153 
 April -18 -6 -23  April 276 477 186 
 May -14 -17 -13  May 431 580 377 
 June -6 2 -14  June 282 388 176 
 Entire 
 
-22 -21 -22  Entire 
 
229 347 181 
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Table S- 26 Coefficient variation (CV %) of illicit drug consumption between normalisation to the de jure population and the estimated de 
facto population. 
 
 Cocaine Methamphetamine MDMA 
With de jure populations 
Weekdays 54% 38% 177% 
Weekends 38% 30% 78% 
Whole period 59% 37% 138% 
With de facto populations 
Weekdays 50% 39% 172% 
Weekends 33% 32% 70% 
Whole period 55% 38% 132% 
Weekdays: Monday–Friday; Weekends: Saturday–Sunday. 
 
229 
 
 
Figure S- 15 A box plot for data comparison (Mann-Whitney test) between weekends and weekdays for the estimated de facto populations 
and drug consumption. A red cross indicates outliers which were defined as above or below three times of the interquartile range of the 
dataset. A circle shows an outlier data which represents the data of specific date/event. 
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Figure S- 16 Percentage differences between the estimated de facto population and the de jure population. Purple line 
represents the median. Blue line represents the inter-quartile range. Red circles represent outliers which were defined as above 
or below three times of the interquartile range of the dataset. 
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Figure S- 17 Daily concentrations (µg/L) of the high use chem
icals for estim
ating the de facto population 
and the daily total w
astew
ater volum
e (M
L) over the m
onitoring period. Correlations (Spearm
an test: r= -
0.51 to -0.62, p< 10-4) betw
een concentrations of these chem
icals and the flow
 rate are show
n in Fig. S3B. 
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Figure S- 18 Concentrations (μg/L) of the high-use chemicals against the flow rate. 
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Figure S- 19 Comparison of drug consumption between a normalisation to the estimated day-specific de facto population (the 
coloured lines) and the de jure population (the grey line) for cocaine estimated from cocaine itself (A) and benzoylecgonine (B); for 
methamphetamine estimated from amphetamine (C) and methamphetamine itself (D); and for MDMA estimated from MDMA 
itself (E). Strong correlation (Spearman test) was observed for drug consumption (A–E: r= 0.86–0.98, p<10-4) between a 
normalisation to the estimated day-specific de facto population and the de jure population. 
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1 5 0 
 
 
1 0 0 
 
 
5 0 
 
 
0 
 
 
- 5 0 
 
 
- 1 0 0 
 
 
- 1 5 0 
 
 
 
 
 
Outliers 
Date Day %difference 
28/07/2011 Thursday 25.2 
2/08/2011 Tuesday 6.8 
27/10/2011 Thursday 7.0 
1/11/2011 Tuesday 7.9 
28/11/2011 Monday -50.4 
14/12/2011 Wednesday 53.0 
4/01/2012 Wednesday 17.4 
24/01/2012 Tuesday 90.5 
26/01/2012 Thursday -54.6 
24/02/2012 Friday 16.8 
25/02/2012 Saturday 27.5 
3/03/2012 Saturday 24.6 
25/03/2012 Sunday 15.1 
28/04/2012 Saturday 119.2 
12/05/2012 Saturday 2.9 
25/05/2012 Friday 21.7 
30/05/2012 Wednesday 28.9 
1/06/2012 Friday 14.9 
2/06/2012 Saturday 5.6 
Figure S- 20 Percentage differences in consumption with normalisation to an estimated de facto population and a de 
jure population. Blue line represents the inter-quartile range. Red circles represent outliers which were defined as above or 
below three times of the interquartile range of the dataset. 
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Figure S- 21 Estimated de facto population-normalised drug consumption for cocaine estimated from cocaine itself and benzoylecgonine 
(A) (Spearman test: r= 0.91, p<10-4) and for methamphetamine estimated from amphetamine and methamphetamine itself (B) 
(Spearman test: r= 0.90, p<10-4). 
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Figure S- 22 Estimated de facto population-normalised consumption for methamphetamine (A) and MDMA (B). Black bars along X-axis = 
missing date (see Table S- 20); triangles along X-axis = days with special dates/events. Grey area indicates Utot(de facto)= 
US+UC+UE+UP(de facto). Figure S- 15 shows a direct comparison of data between the weekends and weekdays for A (see Table S- 25 for 
the numerical data of the monthly average and the average over the entire monitoring period). 
237 
 
  
 
Figure S- 23 Estimated population-normalised consumption for methamphetmine considering different population estimates 
and uncertainty components: A. de facto-population normalised consumption with Utot(de facto)= US+UC+UE+UP(de facto); B. de 
jure-population normalised consumption with a typical Utot= US+UC+UE+UF; C. de jure-population normalised consumption with 
Utot(de jure)= US+UC+UE+UF+UP(de jure). Black bars along X-axis = missing date (see Table S- 20); triangles along X-axis = days with 
special dates/events. 
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Figure S- 24 Estimated population-normalised consumption for MDMA considering different population estimates and 
uncertainty components: A. de facto-population normalised consumption with Utot(de facto)= US+UC+UE+UP(de facto); B. de jure-
population normalised consumption with a typical Utot= US+UC+UE+UF; C. de jure-population normalised consumption with 
Utot(de jure)= US+UC+UE+UF+UP(de jure). Black bars along X-axis = missing date (Table S- 20); triangles along X-axis = days with 
special dates/events. 
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